activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	506165	CHEMBL696186	Inhibition of protein kinase Hck	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	IC50	nM	7700.0	CHEMBL3234	Homo sapiens	IC50	uM	7.7
	506165	CHEMBL696186	Inhibition of protein kinase Hck	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	IC50	nM	7700.0	CHEMBL3234	Homo sapiens	IC50	uM	7.7
	512199	CHEMBL696187	Inhibition of Hck kinase	B	Cc1cccc(Cl)c1NC(=O)c1cnc(NC(=O)C2CC2)s1		CHEMBL131577	=	IC50	nM	310.0	CHEMBL3234	Homo sapiens	IC50	uM	0.31
	512208	CHEMBL696185	Selectivity against Hck kinase	B	Cc1cccc(Cl)c1NC(=O)c1cnc(NC(=O)C2CC2)s1		CHEMBL131577	=	Fold selectivity		10.0	CHEMBL3234	Homo sapiens	Fold selectivity		10.0
	1463598	CHEMBL828514	inhibitory activity against Hck kinase	B	Cc1cc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)nc(C)n1		CHEMBL364623	=	IC50	nM	2.0	CHEMBL3234	Homo sapiens	IC50	uM	0.002
	1466804	CHEMBL832905	Inhibition of Hck kinase	B	Cc1cccc(Cl)c1Nc1nc2ccc(N3CCN[C@@H](C)C3)nc2n2cncc12		CHEMBL189338	>	IC50	nM	23.0	CHEMBL3234	Homo sapiens	IC50	nM	23.0
	1474166	CHEMBL832690	Displacement of PRP-2 peptide from human Hck kinase SH3 domain by fluorescence polarization	B	Nc1ccc2ccccc2n1	Outside typical range	CHEMBL61236	>	EC50	nM	1000000.0	CHEMBL3234	Homo sapiens	EC50	uM	1000.0
Not Active	1650657	CHEMBL860887	Average Binding Constant for HCK; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL3234	Homo sapiens	Kd		
	1650658	CHEMBL860887	Average Binding Constant for HCK; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	2300.0	CHEMBL3234	Homo sapiens	Kd	uM	2.3
Not Active	1650659	CHEMBL860887	Average Binding Constant for HCK; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL3234	Homo sapiens	Kd		
	1650660	CHEMBL860887	Average Binding Constant for HCK; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	3300.0	CHEMBL3234	Homo sapiens	Kd	uM	3.3
Not Active	1650661	CHEMBL860887	Average Binding Constant for HCK; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL3234	Homo sapiens	Kd		
	1650662	CHEMBL860887	Average Binding Constant for HCK; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	2800.0	CHEMBL3234	Homo sapiens	Kd	uM	2.8
Not Active	1650663	CHEMBL860887	Average Binding Constant for HCK; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL3234	Homo sapiens	Kd		
Not Active	1650664	CHEMBL860887	Average Binding Constant for HCK; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL3234	Homo sapiens	Kd		
Not Active	1650665	CHEMBL860887	Average Binding Constant for HCK; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL3234	Homo sapiens	Kd		
	1651082	CHEMBL860887	Average Binding Constant for HCK; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	12.0	CHEMBL3234	Homo sapiens	Kd	uM	0.012
Not Active	1651083	CHEMBL860887	Average Binding Constant for HCK; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL3234	Homo sapiens	Kd		
Not Active	1651084	CHEMBL860887	Average Binding Constant for HCK; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL3234	Homo sapiens	Kd		
	1651085	CHEMBL860887	Average Binding Constant for HCK; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	uM	10.0
Not Active	1651086	CHEMBL860887	Average Binding Constant for HCK; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL3234	Homo sapiens	Kd		
Not Active	1651087	CHEMBL860887	Average Binding Constant for HCK; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Kd			CHEMBL3234	Homo sapiens	Kd		
Not Active	1651088	CHEMBL860887	Average Binding Constant for HCK; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL3234	Homo sapiens	Kd		
Not Active	1651089	CHEMBL860887	Average Binding Constant for HCK; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL3234	Homo sapiens	Kd		
Not Active	1651090	CHEMBL860887	Average Binding Constant for HCK; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL3234	Homo sapiens	Kd		
	1651091	CHEMBL860887	Average Binding Constant for HCK; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	4200.0	CHEMBL3234	Homo sapiens	Kd	uM	4.2
	1651092	CHEMBL860887	Average Binding Constant for HCK; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	5700.0	CHEMBL3234	Homo sapiens	Kd	uM	5.7
	1663201	CHEMBL863884	Inhibitory activity against hck	B	COc1cc(-c2nn([C@H]3CC[C@H](N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL197603	=	IC50	nM	1220.0	CHEMBL3234	Homo sapiens	IC50	uM	1.22
	1755925	CHEMBL868659	Inhibition of human recombinant Hck in presence of 10 mM ATP	B	CCN(CC)CCOc1ccc(Nc2ncc3c(n2)N2CCC(=O)N2C(c2c(Cl)cccc2Cl)=C3)cc1		CHEMBL379517	=	IC50	nM	48.0	CHEMBL3234	Homo sapiens	IC50	nM	48.0
	1755926	CHEMBL868659	Inhibition of human recombinant Hck in presence of 10 mM ATP	B	CN(C)c1ccc(Nc2ncc3c(n2)N2CCC(=O)N2C(c2cc(O)ccc2Cl)=C3)cc1		CHEMBL211852	=	IC50	nM	546.0	CHEMBL3234	Homo sapiens	IC50	nM	546.0
	1755927	CHEMBL868659	Inhibition of human recombinant Hck in presence of 10 mM ATP	B	CN1CCN(c2ccc(Nc3ncc4c(n3)N3CCC(=O)N3C(c3cc(O)ccc3Cl)=C4)cc2)CC1		CHEMBL213356	=	IC50	nM	456.0	CHEMBL3234	Homo sapiens	IC50	nM	456.0
	1755932	CHEMBL868659	Inhibition of human recombinant Hck in presence of 10 mM ATP	B	O=C1CCN2c3nc(Nc4ccc(N5CCOCC5)cc4)ncc3C=C(c3c(Cl)cccc3Cl)N12		CHEMBL213745	=	IC50	nM	160.0	CHEMBL3234	Homo sapiens	IC50	nM	160.0
	1778593	CHEMBL910565	Inhibition of Hck	B	Cc1cc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)nc(C)n1		CHEMBL364623	=	IC50	nM	2.0	CHEMBL3234	Homo sapiens	IC50	nM	2.0
	1812302	CHEMBL908548	Inhibition of human recombinant Hck by ProFlour assay	B	CCN(CC)CCNc1cc(Nc2cc(O)ccc2C)nc(-n2cnc3ccccc32)n1		CHEMBL434369	=	IC50	nM	46.0	CHEMBL3234	Homo sapiens	IC50	nM	46.0
	1849898	CHEMBL914203	Inhibition of Hck	B	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOc5ccccc5)c4)n[nH]c2-3)CC1		CHEMBL390156	>	IC50	nM	50000.0	CHEMBL3234	Homo sapiens	IC50	nM	50000.0
	1849910	CHEMBL914203	Inhibition of Hck	B	COCCOCC#Cc1cc(-c2n[nH]c3c2Cc2ccc(Cn4cncn4)cc2-3)cs1		CHEMBL223971	>	IC50	nM	50000.0	CHEMBL3234	Homo sapiens	IC50	nM	50000.0
Not Active	1912285	CHEMBL889662	Binding affinity to Hck	B	CCOC(=O)c1cnn(CC(O)c2ccccc2)c1NC(=O)NC(C)C		CHEMBL450013		Activity			CHEMBL3234	Homo sapiens	Activity		
Not Active	1912300	CHEMBL889662	Binding affinity to Hck	B	CCOC(=O)c1cnn(CC(O)c2ccccc2)c1NC(=O)Nc1ccccc1		CHEMBL226939		Activity			CHEMBL3234	Homo sapiens	Activity		
Not Active	1912301	CHEMBL889662	Binding affinity to Hck	B	CCOC(=O)c1cnn(CC(O)c2ccccc2)c1NC(=O)NCc1ccccc1		CHEMBL226836		Activity			CHEMBL3234	Homo sapiens	Activity		
	1964457	CHEMBL897108	Inhibition of Hck	B	COc1cc(-c2csc3c(N)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL233965	>	IC50	nM	50000.0	CHEMBL3234	Homo sapiens	IC50	uM	50.0
	1964458	CHEMBL897108	Inhibition of Hck	B	COc1cc(-c2csc3c(/C=C/CN4CCC(O)CC4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL233958	=	IC50	nM	10000.0	CHEMBL3234	Homo sapiens	IC50	uM	10.0
	1964459	CHEMBL897108	Inhibition of Hck	B	COc1cc(-c2csc3c(/C=C/CN[C@H]4CC[C@@H](N)CC4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL395666	=	IC50	nM	20100.0	CHEMBL3234	Homo sapiens	IC50	uM	20.1
	1964460	CHEMBL897108	Inhibition of Hck	B	COc1cc(-c2csc3c(/C=C/CN[C@H]4CC[C@H](N)CC4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL395665	=	IC50	nM	24100.0	CHEMBL3234	Homo sapiens	IC50	uM	24.1
	1964461	CHEMBL897108	Inhibition of Hck	B	COc1cc(-c2csc3c(/C=C/CNC4CCNCC4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL395664	=	IC50	nM	24200.0	CHEMBL3234	Homo sapiens	IC50	uM	24.2
	1964462	CHEMBL897108	Inhibition of Hck	B	COc1cc(-c2csc3c(/C=C/CN4CCN(C)C(=O)C4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL395663	=	IC50	nM	12900.0	CHEMBL3234	Homo sapiens	IC50	uM	12.9
	1964463	CHEMBL897108	Inhibition of Hck	B	COc1cc(-c2csc3c(/C=C/CN4CCN(c5ccccc5)CC4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL233540	>	IC50	nM	50000.0	CHEMBL3234	Homo sapiens	IC50	uM	50.0
	1964464	CHEMBL897108	Inhibition of Hck	B	COc1cc(-c2csc3c(/C=C/CN4CCN(C)CC4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL395662	=	IC50	nM	5970.0	CHEMBL3234	Homo sapiens	IC50	uM	5.97
	1964465	CHEMBL897108	Inhibition of Hck	B	COc1cc(-c2csc3c(/C=C/CNC(C)=O)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL232927	=	IC50	nM	2360.0	CHEMBL3234	Homo sapiens	IC50	uM	2.36
	1964466	CHEMBL897108	Inhibition of Hck	B	COc1cc(-c2csc3c(/C=C/CNC(=O)Nc4ccccc4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL395433	=	IC50	nM	21900.0	CHEMBL3234	Homo sapiens	IC50	uM	21.9
	1964467	CHEMBL897108	Inhibition of Hck	B	COc1cc(-c2csc3c(/C=C/CNS(C)(=O)=O)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL232731	=	IC50	nM	4300.0	CHEMBL3234	Homo sapiens	IC50	uM	4.3
	1964468	CHEMBL897108	Inhibition of Hck	B	CCN(CC)C/C=C/c1cnc(N)c2c(-c3ccc(NC(=O)c4cc5ccccc5n4C)c(OC)c3)csc12		CHEMBL232542	=	IC50	nM	13600.0	CHEMBL3234	Homo sapiens	IC50	uM	13.6
	1964469	CHEMBL897108	Inhibition of Hck	B	CCN(CC)C/C=C\c1cnc(N)c2c(-c3ccc(NC(=O)c4cc5ccccc5n4C)c(OC)c3)csc12		CHEMBL391247	>	IC50	nM	50000.0	CHEMBL3234	Homo sapiens	IC50	uM	50.0
	1964470	CHEMBL897108	Inhibition of Hck	B	COc1cc(-c2csc3c(/C=C/CN)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL232127	=	IC50	nM	8800.0	CHEMBL3234	Homo sapiens	IC50	uM	8.8
	1964471	CHEMBL897108	Inhibition of Hck	B	COc1cc(-c2csc3c(CCCO)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL391044	>	IC50	nM	50000.0	CHEMBL3234	Homo sapiens	IC50	uM	50.0
	1964472	CHEMBL897108	Inhibition of Hck	B	COc1cc(-c2csc3c(/C=C/CO)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL232126	=	IC50	nM	2360.0	CHEMBL3234	Homo sapiens	IC50	uM	2.36
	1964473	CHEMBL897108	Inhibition of Hck	B	COc1cc(-c2csc3c2C(N)=NCC3/C=C/C(=O)NC2CCNCC2)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL396359	=	IC50	nM	1290.0	CHEMBL3234	Homo sapiens	IC50	uM	1.29
	1964474	CHEMBL897108	Inhibition of Hck	B	COc1cc(-c2csc3c(/C=C/C(N)=O)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL231930	=	IC50	nM	2260.0	CHEMBL3234	Homo sapiens	IC50	uM	2.26
	1964475	CHEMBL897108	Inhibition of Hck	B	COc1cc(-c2csc3c(C(=O)NCCN4CCCC4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL232588	=	IC50	nM	2550.0	CHEMBL3234	Homo sapiens	IC50	uM	2.55
	1964476	CHEMBL897108	Inhibition of Hck	B	COc1cc(-c2csc3c(C(=O)N4CCN(C)CC4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL232335	>	IC50	nM	50000.0	CHEMBL3234	Homo sapiens	IC50	uM	50.0
	1964477	CHEMBL897108	Inhibition of Hck	B	COc1cc(-c2csc3c(C(=O)NCCN(C)C)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL232334	=	IC50	nM	1970.0	CHEMBL3234	Homo sapiens	IC50	uM	1.97
	1964478	CHEMBL897108	Inhibition of Hck	B	COc1cc(-c2csc3c(C(N)=O)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL232125	=	IC50	nM	1410.0	CHEMBL3234	Homo sapiens	IC50	uM	1.41
	1964479	CHEMBL897108	Inhibition of Hck	B	COc1cc(-c2csc3c(C(=O)O)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL392904	>	IC50	nM	50000.0	CHEMBL3234	Homo sapiens	IC50	uM	50.0
	1964480	CHEMBL897108	Inhibition of Hck	B	COc1cc(-c2csc3c(NC(=O)NCCN4CCCC4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL413486	>	IC50	nM	50000.0	CHEMBL3234	Homo sapiens	IC50	uM	50.0
	1964481	CHEMBL897108	Inhibition of Hck	B	COc1cc(-c2csc3c(NC(=O)CCN4CCCC4)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL397143	=	IC50	nM	45290.0	CHEMBL3234	Homo sapiens	IC50	uM	45.29
	2027329	CHEMBL906397	Inhibition of Hck by HTRF assay	B	COCC(=O)Nc1cccc2c1Cc1c-2n[nH]c1-c1csc(C#CCOc2ccccc2)c1		CHEMBL245769	=	IC50	nM	30270.0	CHEMBL3234	Homo sapiens	IC50	uM	30.27
	2027352	CHEMBL906397	Inhibition of Hck by HTRF assay	B	CN1CCN(CC(=O)Nc2cccc3c2Cc2c-3n[nH]c2-c2csc(C#CCOc3ccccc3)c2)CC1		CHEMBL245377	>	IC50	nM	50000.0	CHEMBL3234	Homo sapiens	IC50	uM	50.0
	2027353	CHEMBL906397	Inhibition of Hck by HTRF assay	B	CCOC(=O)CC(=O)Nc1cccc2c1Cc1c-2n[nH]c1-c1csc(C#CCOc2ccccc2)c1		CHEMBL395427	>	IC50	nM	50000.0	CHEMBL3234	Homo sapiens	IC50	uM	50.0
	2027354	CHEMBL906397	Inhibition of Hck by HTRF assay	B	COC(=O)C(=O)Nc1cccc2c1Cc1c-2n[nH]c1-c1csc(C#CCOc2ccccc2)c1		CHEMBL246166	>	IC50	nM	50000.0	CHEMBL3234	Homo sapiens	IC50	uM	50.0
	2027355	CHEMBL906397	Inhibition of Hck by HTRF assay	B	COCCOCC(=O)Nc1cccc2c1Cc1c-2n[nH]c1-c1csc(C#CCOc2ccccc2)c1		CHEMBL245968	>	IC50	nM	50000.0	CHEMBL3234	Homo sapiens	IC50	uM	50.0
	2081796	CHEMBL928819	Inhibition of Hck at 10 uM	B	CC[C@@H](C)Nc1nc2ccc(-c3c(-c4ccccc4F)n[nH]c3N)cc2s1		CHEMBL404115	<=	Inhibition	%	20.0	CHEMBL3234	Homo sapiens	Inhibition	%	20.0
	2109090	CHEMBL947978	Inhibition of HCK by HTRF assay	B	COc1ccc(-c2ccc(NC(=O)Nc3cc(C)ccc3F)cc2)c2c(N)noc12		CHEMBL270084	>	IC50	nM	50000.0	CHEMBL3234	Homo sapiens	IC50	nM	50000.0
	2109102	CHEMBL947978	Inhibition of HCK by HTRF assay	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	IC50	nM	50000.0	CHEMBL3234	Homo sapiens	IC50	nM	50000.0
	2109103	CHEMBL947978	Inhibition of HCK by HTRF assay	B	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2)c2c(N)noc12		CHEMBL269884	>	IC50	nM	50000.0	CHEMBL3234	Homo sapiens	IC50	nM	50000.0
	2109104	CHEMBL947978	Inhibition of HCK by HTRF assay	B	COc1ccc(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)c2c(N)noc12		CHEMBL430090	>	IC50	nM	50000.0	CHEMBL3234	Homo sapiens	IC50	nM	50000.0
	2136801	CHEMBL936934	Inhibition of Hck	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	IC50	nM	5.0	CHEMBL3234	Homo sapiens	IC50	nM	5.0
	2147276	CHEMBL921866	Activity of human Hck kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	22.0	CHEMBL3234	Homo sapiens	Activity	%	22.0
	2239373	CHEMBL980062	Inhibition of Hck assessed as residual enzyme activity at 1 uM	B	Cc1ncc(NC(=O)c2cc(NC(=O)c3cccc(C(F)(F)F)c3)ccc2Cl)s1		CHEMBL462132	=	Activity	%	6.0	CHEMBL3234	Homo sapiens	Activity	%	6.0
	2470239	CHEMBL987209	Inhibition of HCK at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL3234	Homo sapiens	INH	%	10.0
	2476607	CHEMBL1035871	Binding affinity to human HCK at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	11.3	CHEMBL3234	Homo sapiens	Activity	%	11.3
Not Evaluated	2476810	CHEMBL1035871	Binding affinity to human HCK at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL3234	Homo sapiens	Activity		
Not Evaluated	2478649	CHEMBL1035871	Binding affinity to human HCK at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL3234	Homo sapiens	Activity		
Not Evaluated	2478852	CHEMBL1035871	Binding affinity to human HCK at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL3234	Homo sapiens	Activity		
Not Evaluated	2479707	CHEMBL1035871	Binding affinity to human HCK at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL3234	Homo sapiens	Activity		
Active	2480706	CHEMBL1035871	Binding affinity to human HCK at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL3234	Homo sapiens	Activity		
	2489351	CHEMBL991256	Inhibition of Hck	B	COc1ccc(CN(C)C)c(-c2cc3c(Nc4ccc5[nH]ccc5c4C)c(C#N)cnc3s2)c1		CHEMBL479835	>	IC50	nM	5000.0	CHEMBL3234	Homo sapiens	IC50	uM	5.0
	2559673	CHEMBL982994	Inhibition of HCK	B	Cc1c(Nc2c(C#N)cnc3sc(/C=C/C(=O)N4CCCC4)cc23)ccc2[nH]ccc12		CHEMBL477817	=	IC50	nM	26.0	CHEMBL3234	Homo sapiens	IC50	nM	26.0
Not Evaluated	2577328	CHEMBL1035871	Binding affinity to human HCK at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL3234	Homo sapiens	Activity		
Not Evaluated	2577531	CHEMBL1035871	Binding affinity to human HCK at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL3234	Homo sapiens	Activity		
Not Evaluated	2593533	CHEMBL1035871	Binding affinity to human HCK at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL3234	Homo sapiens	Activity		
	2593736	CHEMBL1035871	Binding affinity to human HCK at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Activity	%	0.2	CHEMBL3234	Homo sapiens	Activity	%	0.2
	2594002	CHEMBL1035871	Binding affinity to human HCK at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Activity	%	0.1	CHEMBL3234	Homo sapiens	Activity	%	0.1
Not Evaluated	2594945	CHEMBL1035871	Binding affinity to human HCK at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL3234	Homo sapiens	Activity		
Not Evaluated	2595148	CHEMBL1035871	Binding affinity to human HCK at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL3234	Homo sapiens	Activity		
	2595214	CHEMBL1035871	Binding affinity to human HCK at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466	=	Activity	%	18.2	CHEMBL3234	Homo sapiens	Activity	%	18.2
	2596345	CHEMBL1035871	Binding affinity to human HCK at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342	=	Activity	%	3.2	CHEMBL3234	Homo sapiens	Activity	%	3.2
	2597614	CHEMBL1035871	Binding affinity to human HCK at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019	=	Activity	%	26.3	CHEMBL3234	Homo sapiens	Activity	%	26.3
Not Evaluated	2597817	CHEMBL1035871	Binding affinity to human HCK at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL3234	Homo sapiens	Activity		
	2661587	CHEMBL1060451	Inhibition of HCK after 1 hr by mobility shift electrophoresis assay	B	COC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(C(=O)OC)CC4)c3n2)cc1		CHEMBL561708	>	IC50	nM	50000.0	CHEMBL3234	Homo sapiens	IC50	uM	50.0
	2721621	CHEMBL1057449	Inhibition of Hck at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL3234	Homo sapiens	INH	%	50.0
	2895146	CHEMBL1063730	Binding constant for HCK kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	uM	10.0
	2895147	CHEMBL1063730	Binding constant for HCK kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	uM	10.0
	2895148	CHEMBL1063730	Binding constant for HCK kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	880.0	CHEMBL3234	Homo sapiens	Kd	nM	880.0
	2895149	CHEMBL1063730	Binding constant for HCK kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	3900.0	CHEMBL3234	Homo sapiens	Kd	nM	3900.0
	2895150	CHEMBL1063730	Binding constant for HCK kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	uM	10.0
	2895151	CHEMBL1063730	Binding constant for HCK kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	uM	10.0
	2895152	CHEMBL1063730	Binding constant for HCK kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	3300.0	CHEMBL3234	Homo sapiens	Kd	nM	3300.0
	2895153	CHEMBL1063730	Binding constant for HCK kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	1200.0	CHEMBL3234	Homo sapiens	Kd	nM	1200.0
	2895154	CHEMBL1063730	Binding constant for HCK kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	4200.0	CHEMBL3234	Homo sapiens	Kd	nM	4200.0
	2895155	CHEMBL1063730	Binding constant for HCK kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	uM	10.0
	2895156	CHEMBL1063730	Binding constant for HCK kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	uM	10.0
	2895157	CHEMBL1063730	Binding constant for HCK kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	0.35	CHEMBL3234	Homo sapiens	Kd	nM	0.35
	2895158	CHEMBL1063730	Binding constant for HCK kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	2300.0	CHEMBL3234	Homo sapiens	Kd	nM	2300.0
	2895159	CHEMBL1063730	Binding constant for HCK kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	1800.0	CHEMBL3234	Homo sapiens	Kd	nM	1800.0
	2895160	CHEMBL1063730	Binding constant for HCK kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	uM	10.0
	2895161	CHEMBL1063730	Binding constant for HCK kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	4400.0	CHEMBL3234	Homo sapiens	Kd	nM	4400.0
	2895162	CHEMBL1063730	Binding constant for HCK kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	uM	10.0
	2895163	CHEMBL1063730	Binding constant for HCK kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	uM	10.0
	2895164	CHEMBL1063730	Binding constant for HCK kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	uM	10.0
	2895165	CHEMBL1063730	Binding constant for HCK kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	uM	10.0
	2895166	CHEMBL1063730	Binding constant for HCK kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	uM	10.0
	2895167	CHEMBL1063730	Binding constant for HCK kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	uM	10.0
	2895168	CHEMBL1063730	Binding constant for HCK kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	uM	10.0
	2895169	CHEMBL1063730	Binding constant for HCK kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	1500.0	CHEMBL3234	Homo sapiens	Kd	nM	1500.0
	2895170	CHEMBL1063730	Binding constant for HCK kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	uM	10.0
	2895171	CHEMBL1063730	Binding constant for HCK kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	720.0	CHEMBL3234	Homo sapiens	Kd	nM	720.0
	2895172	CHEMBL1063730	Binding constant for HCK kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	uM	10.0
	2895173	CHEMBL1063730	Binding constant for HCK kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	uM	10.0
	2895174	CHEMBL1063730	Binding constant for HCK kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	uM	10.0
	2895175	CHEMBL1063730	Binding constant for HCK kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	uM	10.0
	2895176	CHEMBL1063730	Binding constant for HCK kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	uM	10.0
	2895177	CHEMBL1063730	Binding constant for HCK kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	uM	10.0
	2895178	CHEMBL1063730	Binding constant for HCK kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	20.0	CHEMBL3234	Homo sapiens	Kd	nM	20.0
	2895179	CHEMBL1063730	Binding constant for HCK kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	2200.0	CHEMBL3234	Homo sapiens	Kd	nM	2200.0
	2895180	CHEMBL1063730	Binding constant for HCK kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	880.0	CHEMBL3234	Homo sapiens	Kd	nM	880.0
	2895181	CHEMBL1063730	Binding constant for HCK kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	uM	10.0
	2895182	CHEMBL1063730	Binding constant for HCK kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	uM	10.0
	2895183	CHEMBL1063730	Binding constant for HCK kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	360.0	CHEMBL3234	Homo sapiens	Kd	nM	360.0
	2921318	CHEMBL1053747	Inhibition of HCK assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	53.0	CHEMBL3234	Homo sapiens	Activity	%	53.0
	2928482	CHEMBL1049980	Binding affinity to HCK assessed as percentage of kinase remaining bound to the bead at 1 uM by T7 phage display based binding assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	0.6	CHEMBL3234	Homo sapiens	Activity	%	0.6
	2938499	CHEMBL1041366	Inhibition of HCK at 1 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	3.0	CHEMBL3234	Homo sapiens	INH	%	3.0
	2983209	CHEMBL1046246	Inhibition of Hck	B	CC1(C)CC(NC(=O)c2cccc(-c3cc4nccc(Nc5cccc(O)c5)n4n3)c2)CC(C)(C)N1[O]		CHEMBL1163016	=	IC50	nM	16.0	CHEMBL3234	Homo sapiens	IC50	uM	0.016
	2993559	CHEMBL1040934	Inhibition of human recombinant Hck	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	IC50	nM	10000.0	CHEMBL3234	Homo sapiens	IC50	nM	10000.0
	3052625	CHEMBL1038411	Residual activity of HCK at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	99.0	CHEMBL3234	Homo sapiens	Residual activity	%	99.0
	3053934	CHEMBL1046826	Residual activity of HCK at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	78.0	CHEMBL3234	Homo sapiens	Residual activity	%	78.0
	3054186	CHEMBL1040654	Residual activity of HCK at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	96.0	CHEMBL3234	Homo sapiens	Residual activity	%	96.0
	3055473	CHEMBL1038411	Residual activity of HCK at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	93.0	CHEMBL3234	Homo sapiens	Residual activity	%	93.0
	3056778	CHEMBL1046826	Residual activity of HCK at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	155.0	CHEMBL3234	Homo sapiens	Residual activity	%	155.0
	3057030	CHEMBL1040654	Residual activity of HCK at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	97.0	CHEMBL3234	Homo sapiens	Residual activity	%	97.0
	3058350	CHEMBL1038411	Residual activity of HCK at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	116.0	CHEMBL3234	Homo sapiens	Residual activity	%	116.0
	3058602	CHEMBL1046826	Residual activity of HCK at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	187.0	CHEMBL3234	Homo sapiens	Residual activity	%	187.0
	3072948	CHEMBL1040654	Residual activity of HCK at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	115.0	CHEMBL3234	Homo sapiens	Residual activity	%	115.0
	3089506	CHEMBL1067357	Inhibition of HCK	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC[C@@H](N)C2)ccc2[nH]ccc12		CHEMBL606245	=	IC50	nM	5500.0	CHEMBL3234	Homo sapiens	IC50	nM	5500.0
	3213823	CHEMBL1108410	Inhibition of HCK at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	105.0	CHEMBL3234	Homo sapiens	INH	%	105.0
	3219848	CHEMBL1113999	Inhibition of HCK	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(S(=O)(=O)N3CCN(C)CC3)c2)ccc2[nH]ccc12		CHEMBL1080994	=	IC50	nM	550.0	CHEMBL3234	Homo sapiens	IC50	nM	550.0
	3219849	CHEMBL1113999	Inhibition of HCK	B	Cc1ncc(C#N)c(Nc2ccc3[nH]ccc3c2C)c1/C=C/c1cccc(S(=O)(=O)N2CCN(C)CC2)c1		CHEMBL1080995	>	IC50	nM	50000.0	CHEMBL3234	Homo sapiens	IC50	nM	50000.0
	3220005	CHEMBL1115854	Inhibition of HCK	B	CN1C[C@@H]2C[C@H]1CN2c1ccc(-c2ccnc3c(-c4cccc(O)c4)c(-c4ccncc4)nn23)cc1		CHEMBL1087650	=	IC50	nM	1240.0	CHEMBL3234	Homo sapiens	IC50	uM	1.24
	3222968	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(NC(=O)c2cccc(Cl)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1079422	=	IC50	nM	475.0	CHEMBL3234	Homo sapiens	IC50	nM	475.0
	3222969	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1079945	=	IC50	nM	43.0	CHEMBL3234	Homo sapiens	IC50	nM	43.0
	3222970	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(NC(=O)c2cc(Cl)cc(Cl)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1079946	=	IC50	nM	121.0	CHEMBL3234	Homo sapiens	IC50	nM	121.0
	3222971	CHEMBL1113976	Inhibition of HCK	B	Cc1cccc(C(=O)Nc2ccc(C)c(Nc3nc4ccccc4n3-c3cc(N)ncn3)c2)c1		CHEMBL1080299	=	IC50	nM	245.0	CHEMBL3234	Homo sapiens	IC50	nM	245.0
	3222972	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(NC(=O)c2ccncc2C(C)(C)C)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1080475	=	IC50	nM	46.0	CHEMBL3234	Homo sapiens	IC50	nM	46.0
	3222973	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(NC(=O)c2ccncc2Cl)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1086730	>	IC50	nM	2500.0	CHEMBL3234	Homo sapiens	IC50	nM	2500.0
	3222974	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(NC(=O)c2cc(OC3CCN(C)CC3)cc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1076432	=	IC50	nM	27.0	CHEMBL3234	Homo sapiens	IC50	nM	27.0
	3222975	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(NC(=O)c2ccc(C(C)(C)C)s2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1086731	=	IC50	nM	84.0	CHEMBL3234	Homo sapiens	IC50	nM	84.0
	3222976	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(NC(=O)c2cc(C3CC3)n[nH]2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1086860	=	IC50	nM	446.0	CHEMBL3234	Homo sapiens	IC50	nM	446.0
	3222977	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(NC(=O)c2cc(C(C)(C)C)nn2C)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1088153	=	IC50	nM	844.0	CHEMBL3234	Homo sapiens	IC50	nM	844.0
	3222978	CHEMBL1113976	Inhibition of HCK	B	CCN1CCN(Cc2ccc(C(=O)Nc3ccc(C)c(Nc4nc5ccccc5n4-c4cc(N)ncn4)c3)cc2Cl)CC1		CHEMBL1076433	=	IC50	nM	9.0	CHEMBL3234	Homo sapiens	IC50	nM	9.0
	3222979	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(NC(=O)c2cc(CN3CCN(C)CC3)n(C(C)(C)C)n2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1075628	=	IC50	nM	11.0	CHEMBL3234	Homo sapiens	IC50	nM	11.0
	3222980	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(NC(=O)c2cc(N3CCN(C)CC3)cc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1076436	=	IC50	nM	20.0	CHEMBL3234	Homo sapiens	IC50	nM	20.0
	3222981	CHEMBL1113976	Inhibition of HCK	B	CCN1CCN(c2cc(C(=O)Nc3ccc(C)c(Nc4nc5ccccc5n4-c4cc(N)ncn4)c3)cc(C(F)(F)F)c2)CC1		CHEMBL1076437	=	IC50	nM	16.0	CHEMBL3234	Homo sapiens	IC50	nM	16.0
	3222982	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(Cl)ncn1		CHEMBL1088429	=	IC50	nM	3826.0	CHEMBL3234	Homo sapiens	IC50	nM	3826.0
	3222983	CHEMBL1113976	Inhibition of HCK	B	COc1cc(-n2c(Nc3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)nc3ccccc32)ncn1		CHEMBL1087513	>	IC50	nM	2500.0	CHEMBL3234	Homo sapiens	IC50	nM	2500.0
	3222984	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCN)ncn1		CHEMBL1087636	>	IC50	nM	2500.0	CHEMBL3234	Homo sapiens	IC50	nM	2500.0
	3222985	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCN)ncn1		CHEMBL1076465	=	IC50	nM	1960.0	CHEMBL3234	Homo sapiens	IC50	nM	1960.0
	3222986	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCCN)ncn1		CHEMBL1076466	=	IC50	nM	345.0	CHEMBL3234	Homo sapiens	IC50	nM	345.0
	3222987	CHEMBL1113976	Inhibition of HCK	B	CCN(CC)CCNc1cc(-n2c(Nc3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)nc3ccccc32)ncn1		CHEMBL1076468	=	IC50	nM	378.0	CHEMBL3234	Homo sapiens	IC50	nM	378.0
	3222988	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCCN(C)C)ncn1		CHEMBL1076469	=	IC50	nM	65.0	CHEMBL3234	Homo sapiens	IC50	nM	65.0
	3222989	CHEMBL1113976	Inhibition of HCK	B	CCN(CC)CCCCNc1cc(-n2c(Nc3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)nc3ccccc32)ncn1		CHEMBL1076470	=	IC50	nM	430.0	CHEMBL3234	Homo sapiens	IC50	nM	430.0
	3222990	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCC2COCCN2)ncn1		CHEMBL1076471	=	IC50	nM	49.0	CHEMBL3234	Homo sapiens	IC50	nM	49.0
	3222991	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCC2CCCN2)ncn1		CHEMBL1076472	=	IC50	nM	805.0	CHEMBL3234	Homo sapiens	IC50	nM	805.0
	3222992	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(N[C@H]2CC[C@H](N)CC2)ncn1		CHEMBL1076473	=	IC50	nM	450.0	CHEMBL3234	Homo sapiens	IC50	nM	450.0
	3222993	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NC2CCN(C)CC2)ncn1		CHEMBL1076474	>	IC50	nM	2500.0	CHEMBL3234	Homo sapiens	IC50	nM	2500.0
	3222994	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCc2ccccn2)ncn1		CHEMBL1076475	=	IC50	nM	917.0	CHEMBL3234	Homo sapiens	IC50	nM	917.0
	3222995	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(N2CCOCC2)ncn1		CHEMBL1076476	>	IC50	nM	2500.0	CHEMBL3234	Homo sapiens	IC50	nM	2500.0
	3222996	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCN2CCN(C)CC2)ncn1		CHEMBL1076477	=	IC50	nM	69.0	CHEMBL3234	Homo sapiens	IC50	nM	69.0
	3224838	CHEMBL1100489	Inhibition of HCK at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL3234	Homo sapiens	INH	%	50.0
	3225088	CHEMBL1100489	Inhibition of HCK at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL3234	Homo sapiens	INH	%	50.0
	3226922	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCN2CCN(C)CC2)ncn1		CHEMBL1076478	=	IC50	nM	31.0	CHEMBL3234	Homo sapiens	IC50	nM	31.0
	3226923	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCO)ncn1		CHEMBL1087638	=	IC50	nM	192.0	CHEMBL3234	Homo sapiens	IC50	nM	192.0
	3226924	CHEMBL1113976	Inhibition of HCK	B	COCCNc1cc(-n2c(Nc3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)nc3ccccc32)ncn1		CHEMBL1076480	=	IC50	nM	405.0	CHEMBL3234	Homo sapiens	IC50	nM	405.0
	3226925	CHEMBL1113976	Inhibition of HCK	B	Cc1cccc(NC(=O)c2ccc(C)c(Nc3nc4ccccc4n3-c3cc(N)ncn3)c2)c1		CHEMBL1087002	>	IC50	nM	2500.0	CHEMBL3234	Homo sapiens	IC50	nM	2500.0
	3226926	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(C(=O)Nc2cccc(C(C)C)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1087127	=	IC50	nM	151.0	CHEMBL3234	Homo sapiens	IC50	nM	151.0
	3226927	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1087128	=	IC50	nM	139.0	CHEMBL3234	Homo sapiens	IC50	nM	139.0
	3226928	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(C(=O)Nc2cccc(OC(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1088027	>	IC50	nM	2500.0	CHEMBL3234	Homo sapiens	IC50	nM	2500.0
	3226929	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(C(=O)Nc2cccc(Br)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1088028	>	IC50	nM	2500.0	CHEMBL3234	Homo sapiens	IC50	nM	2500.0
	3226930	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1087524	>	IC50	nM	2500.0	CHEMBL3234	Homo sapiens	IC50	nM	2500.0
	3226931	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(C(=O)Nc2cccc(Cl)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1087649	>	IC50	nM	2500.0	CHEMBL3234	Homo sapiens	IC50	nM	2500.0
	3226932	CHEMBL1113976	Inhibition of HCK	B	COc1cccc(NC(=O)c2ccc(C)c(Nc3nc4ccccc4n3-c3cc(N)ncn3)c2)c1		CHEMBL1081090	>	IC50	nM	2500.0	CHEMBL3234	Homo sapiens	IC50	nM	2500.0
	3226933	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(C(=O)Nc2ccccc2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1076533	>	IC50	nM	2500.0	CHEMBL3234	Homo sapiens	IC50	nM	2500.0
	3226934	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(C(=O)Nc2cccc3cnccc23)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1081436	>	IC50	nM	2500.0	CHEMBL3234	Homo sapiens	IC50	nM	2500.0
	3226935	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(C(=O)Nc2cccc(C(N)=O)c2)cc1Nc1nc2ccccc2n1-c1cc(N)ncn1		CHEMBL1080930	>	IC50	nM	2500.0	CHEMBL3234	Homo sapiens	IC50	nM	2500.0
	3226936	CHEMBL1113976	Inhibition of HCK	B	Cc1cc(NC(=O)c2ccc(C)c(Nc3nc4ccccc4n3-c3cc(N)ncn3)c2)ccn1		CHEMBL1079424	>	IC50	nM	2500.0	CHEMBL3234	Homo sapiens	IC50	nM	2500.0
	3226937	CHEMBL1113976	Inhibition of HCK	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nc5ccccc5n4-c4cc(N)ncn4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL1076193	=	IC50	nM	904.0	CHEMBL3234	Homo sapiens	IC50	nM	904.0
	3226938	CHEMBL1113976	Inhibition of HCK	B	Cc1cccc(NC(=O)c2ccc(C)c(Nc3nc4ccccc4n3-c3cc(NCCCCN(C)C)ncn3)c2)c1		CHEMBL1076194	>	IC50	nM	2500.0	CHEMBL3234	Homo sapiens	IC50	nM	2500.0
	3226939	CHEMBL1113976	Inhibition of HCK	B	CCN(CC)CCCCNc1cc(-n2c(Nc3cc(C(=O)Nc4cccc(C)c4)ccc3C)nc3ccccc32)ncn1		CHEMBL1076195	=	IC50	nM	1810.0	CHEMBL3234	Homo sapiens	IC50	nM	1810.0
	3226940	CHEMBL1113976	Inhibition of HCK	B	Cc1cccc(NC(=O)c2ccc(C)c(Nc3nc4ccccc4n3-c3cc(NCCN4CCN(C)CC4)ncn3)c2)c1		CHEMBL1076196	>	IC50	nM	2500.0	CHEMBL3234	Homo sapiens	IC50	nM	2500.0
	3226941	CHEMBL1113976	Inhibition of HCK	B	Cc1cccc(NC(=O)c2ccc(C)c(Nc3nc4ccccc4n3-c3cc(NCCCN4CCN(C)CC4)ncn3)c2)c1		CHEMBL1076197	=	IC50	nM	1875.0	CHEMBL3234	Homo sapiens	IC50	nM	1875.0
	3226942	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCCN(C)C)ncn1		CHEMBL1076198	=	IC50	nM	56.0	CHEMBL3234	Homo sapiens	IC50	nM	56.0
	3226943	CHEMBL1113976	Inhibition of HCK	B	CCN(CC)CCCCNc1cc(-n2c(Nc3cc(C(=O)Nc4cccc(C(F)(F)F)c4)ccc3C)nc3ccccc32)ncn1		CHEMBL1076199	=	IC50	nM	475.0	CHEMBL3234	Homo sapiens	IC50	nM	475.0
	3226944	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCN2CCN(C)CC2)ncn1		CHEMBL1076200	=	IC50	nM	130.0	CHEMBL3234	Homo sapiens	IC50	nM	130.0
	3226945	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCCN2CCN(C)CC2)ncn1		CHEMBL1076201	=	IC50	nM	260.0	CHEMBL3234	Homo sapiens	IC50	nM	260.0
	3226946	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1cc(NCCC#N)ncn1		CHEMBL1076202	>	IC50	nM	2500.0	CHEMBL3234	Homo sapiens	IC50	nM	2500.0
	3226947	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1ncnc(N)c1C		CHEMBL1080294	>	IC50	nM	2500.0	CHEMBL3234	Homo sapiens	IC50	nM	2500.0
	3226948	CHEMBL1113976	Inhibition of HCK	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1nc2ccccc2n1-c1ncnc(NCCCN2CCN(C)CC2)n1		CHEMBL1076203	=	IC50	nM	54.0	CHEMBL3234	Homo sapiens	IC50	nM	54.0
	3242220	CHEMBL1111606	Inhibition of HCK	B	CC(C)N1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(C5CCOCC5)nc(N5C6CCC5COC6)n4)cc3)cc2)CC1		CHEMBL1091356	<	IC50	nM	50000.0	CHEMBL3234	Homo sapiens	IC50	uM	50.0
	3251267	CHEMBL1110590	Inhibition of HCK	B	Cn1cc(/C=C2\Oc3cccc(O)c3C2=O)c2c(-c3ccc(C(=O)NCCO)cc3)ccnc21		CHEMBL1092754	=	IC50	nM	27100.0	CHEMBL3234	Homo sapiens	IC50	uM	27.1
	3264373	CHEMBL1104642	Inhibition of HCK	B	CC(C)(C)OC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(N)cc4)nc32)CC1		CHEMBL1095627	>	IC50	nM	50000.0	CHEMBL3234	Homo sapiens	IC50	uM	50.0
	3271025	CHEMBL1104642	Inhibition of HCK	B	COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(N)cc4)nc32)CC1		CHEMBL1095626	>	IC50	nM	50000.0	CHEMBL3234	Homo sapiens	IC50	uM	50.0
	3315016	CHEMBL1120229	Inhibition of HCK	B	CN1CCN(c2cccc(-c3cnn4c(N)c(-c5ccc(O)cc5)cnc34)c2)CC1		CHEMBL1083091	=	IC50	nM	342.0	CHEMBL3234	Homo sapiens	IC50	nM	342.0
	3315020	CHEMBL1120229	Inhibition of HCK	B	CN1CCN(c2ccc(-c3cnn4c(N)c(-c5ccc(O)cc5)cnc34)cc2)CC1		CHEMBL1083092	=	IC50	nM	85.0	CHEMBL3234	Homo sapiens	IC50	nM	85.0
	3315024	CHEMBL1120229	Inhibition of HCK	B	CN1CCN(c2cccc(-c3cnn4c(N)c(-c5ccc(NS(=O)(=O)c6cccc(Cl)c6Cl)cc5)cnc34)c2)CC1		CHEMBL1084974	>	IC50	nM	1000.0	CHEMBL3234	Homo sapiens	IC50	nM	1000.0
	3315028	CHEMBL1120229	Inhibition of HCK	B	CN1CCN(c2cccc(-c3cnn4c(N)c(-c5ccc(NC(=O)CCC6CCCC6)cc5)cnc34)c2)CC1		CHEMBL1085316	=	IC50	nM	37.0	CHEMBL3234	Homo sapiens	IC50	nM	37.0
	3315032	CHEMBL1120229	Inhibition of HCK	B	CN1CCN(c2cccc(-c3cnn4c(N)c(-c5ccc(NC(=O)c6ccc(C(F)(F)F)cc6)cc5)cnc34)c2)CC1		CHEMBL1085240	=	IC50	nM	295.0	CHEMBL3234	Homo sapiens	IC50	nM	295.0
	3315036	CHEMBL1120229	Inhibition of HCK	B	CC(C)COC(=O)Nc1ccc(-c2cnc3c(-c4cccc(N5CCN(C)CC5)c4)cnn3c2N)cc1		CHEMBL1085317	=	IC50	nM	594.0	CHEMBL3234	Homo sapiens	IC50	nM	594.0
	3315040	CHEMBL1120229	Inhibition of HCK	B	CN1CCN(c2cccc(-c3cnn4c(N)c(-c5ccc(NC(=O)Oc6ccccc6)cc5)cnc34)c2)CC1		CHEMBL1085564	=	IC50	nM	193.0	CHEMBL3234	Homo sapiens	IC50	nM	193.0
	3315044	CHEMBL1120229	Inhibition of HCK	B	CN1CCN(c2cccc(-c3cnn4c(N)c(-c5ccc(NC(=O)Nc6ccccc6Cl)cc5)cnc34)c2)CC1		CHEMBL1085061	=	IC50	nM	172.0	CHEMBL3234	Homo sapiens	IC50	nM	172.0
	3315048	CHEMBL1120229	Inhibition of HCK	B	CN1CCN(c2cccc(-c3cnn4c(N)c(-c5ccc(NC(=O)NCC6CCCCC6)cc5)cnc34)c2)CC1		CHEMBL1084028	=	IC50	nM	70.0	CHEMBL3234	Homo sapiens	IC50	nM	70.0
	3315052	CHEMBL1120229	Inhibition of HCK	B	CN1CCN(c2cccc(-c3cnn4c(N)c(-c5ccc(NC(=O)N(C)C6CCCCC6)cc5)cnc34)c2)CC1		CHEMBL1084302	=	IC50	nM	110.0	CHEMBL3234	Homo sapiens	IC50	nM	110.0
	3315056	CHEMBL1120229	Inhibition of HCK	B	CN1CCN(c2ccc(-c3cnn4c(N)c(-c5ccc(NC(=O)CCC6CCCC6)cc5)cnc34)cc2)CC1		CHEMBL1083001	=	IC50	nM	14.0	CHEMBL3234	Homo sapiens	IC50	nM	14.0
	3315060	CHEMBL1120229	Inhibition of HCK	B	CN1CCN(c2ccc(-c3cnn4c(N)c(-c5ccc(NC(=O)c6ccc(C(F)(F)F)cc6)cc5)cnc34)cc2)CC1		CHEMBL1085733	=	IC50	nM	256.0	CHEMBL3234	Homo sapiens	IC50	nM	256.0
	3315064	CHEMBL1120229	Inhibition of HCK	B	CC(C)COC(=O)Nc1ccc(-c2cnc3c(-c4ccc(N5CCN(C)CC5)cc4)cnn3c2N)cc1		CHEMBL1085511	=	IC50	nM	181.0	CHEMBL3234	Homo sapiens	IC50	nM	181.0
	3315068	CHEMBL1120229	Inhibition of HCK	B	CN1CCN(c2ccc(-c3cnn4c(N)c(-c5ccc(NC(=O)Oc6ccccc6)cc5)cnc34)cc2)CC1		CHEMBL1085512	=	IC50	nM	88.0	CHEMBL3234	Homo sapiens	IC50	nM	88.0
	3315072	CHEMBL1120229	Inhibition of HCK	B	CN1CCN(c2ccc(-c3cnn4c(N)c(-c5ccc(NC(=O)Nc6ccccc6Cl)cc5)cnc34)cc2)CC1		CHEMBL1084233	=	IC50	nM	215.0	CHEMBL3234	Homo sapiens	IC50	nM	215.0
	3315076	CHEMBL1120229	Inhibition of HCK	B	CN1CCN(c2ccc(-c3cnn4c(N)c(-c5ccc(NC(=O)NCC6CCCCC6)cc5)cnc34)cc2)CC1		CHEMBL1084234	=	IC50	nM	21.0	CHEMBL3234	Homo sapiens	IC50	nM	21.0
	3315080	CHEMBL1120229	Inhibition of HCK	B	CN1CCN(c2ccc(-c3cnn4c(N)c(-c5ccc(NC(=O)N(C)C6CCCCC6)cc5)cnc34)cc2)CC1		CHEMBL1082693	=	IC50	nM	178.0	CHEMBL3234	Homo sapiens	IC50	nM	178.0
	3315098	CHEMBL1120229	Inhibition of HCK	B	Cc1nc2c(-c3cccc(N4CCN(C)CC4)c3)cnn2c(N)c1-c1ccc(NC(=O)OCC(C)C)cc1		CHEMBL1085995	>	IC50	nM	1000.0	CHEMBL3234	Homo sapiens	IC50	nM	1000.0
	3315102	CHEMBL1120229	Inhibition of HCK	B	Cc1cc(NC(=O)OCC(C)C)ccc1-c1cnc2c(-c3cccc(N4CCN(C)CC4)c3)cnn2c1N		CHEMBL1085996	=	IC50	nM	456.0	CHEMBL3234	Homo sapiens	IC50	nM	456.0
	3315106	CHEMBL1120229	Inhibition of HCK	B	COc1cc(-c2cnc3c(-c4cccc(N5CCN(C)CC5)c4)cnn3c2N)ccc1NC(=O)OCC(C)C		CHEMBL1083022	>	IC50	nM	1000.0	CHEMBL3234	Homo sapiens	IC50	nM	1000.0
	3315110	CHEMBL1120229	Inhibition of HCK	B	CN1CCN(c2ccc(-c3cnn4c(N)c(-c5cccc(O)c5)cnc34)cc2)CC1		CHEMBL1083023	=	IC50	nM	8.0	CHEMBL3234	Homo sapiens	IC50	nM	8.0
	3315114	CHEMBL1120229	Inhibition of HCK	B	Cc1nn2c(N)c(-c3cccc(O)c3)cnc2c1-c1ccc(N2CCN(C)CC2)cc1		CHEMBL1083344	>	IC50	nM	1000.0	CHEMBL3234	Homo sapiens	IC50	nM	1000.0
	3315118	CHEMBL1120229	Inhibition of HCK	B	CC(C)COC(=O)Nc1ccc(-c2cnc3c(-c4cccc(N5CCNCC5)c4)cnn3c2N)cc1		CHEMBL1083644	=	IC50	nM	310.0	CHEMBL3234	Homo sapiens	IC50	nM	310.0
	3315122	CHEMBL1120229	Inhibition of HCK	B	CC(C)COC(=O)Nc1ccc(-c2cnc3c(-c4cccc(N5CCN(S(C)(=O)=O)CC5)c4)cnn3c2N)cc1		CHEMBL1082403	=	IC50	nM	676.0	CHEMBL3234	Homo sapiens	IC50	nM	676.0
	3315126	CHEMBL1120229	Inhibition of HCK	B	CC(C)COC(=O)Nc1ccc(-c2cnc3c(-c4cccc(N5CCN(C(=O)CN)CC5)c4)cnn3c2N)cc1		CHEMBL1082404	=	IC50	nM	270.0	CHEMBL3234	Homo sapiens	IC50	nM	270.0
	3315130	CHEMBL1120229	Inhibition of HCK	B	COCCN1CCN(c2ccc(-c3cnn4c(N)c(-c5ccc(NC(=O)OCC(C)C)cc5)cnc34)cc2)CC1		CHEMBL1082958	=	IC50	nM	349.0	CHEMBL3234	Homo sapiens	IC50	nM	349.0
	3315886	CHEMBL1120229	Inhibition of HCK	B	CC(C)COC(=O)Nc1ccc(-c2cnc3c(-c4cccc(N5CCOCC5)c4)cnn3c2N)cc1		CHEMBL1082959	>	IC50	nM	1000.0	CHEMBL3234	Homo sapiens	IC50	nM	1000.0
	3331964	CHEMBL1169254	Inhibition of HCK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL3234	Homo sapiens	INH	%	50.0
	3333379	CHEMBL1169254	Inhibition of HCK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL3234	Homo sapiens	INH	%	50.0
	3334784	CHEMBL1169254	Inhibition of HCK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL3234	Homo sapiens	INH	%	50.0
	3336204	CHEMBL1169254	Inhibition of HCK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL3234	Homo sapiens	INH	%	50.0
	3337547	CHEMBL1169254	Inhibition of HCK at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL3234	Homo sapiens	INH	%	50.0
	3337797	CHEMBL1169254	Inhibition of HCK at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL3234	Homo sapiens	INH	%	50.0
	3339131	CHEMBL1169254	Inhibition of HCK at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL3234	Homo sapiens	INH	%	50.0
	3340433	CHEMBL1169254	Inhibition of HCK at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL3234	Homo sapiens	INH	%	50.0
	3340732	CHEMBL1169254	Inhibition of HCK at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL3234	Homo sapiens	INH	%	50.0
	3342148	CHEMBL1169254	Inhibition of HCK at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL3234	Homo sapiens	INH	%	50.0
	3358600	CHEMBL1174445	Inhibition of HCK at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.05	CHEMBL3234	Homo sapiens	INH	%	0.05
	3359042	CHEMBL1174445	Inhibition of HCK at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.15	CHEMBL3234	Homo sapiens	INH	%	0.15
	3440722	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc(O)cc(Br)c2)c2c(N)ncnc21		CHEMBL1242285	=	IC50	nM	10.0	CHEMBL3234	Homo sapiens	IC50	uM	0.01
	3440736	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COCOc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1Br		CHEMBL1242286	=	IC50	nM	34.0	CHEMBL3234	Homo sapiens	IC50	uM	0.034
	3440750	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241299	=	IC50	nM	24.0	CHEMBL3234	Homo sapiens	IC50	uM	0.024
	3440764	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Br)c(O)c1)nn2C1CCC1		CHEMBL1242287	=	IC50	nM	8.9	CHEMBL3234	Homo sapiens	IC50	uM	0.0089
	3440778	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Br)c(O)c1)nn2C1CCCC1		CHEMBL1242376	=	IC50	nM	12.0	CHEMBL3234	Homo sapiens	IC50	uM	0.012
	3440792	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21		CHEMBL1242377	=	IC50	nM	9.2	CHEMBL3234	Homo sapiens	IC50	uM	0.0092
	3440806	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C[C@H](CN)n1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21		CHEMBL1242378	=	IC50	nM	161.0	CHEMBL3234	Homo sapiens	IC50	uM	0.161
	3440820	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C[C@@H](CN)n1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21		CHEMBL1242468	=	IC50	nM	1400.0	CHEMBL3234	Homo sapiens	IC50	uM	1.4
	3440834	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	N#CCCCn1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21		CHEMBL1242469	=	IC50	nM	258.0	CHEMBL3234	Homo sapiens	IC50	uM	0.258
	3440848	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	N#CCCCCn1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21		CHEMBL1242470	=	IC50	nM	71.0	CHEMBL3234	Homo sapiens	IC50	uM	0.071
	3440862	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2C1CCC1		CHEMBL1242566	=	IC50	nM	11.0	CHEMBL3234	Homo sapiens	IC50	uM	0.011
	3440876	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2C1CNC1		CHEMBL1242567	=	IC50	nM	42.0	CHEMBL3234	Homo sapiens	IC50	uM	0.042
	3440890	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2C1CCCC1		CHEMBL1242568	=	IC50	nM	4.5	CHEMBL3234	Homo sapiens	IC50	uM	0.0045
	3440904	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC1CCC(n2nc(-c3ccc(F)c(O)c3)c3c(N)ncnc32)C1		CHEMBL1242656	=	IC50	nM	5.7	CHEMBL3234	Homo sapiens	IC50	uM	0.0057
	3440918	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2[C@H]1CCNC1		CHEMBL1242657	=	IC50	nM	25.0	CHEMBL3234	Homo sapiens	IC50	uM	0.025
	3440932	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2[C@@H]1CCNC1		CHEMBL1242658	=	IC50	nM	86.0	CHEMBL3234	Homo sapiens	IC50	uM	0.086
	3440946	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2[C@H]1CCOC1		CHEMBL1242748	=	IC50	nM	21.0	CHEMBL3234	Homo sapiens	IC50	uM	0.021
	3440960	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2[C@@H]1CCOC1		CHEMBL1242749	=	IC50	nM	51.0	CHEMBL3234	Homo sapiens	IC50	uM	0.051
	3440974	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2C1CCCCCC1		CHEMBL1242750	=	IC50	nM	30.0	CHEMBL3234	Homo sapiens	IC50	uM	0.03
	3440988	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2CC1CCNCC1		CHEMBL1242844	=	IC50	nM	1530.0	CHEMBL3234	Homo sapiens	IC50	uM	1.53
	3441002	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1nn(-c2ccccc2)nc1Cn1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21		CHEMBL1242845	=	IC50	nM	596.0	CHEMBL3234	Homo sapiens	IC50	uM	0.596
	3441016	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2Cc1ocnc1-c1ccccc1		CHEMBL1241482	=	IC50	nM	714.0	CHEMBL3234	Homo sapiens	IC50	uM	0.714
	3441030	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1F		CHEMBL1241483	=	IC50	nM	37.0	CHEMBL3234	Homo sapiens	IC50	uM	0.037
	3441044	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Cl)c(O)c2)c2c(N)ncnc21		CHEMBL1241484	=	IC50	nM	2.0	CHEMBL3234	Homo sapiens	IC50	uM	0.002
	3441058	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C[C@H](CN)n1nc(-c2ccc(Cl)c(O)c2)c2c(N)ncnc21		CHEMBL1241579	=	IC50	nM	33.0	CHEMBL3234	Homo sapiens	IC50	uM	0.033
	3441072	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C[C@@H](CN)n1nc(-c2ccc(Cl)c(O)c2)c2c(N)ncnc21		CHEMBL1240544	=	IC50	nM	194.0	CHEMBL3234	Homo sapiens	IC50	uM	0.194
	3441086	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2C1CCC1		CHEMBL1241580	=	IC50	nM	5.8	CHEMBL3234	Homo sapiens	IC50	uM	0.0058
	3441622	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1NC(=O)OC(C)(C)C		CHEMBL1241481	<	IC50	nM	1.0	CHEMBL3234	Homo sapiens	IC50	uM	0.001
	3441636	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	IC50	nM	4.0	CHEMBL3234	Homo sapiens	IC50	uM	0.004
	3441650	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	IC50	nM	8.0	CHEMBL3234	Homo sapiens	IC50	uM	0.008
	3441664	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	IC50	nM	88.0	CHEMBL3234	Homo sapiens	IC50	uM	0.088
	3441678	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	IC50	nM	130.0	CHEMBL3234	Homo sapiens	IC50	uM	0.13
	3441692	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	IC50	nM	1200.0	CHEMBL3234	Homo sapiens	IC50	uM	1.2
	3441706	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccn3ccnc3c1)nn2C1CCCC1		CHEMBL1241675	=	IC50	nM	8900.0	CHEMBL3234	Homo sapiens	IC50	uM	8.9
	3441720	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccccc1-n1c(Cn2nc(-c3cccc(O)c3)c3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL1241767	>	IC50	nM	50000.0	CHEMBL3234	Homo sapiens	IC50	uM	50.0
	3441863	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	IC50	nM	23.0	CHEMBL3234	Homo sapiens	IC50	uM	0.023
	3441877	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	IC50	nM	260.0	CHEMBL3234	Homo sapiens	IC50	uM	0.26
Not Determined	3441891	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccccc3)c12		CHEMBL1241104		IC50			CHEMBL3234	Homo sapiens	IC50		
Not Determined	3441905	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc(-c2n[nH]c3ncnc(N)c23)cc1		CHEMBL1241142		IC50			CHEMBL3234	Homo sapiens	IC50		
Not Determined	3441919	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1cccc(-c2n[nH]c3ncnc(N)c23)c1		CHEMBL1241143		IC50			CHEMBL3234	Homo sapiens	IC50		
Not Determined	3441933	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccccc1-c1n[nH]c2ncnc(N)c12		CHEMBL1241144		IC50			CHEMBL3234	Homo sapiens	IC50		
Not Determined	3441947	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1cccc(-c2n[nH]c3ncnc(N)c23)c1C		CHEMBL1241145		IC50			CHEMBL3234	Homo sapiens	IC50		
Not Determined	3441961	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)(C)c1ccc(-c2n[nH]c3ncnc(N)c23)cc1		CHEMBL1241240		IC50			CHEMBL3234	Homo sapiens	IC50		
	3441975	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(O)cc2)c2c(N)ncnc21		CHEMBL1241241	=	IC50	nM	47.0	CHEMBL3234	Homo sapiens	IC50	uM	0.047
Not Determined	3441989	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3cccc(O)c3)c12		CHEMBL1241242		IC50			CHEMBL3234	Homo sapiens	IC50		
Not Determined	3442003	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1cc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1241269		IC50			CHEMBL3234	Homo sapiens	IC50		
Not Determined	3442017	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CNc1ncnc2c1c(-c1cccc(O)c1)nn2C(C)C		CHEMBL1241942		IC50			CHEMBL3234	Homo sapiens	IC50		
	3442031	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1cc(O)ccc1-c1nn(C(C)C)c2ncnc(N)c12		CHEMBL1242024	=	IC50	nM	23.0	CHEMBL3234	Homo sapiens	IC50	uM	0.023
	3442045	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc(-c2n[nH]c3ncnc(N)c23)cc1OCc1ccccc1		CHEMBL1242025	=	IC50	nM	12700.0	CHEMBL3234	Homo sapiens	IC50	uM	12.7
	3442059	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc(-c2n[nH]c3ncnc(N)c23)cc1O		CHEMBL1241270	=	IC50	nM	78.0	CHEMBL3234	Homo sapiens	IC50	uM	0.078
	3442073	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc(-c2nn(C)c3ncnc(N)c23)cc1O		CHEMBL1241271	=	IC50	nM	65.0	CHEMBL3234	Homo sapiens	IC50	uM	0.065
	3442087	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1O		CHEMBL1242026	=	IC50	nM	5.1	CHEMBL3234	Homo sapiens	IC50	uM	0.0051
	3442101	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCC(C)n1nc(-c2ccc(C)c(O)c2)c2c(N)ncnc21		CHEMBL1242109	=	IC50	nM	19.0	CHEMBL3234	Homo sapiens	IC50	uM	0.019
	3442115	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2F)c2c(N)ncnc21		CHEMBL1242110	=	IC50	nM	76.0	CHEMBL3234	Homo sapiens	IC50	uM	0.076
	3442129	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cccc(O)c1F)nn2C1CCCC1		CHEMBL1242111	=	IC50	nM	28.0	CHEMBL3234	Homo sapiens	IC50	uM	0.028
	3442143	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc(O)cc(F)c2)c2c(N)ncnc21		CHEMBL1242198	=	IC50	nM	47.0	CHEMBL3234	Homo sapiens	IC50	uM	0.047
	3442157	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cc(O)cc(F)c1)nn2C1CCCC1		CHEMBL1242199	=	IC50	nM	4.4	CHEMBL3234	Homo sapiens	IC50	uM	0.0044
	3442171	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(Br)cc(-c2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL1242200	=	IC50	nM	436.0	CHEMBL3234	Homo sapiens	IC50	uM	0.436
	3442181	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C[C@H](C)CO)c3ncnc(N)c23)cc1OC		CHEMBL1242380	=	IC50	nM	920.0	CHEMBL3234	Homo sapiens	IC50	uM	0.92
	3442195	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C[C@@H](C)CO)c3ncnc(N)c23)cc1OC		CHEMBL1242381	=	IC50	nM	2000.0	CHEMBL3234	Homo sapiens	IC50	uM	2.0
	3442209	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1OC		CHEMBL1240553	=	IC50	nM	117.0	CHEMBL3234	Homo sapiens	IC50	uM	0.117
	3442223	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1ccc(-c2n[nH]c3ncnc(N)c23)cc1OC		CHEMBL1242471	=	IC50	nM	6000.0	CHEMBL3234	Homo sapiens	IC50	uM	6.0
	3442237	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1OC		CHEMBL1242472	=	IC50	nM	551.0	CHEMBL3234	Homo sapiens	IC50	uM	0.551
	3442251	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C=CCn1nc(-c2ccc(OCC)c(OC)c2)c2c(N)ncnc21		CHEMBL1242569	=	IC50	nM	3400.0	CHEMBL3234	Homo sapiens	IC50	uM	3.4
	3442265	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1OC		CHEMBL1240554	=	IC50	nM	285.0	CHEMBL3234	Homo sapiens	IC50	uM	0.285
	3442279	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1ccc(-c2nn(C3CCCCC3)c3ncnc(N)c23)cc1OC		CHEMBL1242659	=	IC50	nM	861.0	CHEMBL3234	Homo sapiens	IC50	uM	0.861
	3442293	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)cc(OC)c1OC		CHEMBL1242660	=	IC50	nM	96.0	CHEMBL3234	Homo sapiens	IC50	uM	0.096
	3442307	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cccc(-c2nn(C(C)C)c3ncnc(N)c23)c1OC		CHEMBL1242751	=	IC50	nM	733.0	CHEMBL3234	Homo sapiens	IC50	uM	0.733
	3442321	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1OC		CHEMBL1242752	=	IC50	nM	1200.0	CHEMBL3234	Homo sapiens	IC50	uM	1.2
	3442335	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1cc(-c2nn(CCO)c3ncnc(N)c23)ccc1OC		CHEMBL1242753	=	IC50	nM	10500.0	CHEMBL3234	Homo sapiens	IC50	uM	10.5
	3442349	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ncc(-c2nn(C(C)C)c3ncnc(N)c23)c(OC)n1		CHEMBL1242846	=	IC50	nM	1600.0	CHEMBL3234	Homo sapiens	IC50	uM	1.6
	3442363	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1		CHEMBL1242847	=	IC50	nM	380.0	CHEMBL3234	Homo sapiens	IC50	uM	0.38
Not Determined	3442377	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccccc3O)c12		CHEMBL1241355		IC50			CHEMBL3234	Homo sapiens	IC50		
	3442391	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(N)c(O)c2)c2c(N)ncnc21		CHEMBL1242848	=	IC50	nM	46.0	CHEMBL3234	Homo sapiens	IC50	uM	0.046
	3442405	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1N		CHEMBL1241485	=	IC50	nM	37.0	CHEMBL3234	Homo sapiens	IC50	uM	0.037
	3442419	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1NC(C)CO		CHEMBL1241486	=	IC50	nM	567.0	CHEMBL3234	Homo sapiens	IC50	uM	0.567
	3442433	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1O		CHEMBL1241487	=	IC50	nM	13.0	CHEMBL3234	Homo sapiens	IC50	uM	0.013
	3442447	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C3CCCC3)c3ncnc(N)c23)ccc1N		CHEMBL1241581	=	IC50	nM	2.0	CHEMBL3234	Homo sapiens	IC50	uM	0.002
Not Determined	3442461	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ccc(-c2n[nH]c3ncnc(N)c23)cc1		CHEMBL1241356		IC50			CHEMBL3234	Homo sapiens	IC50		
Not Determined	3442475	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1cccc(-c2n[nH]c3ncnc(N)c23)c1		CHEMBL1241357		IC50			CHEMBL3234	Homo sapiens	IC50		
Not Determined	3442489	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccc([N+](=O)[O-])cc3)c12		CHEMBL1241358		IC50			CHEMBL3234	Homo sapiens	IC50		
Not Determined	3442503	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3cccc([N+](=O)[O-])c3)c12		CHEMBL1241389		IC50			CHEMBL3234	Homo sapiens	IC50		
	3442517	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(CO)c2)c2c(N)ncnc21		CHEMBL1241582	=	IC50	nM	2400.0	CHEMBL3234	Homo sapiens	IC50	uM	2.4
	3442531	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(CC#N)c2)c2c(N)ncnc21		CHEMBL1241583	=	IC50	nM	5000.0	CHEMBL3234	Homo sapiens	IC50	uM	5.0
	3442545	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(CC#N)cc2)c2c(N)ncnc21		CHEMBL1240545	=	IC50	nM	510.0	CHEMBL3234	Homo sapiens	IC50	uM	0.51
	3442558	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(C#N)c2)c2c(N)ncnc21		CHEMBL1241679	=	IC50	nM	50000.0	CHEMBL3234	Homo sapiens	IC50	uM	50.0
	3442572	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(F)c(C#N)c2)c2c(N)ncnc21		CHEMBL1241680	=	IC50	nM	1000.0	CHEMBL3234	Homo sapiens	IC50	uM	1.0
	3442586	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(C#N)c(F)c2)c2c(N)ncnc21		CHEMBL1241771	=	IC50	nM	4300.0	CHEMBL3234	Homo sapiens	IC50	uM	4.3
	3442600	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(C#N)nc2)c2c(N)ncnc21		CHEMBL1241772	=	IC50	nM	13000.0	CHEMBL3234	Homo sapiens	IC50	uM	13.0
	3442614	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccnc2)c2c(N)ncnc21		CHEMBL1241390	=	IC50	nM	9200.0	CHEMBL3234	Homo sapiens	IC50	uM	9.2
	3442628	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cncnc2)c2c(N)ncnc21		CHEMBL1241391	=	IC50	nM	13000.0	CHEMBL3234	Homo sapiens	IC50	uM	13.0
	3442642	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(=O)c1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1		CHEMBL1241773	=	IC50	nM	1400.0	CHEMBL3234	Homo sapiens	IC50	uM	1.4
	3442656	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(C=O)c(F)c2)c2c(N)ncnc21		CHEMBL1241860	=	IC50	nM	855.0	CHEMBL3234	Homo sapiens	IC50	uM	0.855
	3442670	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc(F)c(C=O)c(F)c2)c2c(N)ncnc21		CHEMBL1241861	=	IC50	nM	516.0	CHEMBL3234	Homo sapiens	IC50	uM	0.516
	3442684	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(C(N)=O)c(Cl)c2)c2c(N)ncnc21		CHEMBL1241862	=	IC50	nM	7900.0	CHEMBL3234	Homo sapiens	IC50	uM	7.9
	3442698	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(=O)c1cccc(-c2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL1241946	=	IC50	nM	2300.0	CHEMBL3234	Homo sapiens	IC50	uM	2.3
	3442712	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc(C=O)co2)c2c(N)ncnc21		CHEMBL1241439	=	IC50	nM	4400.0	CHEMBL3234	Homo sapiens	IC50	uM	4.4
	3442726	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1cc(-c2nn(C(C)C)c3ncnc(N)c23)sc1C=O		CHEMBL1241947	=	IC50	nM	7900.0	CHEMBL3234	Homo sapiens	IC50	uM	7.9
	3442739	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(NS(C)(=O)=O)c2)c2c(N)ncnc21		CHEMBL1241948	=	IC50	nM	3600.0	CHEMBL3234	Homo sapiens	IC50	uM	3.6
	3442752	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(NS(C)(=O)=O)cc2)c2c(N)ncnc21		CHEMBL1242030	=	IC50	nM	2300.0	CHEMBL3234	Homo sapiens	IC50	uM	2.3
	3442766	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(S(N)(=O)=O)c2)c2c(N)ncnc21		CHEMBL1242031	=	IC50	nM	5300.0	CHEMBL3234	Homo sapiens	IC50	uM	5.3
	3442780	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(S(N)(=O)=O)cc2)c2c(N)ncnc21		CHEMBL1242032	=	IC50	nM	1500.0	CHEMBL3234	Homo sapiens	IC50	uM	1.5
	3442794	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(C(=O)NC3=NCCS3)c2)c2c(N)ncnc21		CHEMBL1242115	=	IC50	nM	2400.0	CHEMBL3234	Homo sapiens	IC50	uM	2.4
Not Determined	3442808	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccc(NC(=O)c4ccc(-c5ccccc5)cc4)cc3)c12		CHEMBL1242116		IC50			CHEMBL3234	Homo sapiens	IC50		
Not Determined	3442822	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccc(Oc4ccccc4)cc3)c12		CHEMBL1242204		IC50			CHEMBL3234	Homo sapiens	IC50		
Not Determined	3442836	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3cccc(Oc4ccccc4)c3)c12		CHEMBL1242205		IC50			CHEMBL3234	Homo sapiens	IC50		
Not Determined	3442850	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc(OCc3ccccc3)cc2)c2c(N)ncnc21		CHEMBL1242206		IC50			CHEMBL3234	Homo sapiens	IC50		
Not Determined	3442864	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1242291		IC50			CHEMBL3234	Homo sapiens	IC50		
Not Determined	3442878	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3cccc(OCc4c(Cl)cccc4Cl)c3)c12		CHEMBL1242292		IC50			CHEMBL3234	Homo sapiens	IC50		
Not Determined	3442892	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3ccccc3c1)nn2CCc1ccccc1		CHEMBL1242382		IC50			CHEMBL3234	Homo sapiens	IC50		
Not Determined	3442906	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	NC(=O)Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1242383		IC50			CHEMBL3234	Homo sapiens	IC50		
Not Determined	3442920	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3ccccc3c1)nn2CC1CC1		CHEMBL1242473		IC50			CHEMBL3234	Homo sapiens	IC50		
Not Determined	3442934	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)CCn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1242474		IC50			CHEMBL3234	Homo sapiens	IC50		
	3442959	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2C1CCCC1		CHEMBL1241676	=	IC50	nM	0.18	CHEMBL3234	Homo sapiens	IC50	uM	0.00018
	3442973	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2[C@@H]1CCNC1		CHEMBL1241677	=	IC50	nM	20.0	CHEMBL3234	Homo sapiens	IC50	uM	0.02
	3442987	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2[C@H]1CCOC1		CHEMBL1241678	=	IC50	nM	8.8	CHEMBL3234	Homo sapiens	IC50	uM	0.0088
	3443001	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2[C@@H]1CCOC1		CHEMBL1241768	=	IC50	nM	8.0	CHEMBL3234	Homo sapiens	IC50	uM	0.008
	3443015	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CC1CCCN1		CHEMBL1241769	=	IC50	nM	328.0	CHEMBL3234	Homo sapiens	IC50	uM	0.328
	3443029	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CC1CCNC1		CHEMBL1241770	=	IC50	nM	67.0	CHEMBL3234	Homo sapiens	IC50	uM	0.067
	3443043	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CC1CCCNC1		CHEMBL1241858	=	IC50	nM	1130.0	CHEMBL3234	Homo sapiens	IC50	uM	1.13
	3443057	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CC1CCNCC1		CHEMBL1241859	=	IC50	nM	862.0	CHEMBL3234	Homo sapiens	IC50	uM	0.862
	3443071	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CCC1CCCNC1		CHEMBL1241943	=	IC50	nM	244.0	CHEMBL3234	Homo sapiens	IC50	uM	0.244
	3443085	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(C#N)c(O)c2)c2c(N)ncnc21		CHEMBL1241944	=	IC50	nM	708.0	CHEMBL3234	Homo sapiens	IC50	uM	0.708
	3443099	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(O)c(F)c2)c2c(N)ncnc21		CHEMBL1241945	=	IC50	nM	26.0	CHEMBL3234	Homo sapiens	IC50	uM	0.026
	3443113	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(F)c(-c2nn(C(C)C)c3ncnc(N)c23)cc1F		CHEMBL1242027	=	IC50	nM	113.0	CHEMBL3234	Homo sapiens	IC50	uM	0.113
	3443127	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc(F)c(O)cc2F)c2c(N)ncnc21		CHEMBL1242028	=	IC50	nM	76.0	CHEMBL3234	Homo sapiens	IC50	uM	0.076
	3443141	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cccc(-c2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL1242029	=	IC50	nM	180.0	CHEMBL3234	Homo sapiens	IC50	uM	0.18
	3443155	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1O		CHEMBL1242112	=	IC50	nM	100.0	CHEMBL3234	Homo sapiens	IC50	uM	0.1
	3443169	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2n[nH]c3ncnc(N)c23)cc1O		CHEMBL1241300	=	IC50	nM	624.0	CHEMBL3234	Homo sapiens	IC50	uM	0.624
	3443183	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C)c3ncnc(N)c23)cc1O		CHEMBL1241301	=	IC50	nM	794.0	CHEMBL3234	Homo sapiens	IC50	uM	0.794
	3443197	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCn1nc(-c2ccc(OC)c(O)c2)c2c(N)ncnc21		CHEMBL1242113	=	IC50	nM	115.0	CHEMBL3234	Homo sapiens	IC50	uM	0.115
	3443211	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1O		CHEMBL1242114	=	IC50	nM	18.0	CHEMBL3234	Homo sapiens	IC50	uM	0.018
	3443225	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1O		CHEMBL1242201	=	IC50	nM	18.0	CHEMBL3234	Homo sapiens	IC50	uM	0.018
	3443239	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC(C)C3)c3ncnc(N)c23)cc1O		CHEMBL1242202	=	IC50	nM	10.0	CHEMBL3234	Homo sapiens	IC50	uM	0.01
	3443253	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CNC3)c3ncnc(N)c23)cc1O		CHEMBL1242203	=	IC50	nM	1200.0	CHEMBL3234	Homo sapiens	IC50	uM	1.2
	3443267	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn([C@@H]3CCNC3)c3ncnc(N)c23)cc1O		CHEMBL1242288	=	IC50	nM	311.0	CHEMBL3234	Homo sapiens	IC50	uM	0.311
	3443281	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1O		CHEMBL1242289	=	IC50	nM	82.0	CHEMBL3234	Homo sapiens	IC50	uM	0.082
	3443295	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1OC		CHEMBL1242290	=	IC50	nM	1100.0	CHEMBL3234	Homo sapiens	IC50	uM	1.1
	3443309	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1OC		CHEMBL1242379	=	IC50	nM	440.0	CHEMBL3234	Homo sapiens	IC50	uM	0.44
	3443413	CHEMBL1244446	Inhibition of HCK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	99.0	CHEMBL3234	Homo sapiens	INH	%	99.0
	3443630	CHEMBL1244446	Inhibition of HCK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	97.0	CHEMBL3234	Homo sapiens	INH	%	97.0
Not Determined	3443742	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3ccccc3c1)nn2C/C=C/c1ccccc1		CHEMBL1242570		IC50			CHEMBL3234	Homo sapiens	IC50		
Not Determined	3443756	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C#CCn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1242571		IC50			CHEMBL3234	Homo sapiens	IC50		
	3443770	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1ccc2cc(-c3nn(C)c4ncnc(N)c34)ccc2c1		CHEMBL1242661	=	IC50	nM	540.0	CHEMBL3234	Homo sapiens	IC50	uM	0.54
	3443784	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3cc(O)ccc3c2)c2c(N)ncnc21		CHEMBL1242662	=	IC50	nM	20.0	CHEMBL3234	Homo sapiens	IC50	uM	0.02
	3443798	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3ccccc3nc2Cl)c2c(N)ncnc21		CHEMBL1242663	=	IC50	nM	1600.0	CHEMBL3234	Homo sapiens	IC50	uM	1.6
	3443812	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cnc3ccccc3c2)c2c(N)ncnc21		CHEMBL1242754	=	IC50	nM	422.0	CHEMBL3234	Homo sapiens	IC50	uM	0.422
	3443826	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3ccccc3c1)nn2C1CCCC1		CHEMBL1242755	=	IC50	nM	326.0	CHEMBL3234	Homo sapiens	IC50	uM	0.326
	3443840	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1242756	=	IC50	nM	100000.0	CHEMBL3234	Homo sapiens	IC50	uM	100.0
Not Determined	3443854	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2cccc(-c3ccccc3)c2)c2c(N)ncnc21		CHEMBL1242849		IC50			CHEMBL3234	Homo sapiens	IC50		
Not Determined	3443868	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccc(-c4ccccc4)cc3)c12		CHEMBL1242850		IC50			CHEMBL3234	Homo sapiens	IC50		
Not Determined	3443882	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(C3CCc4ccccc4C3)c12		CHEMBL1241440		IC50			CHEMBL3234	Homo sapiens	IC50		
Not Determined	3443896	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccc4ccccc4c3)c12		CHEMBL1241441		IC50			CHEMBL3234	Homo sapiens	IC50		
Not Determined	3443910	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1242851		IC50			CHEMBL3234	Homo sapiens	IC50		
Not Determined	3443924	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C=CCn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1241488		IC50			CHEMBL3234	Homo sapiens	IC50		
Not Determined	3443938	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1241489		IC50			CHEMBL3234	Homo sapiens	IC50		
Not Determined	3443952	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)(C)n1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1231371		IC50			CHEMBL3234	Homo sapiens	IC50		
Not Determined	3443966	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3ccccc3c1)nn2C1CCCC1		CHEMBL1241584		IC50			CHEMBL3234	Homo sapiens	IC50		
Not Determined	3443980	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3ccccc3c1)nn2Cc1ccccc1		CHEMBL1241585		IC50			CHEMBL3234	Homo sapiens	IC50		
	3443994	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3ncccc3c1)nn2C1CCCC1		CHEMBL1241681	=	IC50	nM	540.0	CHEMBL3234	Homo sapiens	IC50	uM	0.54
	3444008	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2n1		CHEMBL1241682	=	IC50	nM	2200.0	CHEMBL3234	Homo sapiens	IC50	uM	2.2
	3444022	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nc(Cl)ccc3c2)c2c(N)ncnc21		CHEMBL1241683	=	IC50	nM	878.0	CHEMBL3234	Homo sapiens	IC50	uM	0.878
	3444036	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nccnc3c2)c2c(N)ncnc21		CHEMBL1241774	=	IC50	nM	946.0	CHEMBL3234	Homo sapiens	IC50	uM	0.946
	3444050	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cnc3nccnc3c2)c2c(N)ncnc21		CHEMBL1241775	=	IC50	nM	12000.0	CHEMBL3234	Homo sapiens	IC50	uM	12.0
	3444064	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nc[nH]c(=O)c3c2)c2c(N)ncnc21		CHEMBL1241776	=	IC50	nM	248.0	CHEMBL3234	Homo sapiens	IC50	uM	0.248
	3444078	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3[nH]c(=O)ccc3c2)c2c(N)ncnc21		CHEMBL1241863	=	IC50	nM	2700.0	CHEMBL3234	Homo sapiens	IC50	uM	2.7
	3444092	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3[nH]c(=O)ccc3c1)nn2C1CCCC1		CHEMBL1241864	=	IC50	nM	1100.0	CHEMBL3234	Homo sapiens	IC50	uM	1.1
	3444106	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nc(N)ccc3c2)c2c(N)ncnc21		CHEMBL1241949	=	IC50	nM	17000.0	CHEMBL3234	Homo sapiens	IC50	uM	17.0
	3444120	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nc(NN)ccc3c2)c2c(N)ncnc21		CHEMBL1241950	=	IC50	nM	4300.0	CHEMBL3234	Homo sapiens	IC50	uM	4.3
	3444134	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nccc(NC(=O)OC(C)(C)C)c3c2)c2c(N)ncnc21		CHEMBL1242033	=	IC50	nM	17000.0	CHEMBL3234	Homo sapiens	IC50	uM	17.0
	3444148	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nccc(N)c3c2)c2c(N)ncnc21		CHEMBL1242034	=	IC50	nM	3400.0	CHEMBL3234	Homo sapiens	IC50	uM	3.4
	3444162	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3occc(=O)c3c2)c2c(N)ncnc21		CHEMBL1242117	=	IC50	nM	17000.0	CHEMBL3234	Homo sapiens	IC50	uM	17.0
	3444176	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3occc(=O)c3c2)c2c(N)ncnc21		CHEMBL1242118	=	IC50	nM	2500.0	CHEMBL3234	Homo sapiens	IC50	uM	2.5
	3444190	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3occc(=O)c3c1)nn2C1CCCC1		CHEMBL1242119	=	IC50	nM	1100.0	CHEMBL3234	Homo sapiens	IC50	uM	1.1
	3444204	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3cnccc3c2)c2c(N)ncnc21		CHEMBL1242207	=	IC50	nM	100000.0	CHEMBL3234	Homo sapiens	IC50	uM	100.0
	3444218	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ccncc3c2)c2c(N)ncnc21		CHEMBL1242208	=	IC50	nM	1800.0	CHEMBL3234	Homo sapiens	IC50	uM	1.8
	3444232	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc2ccc(-c3nn(C(C)C)c4ncnc(N)c34)cc2n1		CHEMBL1242209	=	IC50	nM	16000.0	CHEMBL3234	Homo sapiens	IC50	uM	16.0
	3444246	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2cnc3[nH]ccc3c2)c2c(N)ncnc21		CHEMBL1240565	=	IC50	nM	420.0	CHEMBL3234	Homo sapiens	IC50	uM	0.42
	3444260	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cnc3[nH]ccc3c2)c2c(N)ncnc21		CHEMBL1242293	=	IC50	nM	10.0	CHEMBL3234	Homo sapiens	IC50	uM	0.01
	3444274	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3[nH]ccc3c2)c2c(N)ncnc21		CHEMBL1242294	=	IC50	nM	15.0	CHEMBL3234	Homo sapiens	IC50	uM	0.015
	3444288	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1242295	=	IC50	nM	5.4	CHEMBL3234	Homo sapiens	IC50	uM	0.0054
	3444302	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3c(ccn3C)c2)c2c(N)ncnc21		CHEMBL1242384	=	IC50	nM	153.0	CHEMBL3234	Homo sapiens	IC50	uM	0.153
	3444316	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1ccc2cc(-c3nn(C4CCCC4)c4ncnc(N)c34)ccc21		CHEMBL1242385	=	IC50	nM	148.0	CHEMBL3234	Homo sapiens	IC50	uM	0.148
	3444330	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3[nH]ncc3c2)c2c(N)ncnc21		CHEMBL1242386	=	IC50	nM	53.0	CHEMBL3234	Homo sapiens	IC50	uM	0.053
	3444344	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3[nH]ncc3c1)nn2C1CCCC1		CHEMBL1242475	=	IC50	nM	33.0	CHEMBL3234	Homo sapiens	IC50	uM	0.033
	3444358	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3c(N)n[nH]c3c2)c2c(N)ncnc21		CHEMBL1242476	=	IC50	nM	35.0	CHEMBL3234	Homo sapiens	IC50	uM	0.035
	3444372	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3cn[nH]c3c2)c2c(N)ncnc21		CHEMBL1242477	=	IC50	nM	30.0	CHEMBL3234	Homo sapiens	IC50	uM	0.03
	3444386	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3cn[nH]c3c1)nn2C1CCCC1		CHEMBL1242572	=	IC50	nM	37.0	CHEMBL3234	Homo sapiens	IC50	uM	0.037
	3444400	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc(F)c3cn[nH]c3c2)c2c(N)ncnc21		CHEMBL1242573	=	IC50	nM	76.0	CHEMBL3234	Homo sapiens	IC50	uM	0.076
	3444414	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3cc[nH]c3c2)c2c(N)ncnc21		CHEMBL1240566	=	IC50	nM	220.0	CHEMBL3234	Homo sapiens	IC50	uM	0.22
	3444428	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3cc[nH]c3c2)c2c(N)ncnc21		CHEMBL1242574	=	IC50	nM	18.0	CHEMBL3234	Homo sapiens	IC50	uM	0.018
	3444442	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3cc[nH]c3c1)nn2C1CCCC1		CHEMBL1242664	=	IC50	nM	5.0	CHEMBL3234	Homo sapiens	IC50	uM	0.005
	3444456	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccn3ccnc3c2)c2c(N)ncnc21		CHEMBL1242665	=	IC50	nM	100000.0	CHEMBL3234	Homo sapiens	IC50	uM	100.0
	3444470	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3c(C=O)c[nH]c3c2)c2c(N)ncnc21		CHEMBL1242666	=	IC50	nM	270.0	CHEMBL3234	Homo sapiens	IC50	uM	0.27
	3444484	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc3[nH]ccc23)c2c(N)ncnc21		CHEMBL1242757	=	IC50	nM	1200.0	CHEMBL3234	Homo sapiens	IC50	uM	1.2
	3444498	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cccc3[nH]ccc13)nn2C1CCCC1		CHEMBL1242758	=	IC50	nM	57.0	CHEMBL3234	Homo sapiens	IC50	uM	0.057
	3444512	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3c(ccn3C(=O)OC(C)(C)C)c2)c2c(N)ncnc21		CHEMBL1242852	=	IC50	nM	9.0	CHEMBL3234	Homo sapiens	IC50	uM	0.009
	3444526	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)(C)OC(=O)n1ccc2cc(-c3nn(C4CCCC4)c4ncnc(N)c34)ccc21		CHEMBL1242853	=	IC50	nM	48.0	CHEMBL3234	Homo sapiens	IC50	uM	0.048
	3444540	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3occc3c2)c2c(N)ncnc21		CHEMBL1241490	=	IC50	nM	91.0	CHEMBL3234	Homo sapiens	IC50	uM	0.091
	3444554	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3occc3c1)nn2C1CCCC1		CHEMBL1241491	=	IC50	nM	56.0	CHEMBL3234	Homo sapiens	IC50	uM	0.056
	3444568	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nonc3c2)c2c(N)ncnc21		CHEMBL1241492	=	IC50	nM	1300.0	CHEMBL3234	Homo sapiens	IC50	uM	1.3
	3444582	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3[nH]c(=O)[nH]c3c2)c2c(N)ncnc21		CHEMBL1241586	=	IC50	nM	4800.0	CHEMBL3234	Homo sapiens	IC50	uM	4.8
	3444596	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3c(c2)CCO3)c2c(N)ncnc21		CHEMBL1241587	=	IC50	nM	889.0	CHEMBL3234	Homo sapiens	IC50	uM	0.889
Not Determined	3444610	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccc4c(c3)OCO4)c12		CHEMBL1240567		IC50			CHEMBL3234	Homo sapiens	IC50		
	3444624	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3c(c2)OCCO3)c2c(N)ncnc21		CHEMBL1241588	=	IC50	nM	1000.0	CHEMBL3234	Homo sapiens	IC50	uM	1.0
Not Determined	3444638	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2cc3ccccc3s2)c2c(N)ncnc21		CHEMBL1240594		IC50			CHEMBL3234	Homo sapiens	IC50		
	3444652	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(C=O)ccc3s2)c2c(N)ncnc21		CHEMBL1241684	=	IC50	nM	12000.0	CHEMBL3234	Homo sapiens	IC50	uM	12.0
	3444665	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	IC50	nM	110.0	CHEMBL3234	Homo sapiens	IC50	uM	0.11
	3444678	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	IC50	nM	1.0	CHEMBL3234	Homo sapiens	IC50	uM	0.001
	3444691	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	190.0	CHEMBL3234	Homo sapiens	IC50	uM	0.19
	3444785	CHEMBL1244446	Inhibition of HCK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	83.0	CHEMBL3234	Homo sapiens	INH	%	83.0
	3445138	CHEMBL1244861	Binding affinity to HCK	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	270.0	CHEMBL3234	Homo sapiens	Kd	nM	270.0
	3445409	CHEMBL1244446	Inhibition of HCK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	79.0	CHEMBL3234	Homo sapiens	INH	%	79.0
	3445626	CHEMBL1244446	Inhibition of HCK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	45.0	CHEMBL3234	Homo sapiens	INH	%	45.0
	3445834	CHEMBL1244446	Inhibition of HCK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	99.0	CHEMBL3234	Homo sapiens	INH	%	99.0
	3446024	CHEMBL1244446	Inhibition of HCK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	79.0	CHEMBL3234	Homo sapiens	INH	%	79.0
	3446169	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	530.0	CHEMBL3234	Homo sapiens	IC50	uM	0.53
	3446170	CHEMBL1243973	Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	530.0	CHEMBL3234	Homo sapiens	IC50	uM	0.53
	3446192	CHEMBL1244332	Inhibition of HCK	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	3.2	CHEMBL3234	Homo sapiens	IC50	nM	3.2
	3448450	CHEMBL1244861	Binding affinity to HCK	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	uM	10.0
	3448947	CHEMBL1244861	Binding affinity to HCK	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	720.0	CHEMBL3234	Homo sapiens	Kd	nM	720.0
	3449211	CHEMBL1244861	Binding affinity to HCK	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	880.0	CHEMBL3234	Homo sapiens	Kd	nM	880.0
	3449439	CHEMBL1244861	Binding affinity to HCK	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	=	Kd	nM	960.0	CHEMBL3234	Homo sapiens	Kd	nM	960.0
	3449683	CHEMBL1244861	Binding affinity to HCK	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	uM	10.0
	3450093	CHEMBL1244861	Binding affinity to HCK	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	uM	10.0
	3463247	CHEMBL1252435	Inhibition of HCK at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	8.0	CHEMBL3234	Homo sapiens	INH	%	8.0
	3463791	CHEMBL1252435	Inhibition of HCK at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	15.0	CHEMBL3234	Homo sapiens	INH	%	15.0
	3464010	CHEMBL1252435	Inhibition of HCK at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	9.0	CHEMBL3234	Homo sapiens	INH	%	9.0
	5121121	CHEMBL1645982	Inhibition of human Hck at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	112.0	CHEMBL3234	Homo sapiens	INH	%	112.0
	5243714	CHEMBL1685677	Inhibition of Hck at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	61.0	CHEMBL3234	Homo sapiens	INH	%	61.0
	5243822	CHEMBL1685926	Inhibition of Hck at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	7.0	CHEMBL3234	Homo sapiens	INH	%	7.0
	5243935	CHEMBL1685677	Inhibition of Hck at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	15.0	CHEMBL3234	Homo sapiens	INH	%	15.0
	5244043	CHEMBL1685926	Inhibition of Hck at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	0.0	CHEMBL3234	Homo sapiens	INH	%	0.0
	5244916	CHEMBL1685677	Inhibition of Hck at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	65.0	CHEMBL3234	Homo sapiens	INH	%	65.0
	5245024	CHEMBL1685926	Inhibition of Hck at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	18.0	CHEMBL3234	Homo sapiens	INH	%	18.0
	5245175	CHEMBL1685677	Inhibition of Hck at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	51.0	CHEMBL3234	Homo sapiens	INH	%	51.0
	5246005	CHEMBL1685926	Inhibition of Hck at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	14.0	CHEMBL3234	Homo sapiens	INH	%	14.0
	6167645	CHEMBL1769186	Inhibition of HCK	B	CNc1cncc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCC[C@H]4CN4CCCC4)cc3)c2)n1		CHEMBL1765781	>	Ki	nM	1000.0	CHEMBL3234	Homo sapiens	Ki	uM	1.0
	6341068	CHEMBL1828381	Activity of HCK kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL3234	Homo sapiens	Activity	%	100.0
	6372720	CHEMBL1837746	Inhibition human recombinant HcK using KVEKIGEGTYGVVYK peptide substrate in presence of [gamma-32P]-ATP	B	CSc1nc(Nc2cccc(Cl)c2)c2cnn(CCc3ccccc3)c2n1		CHEMBL1836673	=	Ki	nM	1720.0	CHEMBL3234	Homo sapiens	Ki	uM	1.72
	6372721	CHEMBL1837746	Inhibition human recombinant HcK using KVEKIGEGTYGVVYK peptide substrate in presence of [gamma-32P]-ATP	B	CSc1nc(Nc2ccccc2)c2cnn(CC(C)c3ccccc3)c2n1		CHEMBL1836678	=	Ki	nM	3870.0	CHEMBL3234	Homo sapiens	Ki	uM	3.87
	6372722	CHEMBL1837746	Inhibition human recombinant HcK using KVEKIGEGTYGVVYK peptide substrate in presence of [gamma-32P]-ATP	B	CSc1nc(Nc2cccc(Cl)c2)c2cnn(CC(C)c3ccccc3)c2n1		CHEMBL1836679	=	Ki	nM	5000.0	CHEMBL3234	Homo sapiens	Ki	uM	5.0
	6386337	CHEMBL1839878	Inhibition of recombinant HCK	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	>	IC50	nM	10000.0	CHEMBL3234	Homo sapiens	IC50	uM	10.0
	7567252	CHEMBL1908554	Binding constant for HCK kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	590.0	CHEMBL3234	Homo sapiens	Kd	nM	590.0
	7567711	CHEMBL1908554	Binding constant for HCK kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7568182	CHEMBL1908554	Binding constant for HCK kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7568640	CHEMBL1908554	Binding constant for HCK kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	2200.0	CHEMBL3234	Homo sapiens	Kd	nM	2200.0
	7569225	CHEMBL1908554	Binding constant for HCK kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7569685	CHEMBL1908554	Binding constant for HCK kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7570178	CHEMBL1908554	Binding constant for HCK kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7570605	CHEMBL1908554	Binding constant for HCK kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	880.0	CHEMBL3234	Homo sapiens	Kd	nM	880.0
	7571201	CHEMBL1908554	Binding constant for HCK kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7571658	CHEMBL1908554	Binding constant for HCK kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	0.35	CHEMBL3234	Homo sapiens	Kd	nM	0.35
	7571692	CHEMBL1908554	Binding constant for HCK kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7572155	CHEMBL1908554	Binding constant for HCK kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7572571	CHEMBL1908554	Binding constant for HCK kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	410.0	CHEMBL3234	Homo sapiens	Kd	nM	410.0
	7573182	CHEMBL1908554	Binding constant for HCK kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	5300.0	CHEMBL3234	Homo sapiens	Kd	nM	5300.0
	7573673	CHEMBL1908554	Binding constant for HCK kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	3700.0	CHEMBL3234	Homo sapiens	Kd	nM	3700.0
	7574142	CHEMBL1908554	Binding constant for HCK kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	720.0	CHEMBL3234	Homo sapiens	Kd	nM	720.0
	7574550	CHEMBL1908554	Binding constant for HCK kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7575179	CHEMBL1908554	Binding constant for HCK kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	1800.0	CHEMBL3234	Homo sapiens	Kd	nM	1800.0
	7575650	CHEMBL1908554	Binding constant for HCK kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	=	Kd	nM	440.0	CHEMBL3234	Homo sapiens	Kd	nM	440.0
	7576115	CHEMBL1908554	Binding constant for HCK kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	=	Kd	nM	2700.0	CHEMBL3234	Homo sapiens	Kd	nM	2700.0
	7576523	CHEMBL1908554	Binding constant for HCK kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	2100.0	CHEMBL3234	Homo sapiens	Kd	nM	2100.0
	7576692	CHEMBL1908554	Binding constant for HCK kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	=	Kd	nM	2200.0	CHEMBL3234	Homo sapiens	Kd	nM	2200.0
	7577151	CHEMBL1908554	Binding constant for HCK kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	15.0	CHEMBL3234	Homo sapiens	Kd	nM	15.0
	7577629	CHEMBL1908554	Binding constant for HCK kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	4300.0	CHEMBL3234	Homo sapiens	Kd	nM	4300.0
	7578099	CHEMBL1908554	Binding constant for HCK kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	190.0	CHEMBL3234	Homo sapiens	Kd	nM	190.0
	7578504	CHEMBL1908554	Binding constant for HCK kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	360.0	CHEMBL3234	Homo sapiens	Kd	nM	360.0
	7578700	CHEMBL1908554	Binding constant for HCK kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7579074	CHEMBL1908554	Binding constant for HCK kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7579524	CHEMBL1908554	Binding constant for HCK kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7579998	CHEMBL1908554	Binding constant for HCK kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7580467	CHEMBL1908554	Binding constant for HCK kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7580870	CHEMBL1908554	Binding constant for HCK kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	6200.0	CHEMBL3234	Homo sapiens	Kd	nM	6200.0
	7581058	CHEMBL1908554	Binding constant for HCK kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	=	Kd	nM	690.0	CHEMBL3234	Homo sapiens	Kd	nM	690.0
	7581443	CHEMBL1908554	Binding constant for HCK kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7581888	CHEMBL1908554	Binding constant for HCK kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7582359	CHEMBL1908554	Binding constant for HCK kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7582823	CHEMBL1908554	Binding constant for HCK kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	150.0	CHEMBL3234	Homo sapiens	Kd	nM	150.0
	7583404	CHEMBL1908554	Binding constant for HCK kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7583801	CHEMBL1908554	Binding constant for HCK kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7584246	CHEMBL1908554	Binding constant for HCK kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7584717	CHEMBL1908554	Binding constant for HCK kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7585141	CHEMBL1908554	Binding constant for HCK kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7585734	CHEMBL1908554	Binding constant for HCK kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7586142	CHEMBL1908554	Binding constant for HCK kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	=	Kd	nM	2700.0	CHEMBL3234	Homo sapiens	Kd	nM	2700.0
	7586588	CHEMBL1908554	Binding constant for HCK kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	4400.0	CHEMBL3234	Homo sapiens	Kd	nM	4400.0
	7587071	CHEMBL1908554	Binding constant for HCK kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7587695	CHEMBL1908554	Binding constant for HCK kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7588114	CHEMBL1908554	Binding constant for HCK kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	270.0	CHEMBL3234	Homo sapiens	Kd	nM	270.0
	7588596	CHEMBL1908554	Binding constant for HCK kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7589047	CHEMBL1908554	Binding constant for HCK kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7589660	CHEMBL1908554	Binding constant for HCK kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	8600.0	CHEMBL3234	Homo sapiens	Kd	nM	8600.0
	7590084	CHEMBL1908554	Binding constant for HCK kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	3300.0	CHEMBL3234	Homo sapiens	Kd	nM	3300.0
	7590109	CHEMBL1908554	Binding constant for HCK kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7590583	CHEMBL1908554	Binding constant for HCK kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7591034	CHEMBL1908554	Binding constant for HCK kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7592085	CHEMBL1908554	Binding constant for HCK kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7592558	CHEMBL1908554	Binding constant for HCK kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	1500.0	CHEMBL3234	Homo sapiens	Kd	nM	1500.0
	7593011	CHEMBL1908554	Binding constant for HCK kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	3.4	CHEMBL3234	Homo sapiens	Kd	nM	3.4
	7593158	CHEMBL1908554	Binding constant for HCK kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	880.0	CHEMBL3234	Homo sapiens	Kd	nM	880.0
	7593593	CHEMBL1908554	Binding constant for HCK kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	1200.0	CHEMBL3234	Homo sapiens	Kd	nM	1200.0
	7594065	CHEMBL1908554	Binding constant for HCK kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7594538	CHEMBL1908554	Binding constant for HCK kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	390.0	CHEMBL3234	Homo sapiens	Kd	nM	390.0
	7594990	CHEMBL1908554	Binding constant for HCK kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	8500.0	CHEMBL3234	Homo sapiens	Kd	nM	8500.0
	7595126	CHEMBL1908554	Binding constant for HCK kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7595570	CHEMBL1908554	Binding constant for HCK kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	4200.0	CHEMBL3234	Homo sapiens	Kd	nM	4200.0
	7596044	CHEMBL1908554	Binding constant for HCK kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7596515	CHEMBL1908554	Binding constant for HCK kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	5700.0	CHEMBL3234	Homo sapiens	Kd	nM	5700.0
	7596962	CHEMBL1908554	Binding constant for HCK kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	20.0	CHEMBL3234	Homo sapiens	Kd	nM	20.0
	7597098	CHEMBL1908554	Binding constant for HCK kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	3900.0	CHEMBL3234	Homo sapiens	Kd	nM	3900.0
	7597551	CHEMBL1908554	Binding constant for HCK kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL3234	Homo sapiens	Kd	nM	10000.0
	7598024	CHEMBL1908554	Binding constant for HCK kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	490.0	CHEMBL3234	Homo sapiens	Kd	nM	490.0
	7598494	CHEMBL1908554	Binding constant for HCK kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	3.3	CHEMBL3234	Homo sapiens	Kd	nM	3.3
	7922686	CHEMBL1918460	Inhibition of human recombinant HCK at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	39.0	CHEMBL3234	Homo sapiens	INH	%	39.0
	7931096	CHEMBL1919271	Inhibition of HCK relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	Inhibition	%	5.0	CHEMBL3234	Homo sapiens	INH	%	5.0
	7959791	CHEMBL1932870	Inhibition of HCK	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL3234	Homo sapiens	IC50	uM	30.0
	7959792	CHEMBL1932870	Inhibition of HCK	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	1700.0	CHEMBL3234	Homo sapiens	IC50	uM	1.7
	7996697	CHEMBL1944028	Inhibition of HCK	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939491	=	Inhibition	%	96.0	CHEMBL3234	Homo sapiens	INH	%	96.0
	8004400	CHEMBL1943596	Inhibition of human HCK in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940980	<	Inhibition	%	35.0	CHEMBL3234	Homo sapiens	INH	%	35.0
	8004401	CHEMBL1943596	Inhibition of human HCK in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940981	<	Inhibition	%	35.0	CHEMBL3234	Homo sapiens	INH	%	35.0
	8004402	CHEMBL1943596	Inhibition of human HCK in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940987	<	Inhibition	%	35.0	CHEMBL3234	Homo sapiens	INH	%	35.0
	8004403	CHEMBL1943596	Inhibition of human HCK in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940990	<	Inhibition	%	35.0	CHEMBL3234	Homo sapiens	INH	%	35.0
	8013100	CHEMBL1948119	Inhibition of HCK using ATP as substrate	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	>	IC50	nM	10000.0	CHEMBL3234	Homo sapiens	IC50	uM	10.0
	8047125	CHEMBL1958952	Inhibition of HCK at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL3234	Homo sapiens	INH	%	50.0
	8061566	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	33.73	CHEMBL3234	Homo sapiens	Inhibition	%	33.73
	8061673	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	4.85	CHEMBL3234	Homo sapiens	Inhibition	%	4.85
	8061897	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	11.14	CHEMBL3234	Homo sapiens	Inhibition	%	11.14
	8062088	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	6.56	CHEMBL3234	Homo sapiens	Inhibition	%	6.56
	8062204	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	19.93	CHEMBL3234	Homo sapiens	Inhibition	%	19.93
	8062428	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	6.35	CHEMBL3234	Homo sapiens	Inhibition	%	6.35
	8062590	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	6.08	CHEMBL3234	Homo sapiens	Inhibition	%	6.08
	8062912	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	3.12	CHEMBL3234	Homo sapiens	Inhibition	%	3.12
	8063044	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	12.88	CHEMBL3234	Homo sapiens	Inhibition	%	12.88
	8063268	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	55.15	CHEMBL3234	Homo sapiens	Inhibition	%	55.15
	8063435	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.57	CHEMBL3234	Homo sapiens	Inhibition	%	1.57
	8063767	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	3.56	CHEMBL3234	Homo sapiens	Inhibition	%	3.56
	8063949	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	42.08	CHEMBL3234	Homo sapiens	Inhibition	%	42.08
	8064288	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	6.33	CHEMBL3234	Homo sapiens	Inhibition	%	6.33
	8064498	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.53	CHEMBL3234	Homo sapiens	Inhibition	%	1.53
	8064860	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	5.41	CHEMBL3234	Homo sapiens	Inhibition	%	5.41
	8065026	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	4.58	CHEMBL3234	Homo sapiens	Inhibition	%	4.58
	8065366	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	4.66	CHEMBL3234	Homo sapiens	Inhibition	%	4.66
	8065541	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	5.43	CHEMBL3234	Homo sapiens	Inhibition	%	5.43
	8065880	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	4.12	CHEMBL3234	Homo sapiens	Inhibition	%	4.12
	8066090	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	4.13	CHEMBL3234	Homo sapiens	Inhibition	%	4.13
	8066450	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	30.19	CHEMBL3234	Homo sapiens	Inhibition	%	30.19
	8066616	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	-0.93	CHEMBL3234	Homo sapiens	Inhibition	%	-0.93
	8066840	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	5.16	CHEMBL3234	Homo sapiens	Inhibition	%	5.16
	8066964	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	6.2	CHEMBL3234	Homo sapiens	Inhibition	%	6.2
	8067139	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	31.24	CHEMBL3234	Homo sapiens	Inhibition	%	31.24
	8067363	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	3.3	CHEMBL3234	Homo sapiens	Inhibition	%	3.3
	8067484	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	4.03	CHEMBL3234	Homo sapiens	Inhibition	%	4.03
	8067694	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	11.63	CHEMBL3234	Homo sapiens	Inhibition	%	11.63
	8067918	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	16.33	CHEMBL3234	Homo sapiens	Inhibition	%	16.33
	8068053	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	5.71	CHEMBL3234	Homo sapiens	Inhibition	%	5.71
	8068441	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	0.69	CHEMBL3234	Homo sapiens	Inhibition	%	0.69
	8068566	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	6.79	CHEMBL3234	Homo sapiens	Inhibition	%	6.79
	8068964	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	7.43	CHEMBL3234	Homo sapiens	Inhibition	%	7.43
	8069089	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.96	CHEMBL3234	Homo sapiens	Inhibition	%	1.96
	8069313	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	5.95	CHEMBL3234	Homo sapiens	Inhibition	%	5.95
	8069384	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	32.75	CHEMBL3234	Homo sapiens	Inhibition	%	32.75
	8069608	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	7.51	CHEMBL3234	Homo sapiens	Inhibition	%	7.51
	8069769	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	7.33	CHEMBL3234	Homo sapiens	Inhibition	%	7.33
	8069895	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.68	CHEMBL3234	Homo sapiens	Inhibition	%	1.68
	8070119	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	3.88	CHEMBL3234	Homo sapiens	Inhibition	%	3.88
	8070291	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	4.09	CHEMBL3234	Homo sapiens	Inhibition	%	4.09
	8070640	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	2.47	CHEMBL3234	Homo sapiens	Inhibition	%	2.47
	8070938	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	32.57	CHEMBL3234	Homo sapiens	Inhibition	%	32.57
	8071095	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.49	CHEMBL3234	Homo sapiens	Inhibition	%	2.49
	8071445	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.57	CHEMBL3234	Homo sapiens	Inhibition	%	0.57
	8071618	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	6.94	CHEMBL3234	Homo sapiens	Inhibition	%	6.94
	8071967	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	4.67	CHEMBL3234	Homo sapiens	Inhibition	%	4.67
	8072281	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.11	CHEMBL3234	Homo sapiens	Inhibition	%	1.11
	8072438	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	4.3	CHEMBL3234	Homo sapiens	Inhibition	%	4.3
	8072662	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	2.26	CHEMBL3234	Homo sapiens	Inhibition	%	2.26
	8072787	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	5.58	CHEMBL3234	Homo sapiens	Inhibition	%	5.58
	8072954	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	5.5	CHEMBL3234	Homo sapiens	Inhibition	%	5.5
	8073178	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	9.03	CHEMBL3234	Homo sapiens	Inhibition	%	9.03
	8073303	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	8.79	CHEMBL3234	Homo sapiens	Inhibition	%	8.79
	8073646	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	1.4	CHEMBL3234	Homo sapiens	Inhibition	%	1.4
	8073879	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	7.7	CHEMBL3234	Homo sapiens	Inhibition	%	7.7
	8074255	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	4.53	CHEMBL3234	Homo sapiens	Inhibition	%	4.53
	8074385	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	2.13	CHEMBL3234	Homo sapiens	Inhibition	%	2.13
	8074766	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	2.65	CHEMBL3234	Homo sapiens	Inhibition	%	2.65
	8074893	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	28.34	CHEMBL3234	Homo sapiens	Inhibition	%	28.34
	8075117	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.79	CHEMBL3234	Homo sapiens	Inhibition	%	0.79
	8075228	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	6.19	CHEMBL3234	Homo sapiens	Inhibition	%	6.19
	8075465	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-1.79	CHEMBL3234	Homo sapiens	Inhibition	%	-1.79
	8075830	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.57	CHEMBL3234	Homo sapiens	Inhibition	%	3.57
	8075972	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	10.07	CHEMBL3234	Homo sapiens	Inhibition	%	10.07
	8076196	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.81	CHEMBL3234	Homo sapiens	Inhibition	%	0.81
	8076344	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	5.75	CHEMBL3234	Homo sapiens	Inhibition	%	5.75
	8076702	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	1.71	CHEMBL3234	Homo sapiens	Inhibition	%	1.71
	8076804	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-1.42	CHEMBL3234	Homo sapiens	Inhibition	%	-1.42
	8077051	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	2.1	CHEMBL3234	Homo sapiens	Inhibition	%	2.1
	8077275	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	0.41	CHEMBL3234	Homo sapiens	Inhibition	%	0.41
	8077403	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.65	CHEMBL3234	Homo sapiens	Inhibition	%	3.65
	8077778	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	2.14	CHEMBL3234	Homo sapiens	Inhibition	%	2.14
	8077921	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.34	CHEMBL3234	Homo sapiens	Inhibition	%	2.34
	8078284	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	0.38	CHEMBL3234	Homo sapiens	Inhibition	%	0.38
	8078386	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	2.38	CHEMBL3234	Homo sapiens	Inhibition	%	2.38
	8078610	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.2	CHEMBL3234	Homo sapiens	Inhibition	%	0.2
	8078860	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	14.14	CHEMBL3234	Homo sapiens	Inhibition	%	14.14
	8078976	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	4.32	CHEMBL3234	Homo sapiens	Inhibition	%	4.32
	8079358	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.15	CHEMBL3234	Homo sapiens	Inhibition	%	-0.15
	8079500	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	11.19	CHEMBL3234	Homo sapiens	Inhibition	%	11.19
	8079724	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	3.37	CHEMBL3234	Homo sapiens	Inhibition	%	3.37
	8079863	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	11.08	CHEMBL3234	Homo sapiens	Inhibition	%	11.08
	8080192	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	4.24	CHEMBL3234	Homo sapiens	Inhibition	%	4.24
	8080444	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	4.68	CHEMBL3234	Homo sapiens	Inhibition	%	4.68
	8080559	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	5.14	CHEMBL3234	Homo sapiens	Inhibition	%	5.14
	8080783	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	2.78	CHEMBL3234	Homo sapiens	Inhibition	%	2.78
	8080947	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	6.39	CHEMBL3234	Homo sapiens	Inhibition	%	6.39
	8081306	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	7.23	CHEMBL3234	Homo sapiens	Inhibition	%	7.23
	8081450	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	5.95	CHEMBL3234	Homo sapiens	Inhibition	%	5.95
	8081777	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.14	CHEMBL3234	Homo sapiens	Inhibition	%	1.14
	8082029	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	38.5	CHEMBL3234	Homo sapiens	Inhibition	%	38.5
	8082366	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	8.33	CHEMBL3234	Homo sapiens	Inhibition	%	8.33
	8082539	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-2.39	CHEMBL3234	Homo sapiens	Inhibition	%	-2.39
	8082886	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	4.64	CHEMBL3234	Homo sapiens	Inhibition	%	4.64
	8083042	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	11.51	CHEMBL3234	Homo sapiens	Inhibition	%	11.51
	8083266	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	5.3	CHEMBL3234	Homo sapiens	Inhibition	%	5.3
	8083365	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	3.34	CHEMBL3234	Homo sapiens	Inhibition	%	3.34
	8083619	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-1.0	CHEMBL3234	Homo sapiens	Inhibition	%	-1.0
	8083953	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	3.15	CHEMBL3234	Homo sapiens	Inhibition	%	3.15
	8084138	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	2.05	CHEMBL3234	Homo sapiens	Inhibition	%	2.05
	8084362	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	13.58	CHEMBL3234	Homo sapiens	Inhibition	%	13.58
	8084480	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	6.65	CHEMBL3234	Homo sapiens	Inhibition	%	6.65
	8084865	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	17.75	CHEMBL3234	Homo sapiens	Inhibition	%	17.75
	8084963	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	3.53	CHEMBL3234	Homo sapiens	Inhibition	%	3.53
	8085187	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	3.03	CHEMBL3234	Homo sapiens	Inhibition	%	3.03
	8085219	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	0.66	CHEMBL3234	Homo sapiens	Inhibition	%	0.66
	8085443	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	3.29	CHEMBL3234	Homo sapiens	Inhibition	%	3.29
	8085551	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	7.9	CHEMBL3234	Homo sapiens	Inhibition	%	7.9
	8085964	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	73.47	CHEMBL3234	Homo sapiens	Inhibition	%	73.47
	8086079	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	7.12	CHEMBL3234	Homo sapiens	Inhibition	%	7.12
	8086465	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	3.06	CHEMBL3234	Homo sapiens	Inhibition	%	3.06
	8086788	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	3.79	CHEMBL3234	Homo sapiens	Inhibition	%	3.79
	8086999	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	11.59	CHEMBL3234	Homo sapiens	Inhibition	%	11.59
	8087157	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	13.31	CHEMBL3234	Homo sapiens	Inhibition	%	13.31
	8087381	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	5.93	CHEMBL3234	Homo sapiens	Inhibition	%	5.93
	8087495	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	72.07	CHEMBL3234	Homo sapiens	Inhibition	%	72.07
	8087857	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	7.61	CHEMBL3234	Homo sapiens	Inhibition	%	7.61
	8087999	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	6.76	CHEMBL3234	Homo sapiens	Inhibition	%	6.76
	8088223	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	9.25	CHEMBL3234	Homo sapiens	Inhibition	%	9.25
	8088371	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	2.58	CHEMBL3234	Homo sapiens	Inhibition	%	2.58
	8088499	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	6.37	CHEMBL3234	Homo sapiens	Inhibition	%	6.37
	8088723	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	10.76	CHEMBL3234	Homo sapiens	Inhibition	%	10.76
	8088816	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	5.97	CHEMBL3234	Homo sapiens	Inhibition	%	5.97
	8089040	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	8.93	CHEMBL3234	Homo sapiens	Inhibition	%	8.93
	8089168	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	4.1	CHEMBL3234	Homo sapiens	Inhibition	%	4.1
	8089316	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	2.54	CHEMBL3234	Homo sapiens	Inhibition	%	2.54
	8089540	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	2.33	CHEMBL3234	Homo sapiens	Inhibition	%	2.33
	8089660	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	3.5	CHEMBL3234	Homo sapiens	Inhibition	%	3.5
	8090064	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.25	CHEMBL3234	Homo sapiens	Inhibition	%	-0.25
	8090229	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	1.66	CHEMBL3234	Homo sapiens	Inhibition	%	1.66
	8090620	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	3.98	CHEMBL3234	Homo sapiens	Inhibition	%	3.98
	8090759	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	6.8	CHEMBL3234	Homo sapiens	Inhibition	%	6.8
	8090964	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	8.02	CHEMBL3234	Homo sapiens	Inhibition	%	8.02
	8091188	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	7.13	CHEMBL3234	Homo sapiens	Inhibition	%	7.13
	8091325	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	44.86	CHEMBL3234	Homo sapiens	Inhibition	%	44.86
	8091704	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	4.04	CHEMBL3234	Homo sapiens	Inhibition	%	4.04
	8091820	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	9.81	CHEMBL3234	Homo sapiens	Inhibition	%	9.81
	8092044	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	13.35	CHEMBL3234	Homo sapiens	Inhibition	%	13.35
	8092181	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	2.11	CHEMBL3234	Homo sapiens	Inhibition	%	2.11
	8092556	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	6.52	CHEMBL3234	Homo sapiens	Inhibition	%	6.52
	8092704	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	4.51	CHEMBL3234	Homo sapiens	Inhibition	%	4.51
	8093057	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	43.29	CHEMBL3234	Homo sapiens	Inhibition	%	43.29
	8093369	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	5.52	CHEMBL3234	Homo sapiens	Inhibition	%	5.52
	8093509	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	7.31	CHEMBL3234	Homo sapiens	Inhibition	%	7.31
	8093872	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	21.36	CHEMBL3234	Homo sapiens	Inhibition	%	21.36
	8093992	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	4.06	CHEMBL3234	Homo sapiens	Inhibition	%	4.06
	8094216	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	11.83	CHEMBL3234	Homo sapiens	Inhibition	%	11.83
	8094396	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.62	CHEMBL3234	Homo sapiens	Inhibition	%	1.62
	8094571	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	2.73	CHEMBL3234	Homo sapiens	Inhibition	%	2.73
	8094951	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	4.67	CHEMBL3234	Homo sapiens	Inhibition	%	4.67
	8095091	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	25.19	CHEMBL3234	Homo sapiens	Inhibition	%	25.19
	8095315	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	77.32	CHEMBL3234	Homo sapiens	Inhibition	%	77.32
	8095518	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	14.34	CHEMBL3234	Homo sapiens	Inhibition	%	14.34
	8095659	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	7.82	CHEMBL3234	Homo sapiens	Inhibition	%	7.82
	8095883	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	16.29	CHEMBL3234	Homo sapiens	Inhibition	%	16.29
	8096031	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	11.41	CHEMBL3234	Homo sapiens	Inhibition	%	11.41
	8096372	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	7.73	CHEMBL3234	Homo sapiens	Inhibition	%	7.73
	8096511	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.98	CHEMBL3234	Homo sapiens	Inhibition	%	1.98
	8096891	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	7.87	CHEMBL3234	Homo sapiens	Inhibition	%	7.87
	8097038	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.68	CHEMBL3234	Homo sapiens	Inhibition	%	1.68
	8097262	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	3.8	CHEMBL3234	Homo sapiens	Inhibition	%	3.8
	8097349	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	5.31	CHEMBL3234	Homo sapiens	Inhibition	%	5.31
	8097569	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	5.92	CHEMBL3234	Homo sapiens	Inhibition	%	5.92
	8097719	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	5.84	CHEMBL3234	Homo sapiens	Inhibition	%	5.84
	8097943	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	11.91	CHEMBL3234	Homo sapiens	Inhibition	%	11.91
	8098076	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.97	CHEMBL3234	Homo sapiens	Inhibition	%	0.97
	8098420	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-1.32	CHEMBL3234	Homo sapiens	Inhibition	%	-1.32
	8098600	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	3.34	CHEMBL3234	Homo sapiens	Inhibition	%	3.34
	8098785	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	3.05	CHEMBL3234	Homo sapiens	Inhibition	%	3.05
	8099009	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	7.94	CHEMBL3234	Homo sapiens	Inhibition	%	7.94
	8099153	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	4.78	CHEMBL3234	Homo sapiens	Inhibition	%	4.78
	8099519	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	5.79	CHEMBL3234	Homo sapiens	Inhibition	%	5.79
	8099713	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.95	CHEMBL3234	Homo sapiens	Inhibition	%	1.95
	8100084	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	7.32	CHEMBL3234	Homo sapiens	Inhibition	%	7.32
	8100230	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	48.47	CHEMBL3234	Homo sapiens	Inhibition	%	48.47
	8100570	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	8.66	CHEMBL3234	Homo sapiens	Inhibition	%	8.66
	8100710	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	2.6	CHEMBL3234	Homo sapiens	Inhibition	%	2.6
	8100934	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	3.96	CHEMBL3234	Homo sapiens	Inhibition	%	3.96
	8101094	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	6.67	CHEMBL3234	Homo sapiens	Inhibition	%	6.67
	8101460	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	3.3	CHEMBL3234	Homo sapiens	Inhibition	%	3.3
	8101645	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	5.34	CHEMBL3234	Homo sapiens	Inhibition	%	5.34
	8101898	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	12.75	CHEMBL3234	Homo sapiens	Inhibition	%	12.75
	8102277	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	63.98	CHEMBL3234	Homo sapiens	Inhibition	%	63.98
	8102408	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	3.15	CHEMBL3234	Homo sapiens	Inhibition	%	3.15
	8102752	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.98	CHEMBL3234	Homo sapiens	Inhibition	%	-0.98
	8102930	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.03	CHEMBL3234	Homo sapiens	Inhibition	%	1.03
	8103154	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.93	CHEMBL3234	Homo sapiens	Inhibition	%	1.93
	8103350	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	2.17	CHEMBL3234	Homo sapiens	Inhibition	%	2.17
	8103488	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	9.64	CHEMBL3234	Homo sapiens	Inhibition	%	9.64
	8103862	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	9.81	CHEMBL3234	Homo sapiens	Inhibition	%	9.81
	8104047	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.1	CHEMBL3234	Homo sapiens	Inhibition	%	1.1
	8104419	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	16.17	CHEMBL3234	Homo sapiens	Inhibition	%	16.17
	8104565	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	5.08	CHEMBL3234	Homo sapiens	Inhibition	%	5.08
	8104789	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	23.34	CHEMBL3234	Homo sapiens	Inhibition	%	23.34
	8104903	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	5.66	CHEMBL3234	Homo sapiens	Inhibition	%	5.66
	8105267	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.04	CHEMBL3234	Homo sapiens	Inhibition	%	1.04
	8105433	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	9.92	CHEMBL3234	Homo sapiens	Inhibition	%	9.92
	8105795	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	31.25	CHEMBL3234	Homo sapiens	Inhibition	%	31.25
	8106075	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	5.81	CHEMBL3234	Homo sapiens	Inhibition	%	5.81
	8106240	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	51.84	CHEMBL3234	Homo sapiens	Inhibition	%	51.84
	8106620	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	84.57	CHEMBL3234	Homo sapiens	Inhibition	%	84.57
	8106749	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	7.41	CHEMBL3234	Homo sapiens	Inhibition	%	7.41
	8106973	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	28.1	CHEMBL3234	Homo sapiens	Inhibition	%	28.1
	8107094	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.36	CHEMBL3234	Homo sapiens	Inhibition	%	0.36
	8107490	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.82	CHEMBL3234	Homo sapiens	Inhibition	%	2.82
	8107691	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	9.34	CHEMBL3234	Homo sapiens	Inhibition	%	9.34
	8107826	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	3.16	CHEMBL3234	Homo sapiens	Inhibition	%	3.16
	8108050	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	30.81	CHEMBL3234	Homo sapiens	Inhibition	%	30.81
	8108208	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	5.55	CHEMBL3234	Homo sapiens	Inhibition	%	5.55
	8108383	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	3.38	CHEMBL3234	Homo sapiens	Inhibition	%	3.38
	8108607	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	2.91	CHEMBL3234	Homo sapiens	Inhibition	%	2.91
	8108754	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	8.11	CHEMBL3234	Homo sapiens	Inhibition	%	8.11
	8109120	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	3.81	CHEMBL3234	Homo sapiens	Inhibition	%	3.81
	8109234	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	5.1	CHEMBL3234	Homo sapiens	Inhibition	%	5.1
	8109588	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.6	CHEMBL3234	Homo sapiens	Inhibition	%	-0.6
	8109759	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	6.15	CHEMBL3234	Homo sapiens	Inhibition	%	6.15
	8109983	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	12.96	CHEMBL3234	Homo sapiens	Inhibition	%	12.96
	8110115	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	8.41	CHEMBL3234	Homo sapiens	Inhibition	%	8.41
	8110394	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	9.29	CHEMBL3234	Homo sapiens	Inhibition	%	9.29
	8110560	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	3.12	CHEMBL3234	Homo sapiens	Inhibition	%	3.12
	8110784	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	7.89	CHEMBL3234	Homo sapiens	Inhibition	%	7.89
	8110942	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	0.79	CHEMBL3234	Homo sapiens	Inhibition	%	0.79
	8111289	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	4.76	CHEMBL3234	Homo sapiens	Inhibition	%	4.76
	8111416	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	2.34	CHEMBL3234	Homo sapiens	Inhibition	%	2.34
	8111806	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	0.29	CHEMBL3234	Homo sapiens	Inhibition	%	0.29
	8112011	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	4.6	CHEMBL3234	Homo sapiens	Inhibition	%	4.6
	8112372	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	1.01	CHEMBL3234	Homo sapiens	Inhibition	%	1.01
	8112540	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	13.96	CHEMBL3234	Homo sapiens	Inhibition	%	13.96
	8112936	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.7	CHEMBL3234	Homo sapiens	Inhibition	%	0.7
	8113088	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	29.58	CHEMBL3234	Homo sapiens	Inhibition	%	29.58
	8113448	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	6.35	CHEMBL3234	Homo sapiens	Inhibition	%	6.35
	8113572	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	3.08	CHEMBL3234	Homo sapiens	Inhibition	%	3.08
	8113796	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	3.84	CHEMBL3234	Homo sapiens	Inhibition	%	3.84
	8113912	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-2.31	CHEMBL3234	Homo sapiens	Inhibition	%	-2.31
	8114312	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	9.32	CHEMBL3234	Homo sapiens	Inhibition	%	9.32
	8114444	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	19.92	CHEMBL3234	Homo sapiens	Inhibition	%	19.92
	8114720	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	5.78	CHEMBL3234	Homo sapiens	Inhibition	%	5.78
	8115110	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	9.61	CHEMBL3234	Homo sapiens	Inhibition	%	9.61
	8115275	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-3.58	CHEMBL3234	Homo sapiens	Inhibition	%	-3.58
	8115619	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	7.28	CHEMBL3234	Homo sapiens	Inhibition	%	7.28
	8115752	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-1.1	CHEMBL3234	Homo sapiens	Inhibition	%	-1.1
	8115976	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	1.0	CHEMBL3234	Homo sapiens	Inhibition	%	1.0
	8116135	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	0.91	CHEMBL3234	Homo sapiens	Inhibition	%	0.91
	8116338	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	10.15	CHEMBL3234	Homo sapiens	Inhibition	%	10.15
	8116562	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	3.4	CHEMBL3234	Homo sapiens	Inhibition	%	3.4
	8116696	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	3.38	CHEMBL3234	Homo sapiens	Inhibition	%	3.38
	8116868	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	28.19	CHEMBL3234	Homo sapiens	Inhibition	%	28.19
	8117092	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	76.11	CHEMBL3234	Homo sapiens	Inhibition	%	76.11
	8117263	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	5.65	CHEMBL3234	Homo sapiens	Inhibition	%	5.65
	8117421	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	5.42	CHEMBL3234	Homo sapiens	Inhibition	%	5.42
	8117645	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	8.69	CHEMBL3234	Homo sapiens	Inhibition	%	8.69
	8117775	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	1.16	CHEMBL3234	Homo sapiens	Inhibition	%	1.16
	8118137	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	5.11	CHEMBL3234	Homo sapiens	Inhibition	%	5.11
	8118253	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.38	CHEMBL3234	Homo sapiens	Inhibition	%	-1.38
	8118477	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	6.39	CHEMBL3234	Homo sapiens	Inhibition	%	6.39
	8118649	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	11.71	CHEMBL3234	Homo sapiens	Inhibition	%	11.71
	8118785	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	4.32	CHEMBL3234	Homo sapiens	Inhibition	%	4.32
	8119009	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	6.64	CHEMBL3234	Homo sapiens	Inhibition	%	6.64
	8119056	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	7.52	CHEMBL3234	Homo sapiens	Inhibition	%	7.52
	8119280	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	4.13	CHEMBL3234	Homo sapiens	Inhibition	%	4.13
	8119439	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	46.54	CHEMBL3234	Homo sapiens	Inhibition	%	46.54
	8119606	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.02	CHEMBL3234	Homo sapiens	Inhibition	%	-0.02
	8119830	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	2.4	CHEMBL3234	Homo sapiens	Inhibition	%	2.4
	8119949	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	4.76	CHEMBL3234	Homo sapiens	Inhibition	%	4.76
	8120312	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.01	CHEMBL3234	Homo sapiens	Inhibition	%	1.01
	8120472	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	21.19	CHEMBL3234	Homo sapiens	Inhibition	%	21.19
	8120897	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	7.03	CHEMBL3234	Homo sapiens	Inhibition	%	7.03
	8121025	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.57	CHEMBL3234	Homo sapiens	Inhibition	%	0.57
	8121421	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.46	CHEMBL3234	Homo sapiens	Inhibition	%	1.46
	8121588	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	2.52	CHEMBL3234	Homo sapiens	Inhibition	%	2.52
	8121975	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	4.21	CHEMBL3234	Homo sapiens	Inhibition	%	4.21
	8122096	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	5.85	CHEMBL3234	Homo sapiens	Inhibition	%	5.85
	8122458	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	4.68	CHEMBL3234	Homo sapiens	Inhibition	%	4.68
	8122802	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	7.93	CHEMBL3234	Homo sapiens	Inhibition	%	7.93
	8122969	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	10.43	CHEMBL3234	Homo sapiens	Inhibition	%	10.43
	8123335	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	8.32	CHEMBL3234	Homo sapiens	Inhibition	%	8.32
	8123613	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	3.71	CHEMBL3234	Homo sapiens	Inhibition	%	3.71
	8123763	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	8.92	CHEMBL3234	Homo sapiens	Inhibition	%	8.92
	8124154	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	0.9	CHEMBL3234	Homo sapiens	Inhibition	%	0.9
	8124273	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	13.4	CHEMBL3234	Homo sapiens	Inhibition	%	13.4
	8124497	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	7.25	CHEMBL3234	Homo sapiens	Inhibition	%	7.25
	8124636	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	2.01	CHEMBL3234	Homo sapiens	Inhibition	%	2.01
	8124801	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.73	CHEMBL3234	Homo sapiens	Inhibition	%	-0.73
	8125025	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	3.3	CHEMBL3234	Homo sapiens	Inhibition	%	3.3
	8125226	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	4.84	CHEMBL3234	Homo sapiens	Inhibition	%	4.84
	8125356	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	10.98	CHEMBL3234	Homo sapiens	Inhibition	%	10.98
	8125580	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.81	CHEMBL3234	Homo sapiens	Inhibition	%	0.81
	8125748	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	6.92	CHEMBL3234	Homo sapiens	Inhibition	%	6.92
	8125912	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	6.49	CHEMBL3234	Homo sapiens	Inhibition	%	6.49
	8126136	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.33	CHEMBL3234	Homo sapiens	Inhibition	%	0.33
	8126300	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	7.03	CHEMBL3234	Homo sapiens	Inhibition	%	7.03
	8126415	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	2.25	CHEMBL3234	Homo sapiens	Inhibition	%	2.25
	8126639	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	31.6	CHEMBL3234	Homo sapiens	Inhibition	%	31.6
	8126775	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	9.53	CHEMBL3234	Homo sapiens	Inhibition	%	9.53
	8127121	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	5.33	CHEMBL3234	Homo sapiens	Inhibition	%	5.33
	8127288	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	17.61	CHEMBL3234	Homo sapiens	Inhibition	%	17.61
	8127654	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	29.25	CHEMBL3234	Homo sapiens	Inhibition	%	29.25
	8127942	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	3.59	CHEMBL3234	Homo sapiens	Inhibition	%	3.59
	8128094	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	41.61	CHEMBL3234	Homo sapiens	Inhibition	%	41.61
	8128318	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	4.54	CHEMBL3234	Homo sapiens	Inhibition	%	4.54
	8128485	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	16.31	CHEMBL3234	Homo sapiens	Inhibition	%	16.31
	8128828	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	17.41	CHEMBL3234	Homo sapiens	Inhibition	%	17.41
	8128965	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	2.54	CHEMBL3234	Homo sapiens	Inhibition	%	2.54
	8129360	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-2.29	CHEMBL3234	Homo sapiens	Inhibition	%	-2.29
	8129549	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	8.91	CHEMBL3234	Homo sapiens	Inhibition	%	8.91
	8129912	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	2.83	CHEMBL3234	Homo sapiens	Inhibition	%	2.83
	8130073	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.76	CHEMBL3234	Homo sapiens	Inhibition	%	2.76
	8130469	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.65	CHEMBL3234	Homo sapiens	Inhibition	%	0.65
	8130629	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	4.93	CHEMBL3234	Homo sapiens	Inhibition	%	4.93
	8130969	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	5.46	CHEMBL3234	Homo sapiens	Inhibition	%	5.46
	8131108	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	28.91	CHEMBL3234	Homo sapiens	Inhibition	%	28.91
	8131332	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	4.31	CHEMBL3234	Homo sapiens	Inhibition	%	4.31
	8131452	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	8.1	CHEMBL3234	Homo sapiens	Inhibition	%	8.1
	8131619	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	32.95	CHEMBL3234	Homo sapiens	Inhibition	%	32.95
	8131843	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	74.27	CHEMBL3234	Homo sapiens	Inhibition	%	74.27
	8131984	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	11.98	CHEMBL3234	Homo sapiens	Inhibition	%	11.98
	8132270	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	5.25	CHEMBL3234	Homo sapiens	Inhibition	%	5.25
	8132641	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	10.85	CHEMBL3234	Homo sapiens	Inhibition	%	10.85
	8132809	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.18	CHEMBL3234	Homo sapiens	Inhibition	%	1.18
	8133154	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	5.97	CHEMBL3234	Homo sapiens	Inhibition	%	5.97
	8133292	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.75	CHEMBL3234	Homo sapiens	Inhibition	%	0.75
	8133516	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	3.51	CHEMBL3234	Homo sapiens	Inhibition	%	3.51
	8133688	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	2.91	CHEMBL3234	Homo sapiens	Inhibition	%	2.91
	8133868	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	3.98	CHEMBL3234	Homo sapiens	Inhibition	%	3.98
	8134240	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.32	CHEMBL3234	Homo sapiens	Inhibition	%	-0.32
	8134400	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.72	CHEMBL3234	Homo sapiens	Inhibition	%	2.72
	8134624	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	4.54	CHEMBL3234	Homo sapiens	Inhibition	%	4.54
	8134808	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-0.18	CHEMBL3234	Homo sapiens	Inhibition	%	-0.18
	8134968	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	13.49	CHEMBL3234	Homo sapiens	Inhibition	%	13.49
	8135307	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	4.56	CHEMBL3234	Homo sapiens	Inhibition	%	4.56
	8135672	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	7.51	CHEMBL3234	Homo sapiens	Inhibition	%	7.51
	8135793	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	5.89	CHEMBL3234	Homo sapiens	Inhibition	%	5.89
	8136185	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	4.96	CHEMBL3234	Homo sapiens	Inhibition	%	4.96
	8136329	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	48.75	CHEMBL3234	Homo sapiens	Inhibition	%	48.75
	8136553	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	6.2	CHEMBL3234	Homo sapiens	Inhibition	%	6.2
	8136619	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	2.52	CHEMBL3234	Homo sapiens	Inhibition	%	2.52
	8136978	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	6.21	CHEMBL3234	Homo sapiens	Inhibition	%	6.21
	8137141	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	11.29	CHEMBL3234	Homo sapiens	Inhibition	%	11.29
	8137365	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	7.22	CHEMBL3234	Homo sapiens	Inhibition	%	7.22
	8137485	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	5.79	CHEMBL3234	Homo sapiens	Inhibition	%	5.79
	8137857	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.32	CHEMBL3234	Homo sapiens	Inhibition	%	1.32
	8138023	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.54	CHEMBL3234	Homo sapiens	Inhibition	%	-1.54
	8138202	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	22.68	CHEMBL3234	Homo sapiens	Inhibition	%	22.68
	8138426	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	3.91	CHEMBL3234	Homo sapiens	Inhibition	%	3.91
	8138574	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	7.05	CHEMBL3234	Homo sapiens	Inhibition	%	7.05
	8138956	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	5.55	CHEMBL3234	Homo sapiens	Inhibition	%	5.55
	8139141	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	14.07	CHEMBL3234	Homo sapiens	Inhibition	%	14.07
	8139300	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	7.16	CHEMBL3234	Homo sapiens	Inhibition	%	7.16
	8139524	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	17.32	CHEMBL3234	Homo sapiens	Inhibition	%	17.32
	8139638	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	4.59	CHEMBL3234	Homo sapiens	Inhibition	%	4.59
	8140003	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	6.09	CHEMBL3234	Homo sapiens	Inhibition	%	6.09
	8140126	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	8.22	CHEMBL3234	Homo sapiens	Inhibition	%	8.22
	8140350	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	7.45	CHEMBL3234	Homo sapiens	Inhibition	%	7.45
	8140509	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	6.95	CHEMBL3234	Homo sapiens	Inhibition	%	6.95
	8140876	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	10.86	CHEMBL3234	Homo sapiens	Inhibition	%	10.86
	8140954	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	4.78	CHEMBL3234	Homo sapiens	Inhibition	%	4.78
	8141178	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	5.42	CHEMBL3234	Homo sapiens	Inhibition	%	5.42
	8141308	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	7.31	CHEMBL3234	Homo sapiens	Inhibition	%	7.31
	8141692	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	35.84	CHEMBL3234	Homo sapiens	Inhibition	%	35.84
	8141811	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	17.18	CHEMBL3234	Homo sapiens	Inhibition	%	17.18
	8142196	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	13.42	CHEMBL3234	Homo sapiens	Inhibition	%	13.42
	8142364	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	0.95	CHEMBL3234	Homo sapiens	Inhibition	%	0.95
	8142764	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	5.68	CHEMBL3234	Homo sapiens	Inhibition	%	5.68
	8142913	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-3.59	CHEMBL3234	Homo sapiens	Inhibition	%	-3.59
	8143292	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	4.6	CHEMBL3234	Homo sapiens	Inhibition	%	4.6
	8143479	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	6.42	CHEMBL3234	Homo sapiens	Inhibition	%	6.42
	8143862	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	11.26	CHEMBL3234	Homo sapiens	Inhibition	%	11.26
	8143976	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	5.75	CHEMBL3234	Homo sapiens	Inhibition	%	5.75
	8144200	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	7.33	CHEMBL3234	Homo sapiens	Inhibition	%	7.33
	8144339	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	9.6	CHEMBL3234	Homo sapiens	Inhibition	%	9.6
	8144693	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	9.14	CHEMBL3234	Homo sapiens	Inhibition	%	9.14
	8144846	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.71	CHEMBL3234	Homo sapiens	Inhibition	%	2.71
	8145207	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	7.05	CHEMBL3234	Homo sapiens	Inhibition	%	7.05
	8145520	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	10.02	CHEMBL3234	Homo sapiens	Inhibition	%	10.02
	8145644	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	3.22	CHEMBL3234	Homo sapiens	Inhibition	%	3.22
	8146029	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	22.47	CHEMBL3234	Homo sapiens	Inhibition	%	22.47
	8146149	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	58.86	CHEMBL3234	Homo sapiens	Inhibition	%	58.86
	8146373	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	39.5	CHEMBL3234	Homo sapiens	Inhibition	%	39.5
	8146533	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	45.98	CHEMBL3234	Homo sapiens	Inhibition	%	45.98
	8146700	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	3.31	CHEMBL3234	Homo sapiens	Inhibition	%	3.31
	8146924	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	32.59	CHEMBL3234	Homo sapiens	Inhibition	%	32.59
	8147093	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	2.78	CHEMBL3234	Homo sapiens	Inhibition	%	2.78
	8147235	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-1.19	CHEMBL3234	Homo sapiens	Inhibition	%	-1.19
	8147459	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.72	CHEMBL3234	Homo sapiens	Inhibition	%	1.72
	8147612	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	5.04	CHEMBL3234	Homo sapiens	Inhibition	%	5.04
	8147799	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	8.5	CHEMBL3234	Homo sapiens	Inhibition	%	8.5
	8148023	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	5.59	CHEMBL3234	Homo sapiens	Inhibition	%	5.59
	8148181	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	45.07	CHEMBL3234	Homo sapiens	Inhibition	%	45.07
	8148519	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	10.16	CHEMBL3234	Homo sapiens	Inhibition	%	10.16
	8148658	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	7.2	CHEMBL3234	Homo sapiens	Inhibition	%	7.2
	8149020	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	6.86	CHEMBL3234	Homo sapiens	Inhibition	%	6.86
	8149179	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	3.16	CHEMBL3234	Homo sapiens	Inhibition	%	3.16
	8149403	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	2.47	CHEMBL3234	Homo sapiens	Inhibition	%	2.47
	8149537	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	8.65	CHEMBL3234	Homo sapiens	Inhibition	%	8.65
	8149859	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	14.28	CHEMBL3234	Homo sapiens	Inhibition	%	14.28
	8149984	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	7.96	CHEMBL3234	Homo sapiens	Inhibition	%	7.96
	8150208	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	7.54	CHEMBL3234	Homo sapiens	Inhibition	%	7.54
	8150368	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	48.88	CHEMBL3234	Homo sapiens	Inhibition	%	48.88
	8150712	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	14.4	CHEMBL3234	Homo sapiens	Inhibition	%	14.4
	8150877	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	13.98	CHEMBL3234	Homo sapiens	Inhibition	%	13.98
	8151264	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-3.84	CHEMBL3234	Homo sapiens	Inhibition	%	-3.84
	8151441	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	4.64	CHEMBL3234	Homo sapiens	Inhibition	%	4.64
	8151803	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	6.11	CHEMBL3234	Homo sapiens	Inhibition	%	6.11
	8151957	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	4.3	CHEMBL3234	Homo sapiens	Inhibition	%	4.3
	8152369	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	18.29	CHEMBL3234	Homo sapiens	Inhibition	%	18.29
	8152527	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	6.83	CHEMBL3234	Homo sapiens	Inhibition	%	6.83
	8152865	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	39.54	CHEMBL3234	Homo sapiens	Inhibition	%	39.54
	8153004	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	8.3	CHEMBL3234	Homo sapiens	Inhibition	%	8.3
	8153228	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.14	CHEMBL3234	Homo sapiens	Inhibition	%	3.14
	8153365	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	8.21	CHEMBL3234	Homo sapiens	Inhibition	%	8.21
	8153746	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	3.04	CHEMBL3234	Homo sapiens	Inhibition	%	3.04
	8153879	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	4.96	CHEMBL3234	Homo sapiens	Inhibition	%	4.96
	8154200	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	51.09	CHEMBL3234	Homo sapiens	Inhibition	%	51.09
	8154550	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	47.26	CHEMBL3234	Homo sapiens	Inhibition	%	47.26
	8154709	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	2.16	CHEMBL3234	Homo sapiens	Inhibition	%	2.16
	8155053	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	3.46	CHEMBL3234	Homo sapiens	Inhibition	%	3.46
	8155229	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	16.57	CHEMBL3234	Homo sapiens	Inhibition	%	16.57
	8155453	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.1	CHEMBL3234	Homo sapiens	Inhibition	%	-0.1
	8155614	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-2.13	CHEMBL3234	Homo sapiens	Inhibition	%	-2.13
	8155792	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	5.27	CHEMBL3234	Homo sapiens	Inhibition	%	5.27
	8156016	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	5.74	CHEMBL3234	Homo sapiens	Inhibition	%	5.74
	8156154	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	4.28	CHEMBL3234	Homo sapiens	Inhibition	%	4.28
	8156366	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	10.18	CHEMBL3234	Homo sapiens	Inhibition	%	10.18
	8156740	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	71.23	CHEMBL3234	Homo sapiens	Inhibition	%	71.23
	8156883	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	4.43	CHEMBL3234	Homo sapiens	Inhibition	%	4.43
	8157107	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	10.65	CHEMBL3234	Homo sapiens	Inhibition	%	10.65
	8157227	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	4.64	CHEMBL3234	Homo sapiens	Inhibition	%	4.64
	8157592	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	6.2	CHEMBL3234	Homo sapiens	Inhibition	%	6.2
	8157722	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	21.76	CHEMBL3234	Homo sapiens	Inhibition	%	21.76
	8157946	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	5.27	CHEMBL3234	Homo sapiens	Inhibition	%	5.27
	8158107	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	3.12	CHEMBL3234	Homo sapiens	Inhibition	%	3.12
	8158357	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	13.13	CHEMBL3234	Homo sapiens	Inhibition	%	13.13
	8158515	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	4.55	CHEMBL3234	Homo sapiens	Inhibition	%	4.55
	8158739	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	10.69	CHEMBL3234	Homo sapiens	Inhibition	%	10.69
	8158908	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	7.73	CHEMBL3234	Homo sapiens	Inhibition	%	7.73
	8159267	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	3.37	CHEMBL3234	Homo sapiens	Inhibition	%	3.37
	8159387	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	6.23	CHEMBL3234	Homo sapiens	Inhibition	%	6.23
	8159742	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	11.74	CHEMBL3234	Homo sapiens	Inhibition	%	11.74
	8159883	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	2.86	CHEMBL3234	Homo sapiens	Inhibition	%	2.86
	8160107	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.81	CHEMBL3234	Homo sapiens	Inhibition	%	0.81
	8160244	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	2.96	CHEMBL3234	Homo sapiens	Inhibition	%	2.96
	8160618	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	1.96	CHEMBL3234	Homo sapiens	Inhibition	%	1.96
	8160688	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	7.39	CHEMBL3234	Homo sapiens	Inhibition	%	7.39
	8160912	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	21.75	CHEMBL3234	Homo sapiens	Inhibition	%	21.75
	8161062	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	1.67	CHEMBL3234	Homo sapiens	Inhibition	%	1.67
	8161429	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	6.09	CHEMBL3234	Homo sapiens	Inhibition	%	6.09
	8161554	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	9.34	CHEMBL3234	Homo sapiens	Inhibition	%	9.34
	8161916	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	22.56	CHEMBL3234	Homo sapiens	Inhibition	%	22.56
	8162270	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	16.16	CHEMBL3234	Homo sapiens	Inhibition	%	16.16
	8162430	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	4.66	CHEMBL3234	Homo sapiens	Inhibition	%	4.66
	8162683	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	6.43	CHEMBL3234	Homo sapiens	Inhibition	%	6.43
	8163055	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	12.23	CHEMBL3234	Homo sapiens	Inhibition	%	12.23
	8163224	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	8.12	CHEMBL3234	Homo sapiens	Inhibition	%	8.12
	8163582	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	6.71	CHEMBL3234	Homo sapiens	Inhibition	%	6.71
	8163705	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	2.36	CHEMBL3234	Homo sapiens	Inhibition	%	2.36
	8163929	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	4.87	CHEMBL3234	Homo sapiens	Inhibition	%	4.87
	8164063	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	7.06	CHEMBL3234	Homo sapiens	Inhibition	%	7.06
	8164427	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	2.18	CHEMBL3234	Homo sapiens	Inhibition	%	2.18
	8164582	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	8.43	CHEMBL3234	Homo sapiens	Inhibition	%	8.43
	8164950	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	12.72	CHEMBL3234	Homo sapiens	Inhibition	%	12.72
	8165244	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	5.56	CHEMBL3234	Homo sapiens	Inhibition	%	5.56
	8165385	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	13.63	CHEMBL3234	Homo sapiens	Inhibition	%	13.63
	8165752	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	16.79	CHEMBL3234	Homo sapiens	Inhibition	%	16.79
	8165878	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	3.62	CHEMBL3234	Homo sapiens	Inhibition	%	3.62
	8166102	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	5.29	CHEMBL3234	Homo sapiens	Inhibition	%	5.29
	8166240	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	3.23	CHEMBL3234	Homo sapiens	Inhibition	%	3.23
	8166594	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	13.67	CHEMBL3234	Homo sapiens	Inhibition	%	13.67
	8166695	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	31.21	CHEMBL3234	Homo sapiens	Inhibition	%	31.21
	8166919	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	67.74	CHEMBL3234	Homo sapiens	Inhibition	%	67.74
	8167007	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	9.69	CHEMBL3234	Homo sapiens	Inhibition	%	9.69
	8167231	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	6.47	CHEMBL3234	Homo sapiens	Inhibition	%	6.47
	8167372	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	43.83	CHEMBL3234	Homo sapiens	Inhibition	%	43.83
	8167536	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	4.79	CHEMBL3234	Homo sapiens	Inhibition	%	4.79
	8167760	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	6.4	CHEMBL3234	Homo sapiens	Inhibition	%	6.4
	8167893	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	4.97	CHEMBL3234	Homo sapiens	Inhibition	%	4.97
	8168241	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	3.04	CHEMBL3234	Homo sapiens	Inhibition	%	3.04
	8168382	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	11.88	CHEMBL3234	Homo sapiens	Inhibition	%	11.88
	8168742	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	3.22	CHEMBL3234	Homo sapiens	Inhibition	%	3.22
	8168906	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	7.16	CHEMBL3234	Homo sapiens	Inhibition	%	7.16
	8169130	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	35.91	CHEMBL3234	Homo sapiens	Inhibition	%	35.91
	8169272	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	5.35	CHEMBL3234	Homo sapiens	Inhibition	%	5.35
	8169576	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	8.62	CHEMBL3234	Homo sapiens	Inhibition	%	8.62
	8169710	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	1.89	CHEMBL3234	Homo sapiens	Inhibition	%	1.89
	8169934	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	8.37	CHEMBL3234	Homo sapiens	Inhibition	%	8.37
	8170079	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	6.07	CHEMBL3234	Homo sapiens	Inhibition	%	6.07
	8170428	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	4.11	CHEMBL3234	Homo sapiens	Inhibition	%	4.11
	8170568	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	7.76	CHEMBL3234	Homo sapiens	Inhibition	%	7.76
	8170792	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	2.07	CHEMBL3234	Homo sapiens	Inhibition	%	2.07
	8170927	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	51.23	CHEMBL3234	Homo sapiens	Inhibition	%	51.23
	8171124	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	9.14	CHEMBL3234	Homo sapiens	Inhibition	%	9.14
	8171565	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	4.67	CHEMBL3234	Homo sapiens	Inhibition	%	4.67
	8171706	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	6.46	CHEMBL3234	Homo sapiens	Inhibition	%	6.46
	8172083	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	5.13	CHEMBL3234	Homo sapiens	Inhibition	%	5.13
	8172215	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	7.63	CHEMBL3234	Homo sapiens	Inhibition	%	7.63
	8172567	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	2.81	CHEMBL3234	Homo sapiens	Inhibition	%	2.81
	8172709	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	7.1	CHEMBL3234	Homo sapiens	Inhibition	%	7.1
	8172933	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	15.57	CHEMBL3234	Homo sapiens	Inhibition	%	15.57
	8173069	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-0.53	CHEMBL3234	Homo sapiens	Inhibition	%	-0.53
	8173458	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	15.71	CHEMBL3234	Homo sapiens	Inhibition	%	15.71
	8173599	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	8.62	CHEMBL3234	Homo sapiens	Inhibition	%	8.62
	8173910	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	9.6	CHEMBL3234	Homo sapiens	Inhibition	%	9.6
	8174266	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	8.77	CHEMBL3234	Homo sapiens	Inhibition	%	8.77
	8174414	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	27.13	CHEMBL3234	Homo sapiens	Inhibition	%	27.13
	8174638	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.5	CHEMBL3234	Homo sapiens	Inhibition	%	2.5
	8174760	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	6.57	CHEMBL3234	Homo sapiens	Inhibition	%	6.57
	8175127	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	5.41	CHEMBL3234	Homo sapiens	Inhibition	%	5.41
	8175263	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	4.0	CHEMBL3234	Homo sapiens	Inhibition	%	4.0
	8175519	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	5.82	CHEMBL3234	Homo sapiens	Inhibition	%	5.82
	8175906	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	12.79	CHEMBL3234	Homo sapiens	Inhibition	%	12.79
	8176059	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	12.92	CHEMBL3234	Homo sapiens	Inhibition	%	12.92
	8176283	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	6.26	CHEMBL3234	Homo sapiens	Inhibition	%	6.26
	8176432	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	20.77	CHEMBL3234	Homo sapiens	Inhibition	%	20.77
	8176564	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	7.89	CHEMBL3234	Homo sapiens	Inhibition	%	7.89
	8176788	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	21.54	CHEMBL3234	Homo sapiens	Inhibition	%	21.54
	8176918	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	1.8	CHEMBL3234	Homo sapiens	Inhibition	%	1.8
	8177284	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	20.64	CHEMBL3234	Homo sapiens	Inhibition	%	20.64
	8177422	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	1.86	CHEMBL3234	Homo sapiens	Inhibition	%	1.86
	8177646	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	20.15	CHEMBL3234	Homo sapiens	Inhibition	%	20.15
	8177810	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	59.23	CHEMBL3234	Homo sapiens	Inhibition	%	59.23
	8177950	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	3.63	CHEMBL3234	Homo sapiens	Inhibition	%	3.63
	8178174	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	11.12	CHEMBL3234	Homo sapiens	Inhibition	%	11.12
	8178262	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	24.97	CHEMBL3234	Homo sapiens	Inhibition	%	24.97
	8178486	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	4.49	CHEMBL3234	Homo sapiens	Inhibition	%	4.49
	8178613	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	37.49	CHEMBL3234	Homo sapiens	Inhibition	%	37.49
	8178986	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	7.59	CHEMBL3234	Homo sapiens	Inhibition	%	7.59
	8179109	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	5.66	CHEMBL3234	Homo sapiens	Inhibition	%	5.66
	8179477	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	5.39	CHEMBL3234	Homo sapiens	Inhibition	%	5.39
	8179614	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	8.83	CHEMBL3234	Homo sapiens	Inhibition	%	8.83
	8179838	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	4.4	CHEMBL3234	Homo sapiens	Inhibition	%	4.4
	8179871	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	11.74	CHEMBL3234	Homo sapiens	Inhibition	%	11.74
	8180095	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	3.42	CHEMBL3234	Homo sapiens	Inhibition	%	3.42
	8180249	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	50.16	CHEMBL3234	Homo sapiens	Inhibition	%	50.16
	8180629	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	10.41	CHEMBL3234	Homo sapiens	Inhibition	%	10.41
	8180777	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	4.88	CHEMBL3234	Homo sapiens	Inhibition	%	4.88
	8181134	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	87.17	CHEMBL3234	Homo sapiens	Inhibition	%	87.17
	8181265	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	9.8	CHEMBL3234	Homo sapiens	Inhibition	%	9.8
	8181489	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-0.82	CHEMBL3234	Homo sapiens	Inhibition	%	-0.82
	8181629	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	74.94	CHEMBL3234	Homo sapiens	Inhibition	%	74.94
	8181992	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	75.62	CHEMBL3234	Homo sapiens	Inhibition	%	75.62
	8182155	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	5.89	CHEMBL3234	Homo sapiens	Inhibition	%	5.89
	8182519	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	4.54	CHEMBL3234	Homo sapiens	Inhibition	%	4.54
	8182835	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	10.54	CHEMBL3234	Homo sapiens	Inhibition	%	10.54
	8182957	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	6.41	CHEMBL3234	Homo sapiens	Inhibition	%	6.41
	8183330	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	21.12	CHEMBL3234	Homo sapiens	Inhibition	%	21.12
	8183459	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	5.6	CHEMBL3234	Homo sapiens	Inhibition	%	5.6
	8183683	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	0.59	CHEMBL3234	Homo sapiens	Inhibition	%	0.59
	8183825	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	16.3	CHEMBL3234	Homo sapiens	Inhibition	%	16.3
	8184185	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	8.65	CHEMBL3234	Homo sapiens	Inhibition	%	8.65
	8184451	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	7.61	CHEMBL3234	Homo sapiens	Inhibition	%	7.61
	8184598	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	3.68	CHEMBL3234	Homo sapiens	Inhibition	%	3.68
	8184979	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	26.29	CHEMBL3234	Homo sapiens	Inhibition	%	26.29
	8185128	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	20.49	CHEMBL3234	Homo sapiens	Inhibition	%	20.49
	8185352	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	2.8	CHEMBL3234	Homo sapiens	Inhibition	%	2.8
	8185483	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	89.91	CHEMBL3234	Homo sapiens	Inhibition	%	89.91
	8185838	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	6.24	CHEMBL3234	Homo sapiens	Inhibition	%	6.24
	8185977	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	8.61	CHEMBL3234	Homo sapiens	Inhibition	%	8.61
	8186342	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	3.38	CHEMBL3234	Homo sapiens	Inhibition	%	3.38
	8186506	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	17.46	CHEMBL3234	Homo sapiens	Inhibition	%	17.46
	8186730	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	8.17	CHEMBL3234	Homo sapiens	Inhibition	%	8.17
	8186869	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	7.92	CHEMBL3234	Homo sapiens	Inhibition	%	7.92
	8187191	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	15.18	CHEMBL3234	Homo sapiens	Inhibition	%	15.18
	8187315	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	17.48	CHEMBL3234	Homo sapiens	Inhibition	%	17.48
	8187539	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	5.89	CHEMBL3234	Homo sapiens	Inhibition	%	5.89
	8187687	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	67.18	CHEMBL3234	Homo sapiens	Inhibition	%	67.18
	8188040	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	15.09	CHEMBL3234	Homo sapiens	Inhibition	%	15.09
	8188183	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	5.0	CHEMBL3234	Homo sapiens	Inhibition	%	5.0
	8188542	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	16.97	CHEMBL3234	Homo sapiens	Inhibition	%	16.97
	8188816	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.38	CHEMBL3234	Homo sapiens	Inhibition	%	4.38
	8188964	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	9.04	CHEMBL3234	Homo sapiens	Inhibition	%	9.04
	8189188	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	7.16	CHEMBL3234	Homo sapiens	Inhibition	%	7.16
	8189344	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	71.48	CHEMBL3234	Homo sapiens	Inhibition	%	71.48
	8189717	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	2.97	CHEMBL3234	Homo sapiens	Inhibition	%	2.97
	8189849	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	11.05	CHEMBL3234	Homo sapiens	Inhibition	%	11.05
	8190205	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	7.67	CHEMBL3234	Homo sapiens	Inhibition	%	7.67
	8190345	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	15.82	CHEMBL3234	Homo sapiens	Inhibition	%	15.82
	8190569	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	12.09	CHEMBL3234	Homo sapiens	Inhibition	%	12.09
	8190706	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	16.47	CHEMBL3234	Homo sapiens	Inhibition	%	16.47
	8191094	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	9.54	CHEMBL3234	Homo sapiens	Inhibition	%	9.54
	8191232	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	6.05	CHEMBL3234	Homo sapiens	Inhibition	%	6.05
	8191552	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	65.31	CHEMBL3234	Homo sapiens	Inhibition	%	65.31
	8191898	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	11.26	CHEMBL3234	Homo sapiens	Inhibition	%	11.26
	8192047	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	5.19	CHEMBL3234	Homo sapiens	Inhibition	%	5.19
	8192400	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	5.56	CHEMBL3234	Homo sapiens	Inhibition	%	5.56
	8192544	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	11.41	CHEMBL3234	Homo sapiens	Inhibition	%	11.41
	8192768	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	6.15	CHEMBL3234	Homo sapiens	Inhibition	%	6.15
	8192904	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	55.7	CHEMBL3234	Homo sapiens	Inhibition	%	55.7
	8193176	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	13.09	CHEMBL3234	Homo sapiens	Inhibition	%	13.09
	8193545	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	32.61	CHEMBL3234	Homo sapiens	Inhibition	%	32.61
	8193702	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	6.87	CHEMBL3234	Homo sapiens	Inhibition	%	6.87
	8194075	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.01	CHEMBL3234	Homo sapiens	Inhibition	%	-0.01
	8194206	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	20.52	CHEMBL3234	Homo sapiens	Inhibition	%	20.52
	8194430	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	44.86	CHEMBL3234	Homo sapiens	Inhibition	%	44.86
	8194561	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	12.52	CHEMBL3234	Homo sapiens	Inhibition	%	12.52
	8194928	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	43.71	CHEMBL3234	Homo sapiens	Inhibition	%	43.71
	8195061	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	3.07	CHEMBL3234	Homo sapiens	Inhibition	%	3.07
	8195449	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	5.82	CHEMBL3234	Homo sapiens	Inhibition	%	5.82
	8195588	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	12.34	CHEMBL3234	Homo sapiens	Inhibition	%	12.34
	8195812	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	9.2	CHEMBL3234	Homo sapiens	Inhibition	%	9.2
	8195910	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	4.24	CHEMBL3234	Homo sapiens	Inhibition	%	4.24
	8196251	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	3.53	CHEMBL3234	Homo sapiens	Inhibition	%	3.53
	8196401	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	10.03	CHEMBL3234	Homo sapiens	Inhibition	%	10.03
	8196625	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	11.95	CHEMBL3234	Homo sapiens	Inhibition	%	11.95
	8196753	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	4.62	CHEMBL3234	Homo sapiens	Inhibition	%	4.62
	8197118	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	20.11	CHEMBL3234	Homo sapiens	Inhibition	%	20.11
	8197255	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	3.74	CHEMBL3234	Homo sapiens	Inhibition	%	3.74
	8197479	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	4.95	CHEMBL3234	Homo sapiens	Inhibition	%	4.95
	8197530	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	6.59	CHEMBL3234	Homo sapiens	Inhibition	%	6.59
	8197754	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	7.14	CHEMBL3234	Homo sapiens	Inhibition	%	7.14
	8197894	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	4.09	CHEMBL3234	Homo sapiens	Inhibition	%	4.09
	8198051	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	17.57	CHEMBL3234	Homo sapiens	Inhibition	%	17.57
	8198275	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	4.65	CHEMBL3234	Homo sapiens	Inhibition	%	4.65
	8198413	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	2.43	CHEMBL3234	Homo sapiens	Inhibition	%	2.43
	8198767	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	75.14	CHEMBL3234	Homo sapiens	Inhibition	%	75.14
	8198898	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	8.78	CHEMBL3234	Homo sapiens	Inhibition	%	8.78
	8199122	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	12.72	CHEMBL3234	Homo sapiens	Inhibition	%	12.72
	8199270	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	11.49	CHEMBL3234	Homo sapiens	Inhibition	%	11.49
	8199404	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	9.14	CHEMBL3234	Homo sapiens	Inhibition	%	9.14
	8199628	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	5.09	CHEMBL3234	Homo sapiens	Inhibition	%	5.09
	8199791	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	17.38	CHEMBL3234	Homo sapiens	Inhibition	%	17.38
	8200153	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	9.7	CHEMBL3234	Homo sapiens	Inhibition	%	9.7
	8200257	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	12.16	CHEMBL3234	Homo sapiens	Inhibition	%	12.16
	8200481	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	7.64	CHEMBL3234	Homo sapiens	Inhibition	%	7.64
	8200596	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	11.48	CHEMBL3234	Homo sapiens	Inhibition	%	11.48
	8200970	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	43.92	CHEMBL3234	Homo sapiens	Inhibition	%	43.92
	8201100	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	4.48	CHEMBL3234	Homo sapiens	Inhibition	%	4.48
	8201324	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	23.36	CHEMBL3234	Homo sapiens	Inhibition	%	23.36
	8201459	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	4.9	CHEMBL3234	Homo sapiens	Inhibition	%	4.9
	8201816	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.56	CHEMBL3234	Homo sapiens	Inhibition	%	-0.56
	8202095	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	5.21	CHEMBL3234	Homo sapiens	Inhibition	%	5.21
	8202235	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	27.15	CHEMBL3234	Homo sapiens	Inhibition	%	27.15
	8202626	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	7.02	CHEMBL3234	Homo sapiens	Inhibition	%	7.02
	8202751	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	5.58	CHEMBL3234	Homo sapiens	Inhibition	%	5.58
	8203105	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	10.24	CHEMBL3234	Homo sapiens	Inhibition	%	10.24
	8203460	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	31.18	CHEMBL3234	Homo sapiens	Inhibition	%	31.18
	8203606	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	30.63	CHEMBL3234	Homo sapiens	Inhibition	%	30.63
	8203964	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	7.44	CHEMBL3234	Homo sapiens	Inhibition	%	7.44
	8204130	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	11.27	CHEMBL3234	Homo sapiens	Inhibition	%	11.27
	8204491	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	70.88	CHEMBL3234	Homo sapiens	Inhibition	%	70.88
	8204820	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	34.07	CHEMBL3234	Homo sapiens	Inhibition	%	34.07
	8204935	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	11.05	CHEMBL3234	Homo sapiens	Inhibition	%	11.05
	8205159	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	54.16	CHEMBL3234	Homo sapiens	Inhibition	%	54.16
	8205308	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	7.14	CHEMBL3234	Homo sapiens	Inhibition	%	7.14
	8205668	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	4.58	CHEMBL3234	Homo sapiens	Inhibition	%	4.58
	8205807	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	6.46	CHEMBL3234	Homo sapiens	Inhibition	%	6.46
	8206163	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	4.6	CHEMBL3234	Homo sapiens	Inhibition	%	4.6
	8206439	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	4.98	CHEMBL3234	Homo sapiens	Inhibition	%	4.98
	8206582	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-1.41	CHEMBL3234	Homo sapiens	Inhibition	%	-1.41
	8206806	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	7.14	CHEMBL3234	Homo sapiens	Inhibition	%	7.14
	8206986	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	5.43	CHEMBL3234	Homo sapiens	Inhibition	%	5.43
	8207112	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	6.04	CHEMBL3234	Homo sapiens	Inhibition	%	6.04
	8207336	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	3.98	CHEMBL3234	Homo sapiens	Inhibition	%	3.98
	8207466	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	15.07	CHEMBL3234	Homo sapiens	Inhibition	%	15.07
	8207822	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	73.76	CHEMBL3234	Homo sapiens	Inhibition	%	73.76
	8207967	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	8.43	CHEMBL3234	Homo sapiens	Inhibition	%	8.43
	8208191	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	6.17	CHEMBL3234	Homo sapiens	Inhibition	%	6.17
	8208323	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	4.81	CHEMBL3234	Homo sapiens	Inhibition	%	4.81
	8208489	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	51.49	CHEMBL3234	Homo sapiens	Inhibition	%	51.49
	8208713	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	4.76	CHEMBL3234	Homo sapiens	Inhibition	%	4.76
	8208846	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	87.9	CHEMBL3234	Homo sapiens	Inhibition	%	87.9
	8209175	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	16.9	CHEMBL3234	Homo sapiens	Inhibition	%	16.9
	8209515	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.25	CHEMBL3234	Homo sapiens	Inhibition	%	2.25
	8209665	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	11.68	CHEMBL3234	Homo sapiens	Inhibition	%	11.68
	8210025	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	11.39	CHEMBL3234	Homo sapiens	Inhibition	%	11.39
	8210166	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	9.0	CHEMBL3234	Homo sapiens	Inhibition	%	9.0
	8210390	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	10.26	CHEMBL3234	Homo sapiens	Inhibition	%	10.26
	8210526	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-0.44	CHEMBL3234	Homo sapiens	Inhibition	%	-0.44
	8210785	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	4.39	CHEMBL3234	Homo sapiens	Inhibition	%	4.39
	8211153	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	9.79	CHEMBL3234	Homo sapiens	Inhibition	%	9.79
	8211323	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	6.49	CHEMBL3234	Homo sapiens	Inhibition	%	6.49
	8211670	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	9.71	CHEMBL3234	Homo sapiens	Inhibition	%	9.71
	8211799	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	12.2	CHEMBL3234	Homo sapiens	Inhibition	%	12.2
	8212023	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	28.45	CHEMBL3234	Homo sapiens	Inhibition	%	28.45
	8212155	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	7.87	CHEMBL3234	Homo sapiens	Inhibition	%	7.87
	8212520	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	5.36	CHEMBL3234	Homo sapiens	Inhibition	%	5.36
	8212653	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	10.31	CHEMBL3234	Homo sapiens	Inhibition	%	10.31
	8213047	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	17.88	CHEMBL3234	Homo sapiens	Inhibition	%	17.88
	8213176	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	5.06	CHEMBL3234	Homo sapiens	Inhibition	%	5.06
	8213400	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	10.45	CHEMBL3234	Homo sapiens	Inhibition	%	10.45
	8213504	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	64.38	CHEMBL3234	Homo sapiens	Inhibition	%	64.38
	8213841	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	6.89	CHEMBL3234	Homo sapiens	Inhibition	%	6.89
	8213988	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	4.22	CHEMBL3234	Homo sapiens	Inhibition	%	4.22
	8214212	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	9.28	CHEMBL3234	Homo sapiens	Inhibition	%	9.28
	8214349	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	11.73	CHEMBL3234	Homo sapiens	Inhibition	%	11.73
	8214707	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	58.83	CHEMBL3234	Homo sapiens	Inhibition	%	58.83
	8214859	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	0.93	CHEMBL3234	Homo sapiens	Inhibition	%	0.93
	8215110	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	5.02	CHEMBL3234	Homo sapiens	Inhibition	%	5.02
	8215487	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	28.06	CHEMBL3234	Homo sapiens	Inhibition	%	28.06
	8215651	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	4.89	CHEMBL3234	Homo sapiens	Inhibition	%	4.89
	8215994	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	3.99	CHEMBL3234	Homo sapiens	Inhibition	%	3.99
	8216337	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	5.59	CHEMBL3234	Homo sapiens	Inhibition	%	5.59
	8216473	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	11.09	CHEMBL3234	Homo sapiens	Inhibition	%	11.09
	8216835	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	8.36	CHEMBL3234	Homo sapiens	Inhibition	%	8.36
	8216969	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	5.93	CHEMBL3234	Homo sapiens	Inhibition	%	5.93
	8217193	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	8.3	CHEMBL3234	Homo sapiens	Inhibition	%	8.3
	8217367	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	3.85	CHEMBL3234	Homo sapiens	Inhibition	%	3.85
	8217722	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	16.2	CHEMBL3234	Homo sapiens	Inhibition	%	16.2
	8217823	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	0.67	CHEMBL3234	Homo sapiens	Inhibition	%	0.67
	8218047	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	3.62	CHEMBL3234	Homo sapiens	Inhibition	%	3.62
	8218162	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	3.04	CHEMBL3234	Homo sapiens	Inhibition	%	3.04
	8218513	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	23.09	CHEMBL3234	Homo sapiens	Inhibition	%	23.09
	8218656	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	51.82	CHEMBL3234	Homo sapiens	Inhibition	%	51.82
	8219011	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	83.45	CHEMBL3234	Homo sapiens	Inhibition	%	83.45
	8219171	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	1.69	CHEMBL3234	Homo sapiens	Inhibition	%	1.69
	8219395	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	4.55	CHEMBL3234	Homo sapiens	Inhibition	%	4.55
	8219421	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	5.16	CHEMBL3234	Homo sapiens	Inhibition	%	5.16
	8219645	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	6.92	CHEMBL3234	Homo sapiens	Inhibition	%	6.92
	8219806	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	5.63	CHEMBL3234	Homo sapiens	Inhibition	%	5.63
	8219975	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	8.93	CHEMBL3234	Homo sapiens	Inhibition	%	8.93
	8220199	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	6.64	CHEMBL3234	Homo sapiens	Inhibition	%	6.64
	8220328	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	5.0	CHEMBL3234	Homo sapiens	Inhibition	%	5.0
	8220666	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	5.95	CHEMBL3234	Homo sapiens	Inhibition	%	5.95
	8220804	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	6.34	CHEMBL3234	Homo sapiens	Inhibition	%	6.34
	8221028	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	14.6	CHEMBL3234	Homo sapiens	Inhibition	%	14.6
	8221164	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.65	CHEMBL3234	Homo sapiens	Inhibition	%	2.65
	8221521	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	4.6	CHEMBL3234	Homo sapiens	Inhibition	%	4.6
	8221686	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	5.01	CHEMBL3234	Homo sapiens	Inhibition	%	5.01
	8222041	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	61.81	CHEMBL3234	Homo sapiens	Inhibition	%	61.81
	8222363	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	11.02	CHEMBL3234	Homo sapiens	Inhibition	%	11.02
	8222497	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	8.01	CHEMBL3234	Homo sapiens	Inhibition	%	8.01
	8222839	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	68.85	CHEMBL3234	Homo sapiens	Inhibition	%	68.85
	8222983	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	31.04	CHEMBL3234	Homo sapiens	Inhibition	%	31.04
	8223207	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	86.09	CHEMBL3234	Homo sapiens	Inhibition	%	86.09
	8223336	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	7.45	CHEMBL3234	Homo sapiens	Inhibition	%	7.45
	8223721	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	3.28	CHEMBL3234	Homo sapiens	Inhibition	%	3.28
	8223971	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	5.89	CHEMBL3234	Homo sapiens	Inhibition	%	5.89
	8224133	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	8.51	CHEMBL3234	Homo sapiens	Inhibition	%	8.51
	8224527	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	8.47	CHEMBL3234	Homo sapiens	Inhibition	%	8.47
	8224662	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	4.77	CHEMBL3234	Homo sapiens	Inhibition	%	4.77
	8224886	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	4.14	CHEMBL3234	Homo sapiens	Inhibition	%	4.14
	8225000	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	4.68	CHEMBL3234	Homo sapiens	Inhibition	%	4.68
	8225358	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	5.06	CHEMBL3234	Homo sapiens	Inhibition	%	5.06
	8225496	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	4.62	CHEMBL3234	Homo sapiens	Inhibition	%	4.62
	8225855	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	9.23	CHEMBL3234	Homo sapiens	Inhibition	%	9.23
	8226013	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	2.85	CHEMBL3234	Homo sapiens	Inhibition	%	2.85
	8226237	CHEMBL1962107	GSK_PKIS: HCK mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	5.24	CHEMBL3234	Homo sapiens	Inhibition	%	5.24
	8226362	CHEMBL1962106	GSK_PKIS: HCK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	5.32	CHEMBL3234	Homo sapiens	Inhibition	%	5.32
active	9570203	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	NC(=O)c1ccc(NC2CCCCC2N)nc1Nc1cccc(Cl)c1		CHEMBL1982753	=	Ki	nM	1584.89	CHEMBL3234	Homo sapiens	pKi		5.8
inactive	9570204	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	<	Ki	nM	3162.28	CHEMBL3234	Homo sapiens	pKi		5.5
active	9570205	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	Oc1cc(O)cc(C=Cc2ccc(O)c(O)c2)c1		CHEMBL1972346	=	Ki	nM	398.11	CHEMBL3234	Homo sapiens	pKi		6.4
inactive	9570206	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	3162.28	CHEMBL3234	Homo sapiens	pKi		5.5
active	9570207	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Ki	nM	0.3162	CHEMBL3234	Homo sapiens	pKi		9.5
active	9570208	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	Ki	nM	1584.89	CHEMBL3234	Homo sapiens	pKi		5.8
inactive	9570209	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	3162.28	CHEMBL3234	Homo sapiens	pKi		5.5
active	9570210	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	3162.28	CHEMBL3234	Homo sapiens	pKi		5.5
active	9570211	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	199.53	CHEMBL3234	Homo sapiens	pKi		6.7
inactive	9570212	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	3162.28	CHEMBL3234	Homo sapiens	pKi		5.5
inactive	9570213	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	3162.28	CHEMBL3234	Homo sapiens	pKi		5.5
inactive	9570214	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	<	Ki	nM	3162.28	CHEMBL3234	Homo sapiens	pKi		5.5
active	9570215	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	=	Ki	nM	199.53	CHEMBL3234	Homo sapiens	pKi		6.7
inactive	9570216	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	3162.28	CHEMBL3234	Homo sapiens	pKi		5.5
active	9570217	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Ki	nM	100.0	CHEMBL3234	Homo sapiens	pKi		7.0
inactive	9570218	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	<	Ki	nM	3162.28	CHEMBL3234	Homo sapiens	pKi		5.5
inactive	9570219	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	<	Ki	nM	3162.28	CHEMBL3234	Homo sapiens	pKi		5.5
active	9570220	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Ki	nM	2511.89	CHEMBL3234	Homo sapiens	pKi		5.6
inactive	9570221	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	<	Ki	nM	3162.28	CHEMBL3234	Homo sapiens	pKi		5.5
active	9570222	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	1258.93	CHEMBL3234	Homo sapiens	pKi		5.9
active	9570223	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Ki	nM	630.96	CHEMBL3234	Homo sapiens	pKi		6.2
inactive	9570224	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	<	Ki	nM	3162.28	CHEMBL3234	Homo sapiens	pKi		5.5
inactive	9570225	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	3162.28	CHEMBL3234	Homo sapiens	pKi		5.5
inactive	9570226	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	3162.28	CHEMBL3234	Homo sapiens	pKi		5.5
inactive	9570227	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	<	Ki	nM	3162.28	CHEMBL3234	Homo sapiens	pKi		5.5
active	9570228	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	1258.93	CHEMBL3234	Homo sapiens	pKi		5.9
active	9570229	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Ki	nM	2511.89	CHEMBL3234	Homo sapiens	pKi		5.6
active	9570230	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Ki	nM	199.53	CHEMBL3234	Homo sapiens	pKi		6.7
inactive	9570231	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	<	Ki	nM	3162.28	CHEMBL3234	Homo sapiens	pKi		5.5
inactive	9570232	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	3162.28	CHEMBL3234	Homo sapiens	pKi		5.5
active	9570233	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Ki	nM	158.49	CHEMBL3234	Homo sapiens	pKi		6.8
active	9570234	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Ki	nM	125.89	CHEMBL3234	Homo sapiens	pKi		6.9
inactive	9570235	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	3162.28	CHEMBL3234	Homo sapiens	pKi		5.5
active	9570236	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	5.012	CHEMBL3234	Homo sapiens	pKi		8.3
inactive	9570237	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	3162.28	CHEMBL3234	Homo sapiens	pKi		5.5
active	9570238	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	50.12	CHEMBL3234	Homo sapiens	pKi		7.3
inactive	9570239	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	3162.28	CHEMBL3234	Homo sapiens	pKi		5.5
inactive	9570240	CHEMBL1963709	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: HCK	F	c1ccc(-c2c[nH]c3ncnc(N4CCCCC4)c23)cc1		CHEMBL1998953	<	Ki	nM	3162.28	CHEMBL3234	Homo sapiens	pKi		5.5
	10838595	CHEMBL2014435	Inhibition of HCK at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	1.0	CHEMBL3234	Homo sapiens	INH	%	1.0
	10850682	CHEMBL2019802	Inhibition of human Hck at 1 uM	B	Cn1cc(-c2cccc(-c3cnc(N)c(C(=O)N[C@H]4C5CC6CC4C[C@@](O)(C6)C5)n3)c2)cn1		CHEMBL2018022	>	Inhibition	%	50.0	CHEMBL3234	Homo sapiens	INH	%	50.0
	10984768	CHEMBL2072064	Inhibition of human Hck at 1 uM	B	Nc1cc(Nc2cnccn2)nc(-c2ccnc(N3CCNCC3)c2)c1		CHEMBL2069349	>	Inhibition	%	50.0	CHEMBL3234	Homo sapiens	INH	%	50.0
	12046324	CHEMBL2156654	Inhibition of Hck at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	19.8	CHEMBL3234	Homo sapiens	INH	%	19.8
	12074638	CHEMBL2161200	Inhibition of Hck at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL3234	Homo sapiens	INH	%	50.0
	12173588	CHEMBL2213527	Inhibition of HCK assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL3234	Homo sapiens	Activity	%	100.0
	12209084	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	67.0	CHEMBL3234	Homo sapiens	Residual Activity	%	67.0
	12209085	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	98.0	CHEMBL3234	Homo sapiens	Residual Activity	%	98.0
	12209086	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	102.0	CHEMBL3234	Homo sapiens	Residual Activity	%	102.0
	12209087	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	103.0	CHEMBL3234	Homo sapiens	Residual Activity	%	103.0
	12209088	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	100.0	CHEMBL3234	Homo sapiens	Residual Activity	%	100.0
	12209089	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	101.0	CHEMBL3234	Homo sapiens	Residual Activity	%	101.0
	12209090	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	98.0	CHEMBL3234	Homo sapiens	Residual Activity	%	98.0
	12209091	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	106.0	CHEMBL3234	Homo sapiens	Residual Activity	%	106.0
	12209092	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	86.0	CHEMBL3234	Homo sapiens	Residual Activity	%	86.0
	12209093	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	13.0	CHEMBL3234	Homo sapiens	Residual Activity	%	13.0
	12209094	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	99.0	CHEMBL3234	Homo sapiens	Residual Activity	%	99.0
	12209095	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	109.0	CHEMBL3234	Homo sapiens	Residual Activity	%	109.0
	12209096	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	101.0	CHEMBL3234	Homo sapiens	Residual Activity	%	101.0
	12209097	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	102.0	CHEMBL3234	Homo sapiens	Residual Activity	%	102.0
	12209098	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	107.0	CHEMBL3234	Homo sapiens	Residual Activity	%	107.0
	12209099	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	111.0	CHEMBL3234	Homo sapiens	Residual Activity	%	111.0
	12209100	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	105.0	CHEMBL3234	Homo sapiens	Residual Activity	%	105.0
	12209101	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	20.0	CHEMBL3234	Homo sapiens	Residual Activity	%	20.0
	12209102	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	105.0	CHEMBL3234	Homo sapiens	Residual Activity	%	105.0
	12209103	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	78.0	CHEMBL3234	Homo sapiens	Residual Activity	%	78.0
	12209104	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	113.0	CHEMBL3234	Homo sapiens	Residual Activity	%	113.0
	12209105	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	90.0	CHEMBL3234	Homo sapiens	Residual Activity	%	90.0
	12209106	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	71.0	CHEMBL3234	Homo sapiens	Residual Activity	%	71.0
	12209107	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	56.0	CHEMBL3234	Homo sapiens	Residual Activity	%	56.0
	12209108	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	115.0	CHEMBL3234	Homo sapiens	Residual Activity	%	115.0
	12209109	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	9.0	CHEMBL3234	Homo sapiens	Residual Activity	%	9.0
	12209110	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	106.0	CHEMBL3234	Homo sapiens	Residual Activity	%	106.0
	12209111	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	2.0	CHEMBL3234	Homo sapiens	Residual Activity	%	2.0
	12209112	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	102.0	CHEMBL3234	Homo sapiens	Residual Activity	%	102.0
	12209113	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	75.0	CHEMBL3234	Homo sapiens	Residual Activity	%	75.0
	12209114	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	97.0	CHEMBL3234	Homo sapiens	Residual Activity	%	97.0
	12209115	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	91.0	CHEMBL3234	Homo sapiens	Residual Activity	%	91.0
	12209116	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	73.0	CHEMBL3234	Homo sapiens	Residual Activity	%	73.0
	12209117	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	106.0	CHEMBL3234	Homo sapiens	Residual Activity	%	106.0
	12209118	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	102.0	CHEMBL3234	Homo sapiens	Residual Activity	%	102.0
	12209119	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	93.0	CHEMBL3234	Homo sapiens	Residual Activity	%	93.0
	12209120	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	101.0	CHEMBL3234	Homo sapiens	Residual Activity	%	101.0
	12209121	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	8.0	CHEMBL3234	Homo sapiens	Residual Activity	%	8.0
	12209122	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	101.0	CHEMBL3234	Homo sapiens	Residual Activity	%	101.0
	12209123	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	87.0	CHEMBL3234	Homo sapiens	Residual Activity	%	87.0
	12209124	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	27.0	CHEMBL3234	Homo sapiens	Residual Activity	%	27.0
	12209125	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	100.0	CHEMBL3234	Homo sapiens	Residual Activity	%	100.0
	12209126	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	103.0	CHEMBL3234	Homo sapiens	Residual Activity	%	103.0
	12209127	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	106.0	CHEMBL3234	Homo sapiens	Residual Activity	%	106.0
	12209128	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	99.0	CHEMBL3234	Homo sapiens	Residual Activity	%	99.0
	12209129	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	98.0	CHEMBL3234	Homo sapiens	Residual Activity	%	98.0
	12209130	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	103.0	CHEMBL3234	Homo sapiens	Residual Activity	%	103.0
	12209131	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	92.0	CHEMBL3234	Homo sapiens	Residual Activity	%	92.0
	12209132	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	38.0	CHEMBL3234	Homo sapiens	Residual Activity	%	38.0
	12209133	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	1.0	CHEMBL3234	Homo sapiens	Residual Activity	%	1.0
	12209134	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	106.0	CHEMBL3234	Homo sapiens	Residual Activity	%	106.0
	12209135	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	92.0	CHEMBL3234	Homo sapiens	Residual Activity	%	92.0
	12209136	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	81.0	CHEMBL3234	Homo sapiens	Residual Activity	%	81.0
	12209137	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	84.0	CHEMBL3234	Homo sapiens	Residual Activity	%	84.0
	12209138	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	94.0	CHEMBL3234	Homo sapiens	Residual Activity	%	94.0
	12209139	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	89.0	CHEMBL3234	Homo sapiens	Residual Activity	%	89.0
	12209140	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	93.0	CHEMBL3234	Homo sapiens	Residual Activity	%	93.0
	12209141	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	46.0	CHEMBL3234	Homo sapiens	Residual Activity	%	46.0
	12209142	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	97.0	CHEMBL3234	Homo sapiens	Residual Activity	%	97.0
	12209143	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	96.0	CHEMBL3234	Homo sapiens	Residual Activity	%	96.0
	12209144	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	27.0	CHEMBL3234	Homo sapiens	Residual Activity	%	27.0
	12209145	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	95.0	CHEMBL3234	Homo sapiens	Residual Activity	%	95.0
	12209146	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	96.0	CHEMBL3234	Homo sapiens	Residual Activity	%	96.0
	12209147	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	89.0	CHEMBL3234	Homo sapiens	Residual Activity	%	89.0
	12209148	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	37.0	CHEMBL3234	Homo sapiens	Residual Activity	%	37.0
	12209149	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	98.0	CHEMBL3234	Homo sapiens	Residual Activity	%	98.0
	12209150	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	91.0	CHEMBL3234	Homo sapiens	Residual Activity	%	91.0
	12209151	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	104.0	CHEMBL3234	Homo sapiens	Residual Activity	%	104.0
	12209152	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	63.0	CHEMBL3234	Homo sapiens	Residual Activity	%	63.0
	12209153	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	24.0	CHEMBL3234	Homo sapiens	Residual Activity	%	24.0
	12209154	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	57.0	CHEMBL3234	Homo sapiens	Residual Activity	%	57.0
	12209155	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	85.0	CHEMBL3234	Homo sapiens	Residual Activity	%	85.0
	12209156	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	8.0	CHEMBL3234	Homo sapiens	Residual Activity	%	8.0
	12209157	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	90.0	CHEMBL3234	Homo sapiens	Residual Activity	%	90.0
	12209158	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	30.0	CHEMBL3234	Homo sapiens	Residual Activity	%	30.0
	12209159	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	97.0	CHEMBL3234	Homo sapiens	Residual Activity	%	97.0
	12209160	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	75.0	CHEMBL3234	Homo sapiens	Residual Activity	%	75.0
	12209161	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	13.0	CHEMBL3234	Homo sapiens	Residual Activity	%	13.0
	12209162	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	102.0	CHEMBL3234	Homo sapiens	Residual Activity	%	102.0
	12209163	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	52.0	CHEMBL3234	Homo sapiens	Residual Activity	%	52.0
	12209164	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	80.0	CHEMBL3234	Homo sapiens	Residual Activity	%	80.0
	12209165	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	91.0	CHEMBL3234	Homo sapiens	Residual Activity	%	91.0
	12209166	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	-3.0	CHEMBL3234	Homo sapiens	Residual Activity	%	-3.0
	12209167	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	50.0	CHEMBL3234	Homo sapiens	Residual Activity	%	50.0
	12209168	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	104.0	CHEMBL3234	Homo sapiens	Residual Activity	%	104.0
	12209169	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	43.0	CHEMBL3234	Homo sapiens	Residual Activity	%	43.0
	12209170	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	1.0	CHEMBL3234	Homo sapiens	Residual Activity	%	1.0
	12209171	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	96.0	CHEMBL3234	Homo sapiens	Residual Activity	%	96.0
	12209172	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	99.0	CHEMBL3234	Homo sapiens	Residual Activity	%	99.0
	12209173	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	101.0	CHEMBL3234	Homo sapiens	Residual Activity	%	101.0
	12209174	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	104.0	CHEMBL3234	Homo sapiens	Residual Activity	%	104.0
	12209175	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	32.0	CHEMBL3234	Homo sapiens	Residual Activity	%	32.0
	12209176	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	105.0	CHEMBL3234	Homo sapiens	Residual Activity	%	105.0
	12209177	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	98.0	CHEMBL3234	Homo sapiens	Residual Activity	%	98.0
	12209178	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	3.0	CHEMBL3234	Homo sapiens	Residual Activity	%	3.0
	12209179	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	88.0	CHEMBL3234	Homo sapiens	Residual Activity	%	88.0
	12209180	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	56.0	CHEMBL3234	Homo sapiens	Residual Activity	%	56.0
	12209181	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	115.0	CHEMBL3234	Homo sapiens	Residual Activity	%	115.0
	12209182	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	101.0	CHEMBL3234	Homo sapiens	Residual Activity	%	101.0
	12209183	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	107.0	CHEMBL3234	Homo sapiens	Residual Activity	%	107.0
	12209184	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	102.0	CHEMBL3234	Homo sapiens	Residual Activity	%	102.0
	12209185	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	95.0	CHEMBL3234	Homo sapiens	Residual Activity	%	95.0
	12209186	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	109.0	CHEMBL3234	Homo sapiens	Residual Activity	%	109.0
	12209187	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	97.0	CHEMBL3234	Homo sapiens	Residual Activity	%	97.0
	12209188	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	98.0	CHEMBL3234	Homo sapiens	Residual Activity	%	98.0
	12209189	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	109.0	CHEMBL3234	Homo sapiens	Residual Activity	%	109.0
	12209190	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	91.0	CHEMBL3234	Homo sapiens	Residual Activity	%	91.0
	12209191	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	63.0	CHEMBL3234	Homo sapiens	Residual Activity	%	63.0
	12209192	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	83.0	CHEMBL3234	Homo sapiens	Residual Activity	%	83.0
	12209193	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	98.0	CHEMBL3234	Homo sapiens	Residual Activity	%	98.0
	12209194	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	50.0	CHEMBL3234	Homo sapiens	Residual Activity	%	50.0
	12209195	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	85.0	CHEMBL3234	Homo sapiens	Residual Activity	%	85.0
	12209196	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	47.0	CHEMBL3234	Homo sapiens	Residual Activity	%	47.0
	12209197	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	4.0	CHEMBL3234	Homo sapiens	Residual Activity	%	4.0
	12209198	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	34.0	CHEMBL3234	Homo sapiens	Residual Activity	%	34.0
	12209199	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	25.0	CHEMBL3234	Homo sapiens	Residual Activity	%	25.0
	12209200	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	88.0	CHEMBL3234	Homo sapiens	Residual Activity	%	88.0
	12209201	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	97.0	CHEMBL3234	Homo sapiens	Residual Activity	%	97.0
	12209202	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	66.0	CHEMBL3234	Homo sapiens	Residual Activity	%	66.0
	12209203	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	9.0	CHEMBL3234	Homo sapiens	Residual Activity	%	9.0
	12209204	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	14.0	CHEMBL3234	Homo sapiens	Residual Activity	%	14.0
	12209205	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	97.0	CHEMBL3234	Homo sapiens	Residual Activity	%	97.0
	12209206	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	95.0	CHEMBL3234	Homo sapiens	Residual Activity	%	95.0
	12209207	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	92.0	CHEMBL3234	Homo sapiens	Residual Activity	%	92.0
	12209208	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	94.0	CHEMBL3234	Homo sapiens	Residual Activity	%	94.0
	12209209	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	60.0	CHEMBL3234	Homo sapiens	Residual Activity	%	60.0
	12209210	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	94.0	CHEMBL3234	Homo sapiens	Residual Activity	%	94.0
	12209211	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	49.0	CHEMBL3234	Homo sapiens	Residual Activity	%	49.0
	12209212	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	94.0	CHEMBL3234	Homo sapiens	Residual Activity	%	94.0
	12209213	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	96.0	CHEMBL3234	Homo sapiens	Residual Activity	%	96.0
	12209214	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	105.0	CHEMBL3234	Homo sapiens	Residual Activity	%	105.0
	12209215	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	4.0	CHEMBL3234	Homo sapiens	Residual Activity	%	4.0
	12209216	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	3.0	CHEMBL3234	Homo sapiens	Residual Activity	%	3.0
	12209217	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	7.0	CHEMBL3234	Homo sapiens	Residual Activity	%	7.0
	12209218	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	85.0	CHEMBL3234	Homo sapiens	Residual Activity	%	85.0
	12209219	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	74.0	CHEMBL3234	Homo sapiens	Residual Activity	%	74.0
	12209220	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	69.0	CHEMBL3234	Homo sapiens	Residual Activity	%	69.0
	12209221	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	6.0	CHEMBL3234	Homo sapiens	Residual Activity	%	6.0
	12209222	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	91.0	CHEMBL3234	Homo sapiens	Residual Activity	%	91.0
	12209223	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	110.0	CHEMBL3234	Homo sapiens	Residual Activity	%	110.0
	12209224	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	87.0	CHEMBL3234	Homo sapiens	Residual Activity	%	87.0
	12209225	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	89.0	CHEMBL3234	Homo sapiens	Residual Activity	%	89.0
	12209226	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	2.0	CHEMBL3234	Homo sapiens	Residual Activity	%	2.0
	12209227	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	87.0	CHEMBL3234	Homo sapiens	Residual Activity	%	87.0
	12209228	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	99.0	CHEMBL3234	Homo sapiens	Residual Activity	%	99.0
	12209229	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	82.0	CHEMBL3234	Homo sapiens	Residual Activity	%	82.0
	12209230	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	112.0	CHEMBL3234	Homo sapiens	Residual Activity	%	112.0
	12209231	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	107.0	CHEMBL3234	Homo sapiens	Residual Activity	%	107.0
	12209232	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	58.0	CHEMBL3234	Homo sapiens	Residual Activity	%	58.0
	12209233	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	8.0	CHEMBL3234	Homo sapiens	Residual Activity	%	8.0
	12209234	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	3.0	CHEMBL3234	Homo sapiens	Residual Activity	%	3.0
	12209235	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	89.0	CHEMBL3234	Homo sapiens	Residual Activity	%	89.0
	12209236	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	96.0	CHEMBL3234	Homo sapiens	Residual Activity	%	96.0
	12209237	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	40.0	CHEMBL3234	Homo sapiens	Residual Activity	%	40.0
	12209238	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	103.0	CHEMBL3234	Homo sapiens	Residual Activity	%	103.0
	12209239	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	102.0	CHEMBL3234	Homo sapiens	Residual Activity	%	102.0
	12209240	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	72.0	CHEMBL3234	Homo sapiens	Residual Activity	%	72.0
	12209241	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	-2.0	CHEMBL3234	Homo sapiens	Residual Activity	%	-2.0
	12209242	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	24.0	CHEMBL3234	Homo sapiens	Residual Activity	%	24.0
	12209243	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	73.0	CHEMBL3234	Homo sapiens	Residual Activity	%	73.0
	12209244	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	80.0	CHEMBL3234	Homo sapiens	Residual Activity	%	80.0
	12209245	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	90.0	CHEMBL3234	Homo sapiens	Residual Activity	%	90.0
	12209246	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	60.0	CHEMBL3234	Homo sapiens	Residual Activity	%	60.0
	12209247	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	101.0	CHEMBL3234	Homo sapiens	Residual Activity	%	101.0
	12209248	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	81.0	CHEMBL3234	Homo sapiens	Residual Activity	%	81.0
	12209249	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	86.0	CHEMBL3234	Homo sapiens	Residual Activity	%	86.0
	12209250	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	53.0	CHEMBL3234	Homo sapiens	Residual Activity	%	53.0
	12209251	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	12.0	CHEMBL3234	Homo sapiens	Residual Activity	%	12.0
	12209252	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	87.0	CHEMBL3234	Homo sapiens	Residual Activity	%	87.0
	12209253	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	93.0	CHEMBL3234	Homo sapiens	Residual Activity	%	93.0
	12209254	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	97.0	CHEMBL3234	Homo sapiens	Residual Activity	%	97.0
	12209255	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	77.0	CHEMBL3234	Homo sapiens	Residual Activity	%	77.0
	12209256	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	103.0	CHEMBL3234	Homo sapiens	Residual Activity	%	103.0
	12209257	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	95.0	CHEMBL3234	Homo sapiens	Residual Activity	%	95.0
	12209258	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	90.0	CHEMBL3234	Homo sapiens	Residual Activity	%	90.0
	12209259	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	3.0	CHEMBL3234	Homo sapiens	Residual Activity	%	3.0
	12209260	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	99.0	CHEMBL3234	Homo sapiens	Residual Activity	%	99.0
	12209261	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	78.0	CHEMBL3234	Homo sapiens	Residual Activity	%	78.0
	12209262	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	84.0	CHEMBL3234	Homo sapiens	Residual Activity	%	84.0
	12209263	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	83.0	CHEMBL3234	Homo sapiens	Residual Activity	%	83.0
	12209264	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	11.0	CHEMBL3234	Homo sapiens	Residual Activity	%	11.0
	12209265	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	22.0	CHEMBL3234	Homo sapiens	Residual Activity	%	22.0
	12209266	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	94.0	CHEMBL3234	Homo sapiens	Residual Activity	%	94.0
	12209267	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	0.0	CHEMBL3234	Homo sapiens	Residual Activity	%	0.0
	12209268	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	85.0	CHEMBL3234	Homo sapiens	Residual Activity	%	85.0
	12209269	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	2.0	CHEMBL3234	Homo sapiens	Residual Activity	%	2.0
	12209270	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	98.0	CHEMBL3234	Homo sapiens	Residual Activity	%	98.0
	12209271	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	21.0	CHEMBL3234	Homo sapiens	Residual Activity	%	21.0
	12209272	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	78.0	CHEMBL3234	Homo sapiens	Residual Activity	%	78.0
	12209273	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	97.0	CHEMBL3234	Homo sapiens	Residual Activity	%	97.0
	12209274	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	74.0	CHEMBL3234	Homo sapiens	Residual Activity	%	74.0
	12209275	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	89.0	CHEMBL3234	Homo sapiens	Residual Activity	%	89.0
	12209276	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	86.0	CHEMBL3234	Homo sapiens	Residual Activity	%	86.0
	12209277	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	61.0	CHEMBL3234	Homo sapiens	Residual Activity	%	61.0
	12209278	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	100.0	CHEMBL3234	Homo sapiens	Residual Activity	%	100.0
	12209279	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	1.0	CHEMBL3234	Homo sapiens	Residual Activity	%	1.0
	12209280	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	95.0	CHEMBL3234	Homo sapiens	Residual Activity	%	95.0
	12209281	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	40.0	CHEMBL3234	Homo sapiens	Residual Activity	%	40.0
	12209282	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	5.0	CHEMBL3234	Homo sapiens	Residual Activity	%	5.0
	12209283	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	92.0	CHEMBL3234	Homo sapiens	Residual Activity	%	92.0
	12209284	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	81.0	CHEMBL3234	Homo sapiens	Residual Activity	%	81.0
	12209285	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	103.0	CHEMBL3234	Homo sapiens	Residual Activity	%	103.0
	12209286	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	112.0	CHEMBL3234	Homo sapiens	Residual Activity	%	112.0
	12209287	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	97.0	CHEMBL3234	Homo sapiens	Residual Activity	%	97.0
	12209288	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	99.0	CHEMBL3234	Homo sapiens	Residual Activity	%	99.0
	12209289	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	80.0	CHEMBL3234	Homo sapiens	Residual Activity	%	80.0
	12209290	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	35.0	CHEMBL3234	Homo sapiens	Residual Activity	%	35.0
	12209291	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	4.0	CHEMBL3234	Homo sapiens	Residual Activity	%	4.0
	12209292	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	105.0	CHEMBL3234	Homo sapiens	Residual Activity	%	105.0
	12209293	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	83.0	CHEMBL3234	Homo sapiens	Residual Activity	%	83.0
	12209294	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	81.0	CHEMBL3234	Homo sapiens	Residual Activity	%	81.0
	12209295	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	81.0	CHEMBL3234	Homo sapiens	Residual Activity	%	81.0
	12209296	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	79.0	CHEMBL3234	Homo sapiens	Residual Activity	%	79.0
	12209297	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	83.0	CHEMBL3234	Homo sapiens	Residual Activity	%	83.0
	12209298	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	88.0	CHEMBL3234	Homo sapiens	Residual Activity	%	88.0
	12209299	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	8.0	CHEMBL3234	Homo sapiens	Residual Activity	%	8.0
	12209300	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	97.0	CHEMBL3234	Homo sapiens	Residual Activity	%	97.0
	12209301	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	91.0	CHEMBL3234	Homo sapiens	Residual Activity	%	91.0
	12209302	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	16.0	CHEMBL3234	Homo sapiens	Residual Activity	%	16.0
	12209303	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	87.0	CHEMBL3234	Homo sapiens	Residual Activity	%	87.0
	12209304	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	89.0	CHEMBL3234	Homo sapiens	Residual Activity	%	89.0
	12209305	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	90.0	CHEMBL3234	Homo sapiens	Residual Activity	%	90.0
	12209306	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	7.0	CHEMBL3234	Homo sapiens	Residual Activity	%	7.0
	12209307	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	90.0	CHEMBL3234	Homo sapiens	Residual Activity	%	90.0
	12209308	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	43.0	CHEMBL3234	Homo sapiens	Residual Activity	%	43.0
	12209309	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	105.0	CHEMBL3234	Homo sapiens	Residual Activity	%	105.0
	12209310	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	64.0	CHEMBL3234	Homo sapiens	Residual Activity	%	64.0
	12209311	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	4.0	CHEMBL3234	Homo sapiens	Residual Activity	%	4.0
	12209312	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	13.0	CHEMBL3234	Homo sapiens	Residual Activity	%	13.0
	12209313	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	89.0	CHEMBL3234	Homo sapiens	Residual Activity	%	89.0
	12209314	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	7.0	CHEMBL3234	Homo sapiens	Residual Activity	%	7.0
	12209315	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	86.0	CHEMBL3234	Homo sapiens	Residual Activity	%	86.0
	12209316	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	4.0	CHEMBL3234	Homo sapiens	Residual Activity	%	4.0
	12209317	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	86.0	CHEMBL3234	Homo sapiens	Residual Activity	%	86.0
	12209318	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	81.0	CHEMBL3234	Homo sapiens	Residual Activity	%	81.0
	12209319	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	1.0	CHEMBL3234	Homo sapiens	Residual Activity	%	1.0
	12212158	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	91.0	CHEMBL3234	Homo sapiens	Residual Activity	%	91.0
	12212159	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	54.0	CHEMBL3234	Homo sapiens	Residual Activity	%	54.0
	12212160	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	83.0	CHEMBL3234	Homo sapiens	Residual Activity	%	83.0
	12212161	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	103.0	CHEMBL3234	Homo sapiens	Residual Activity	%	103.0
	12212162	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	-1.0	CHEMBL3234	Homo sapiens	Residual Activity	%	-1.0
	12212163	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	9.0	CHEMBL3234	Homo sapiens	Residual Activity	%	9.0
	12212164	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	88.0	CHEMBL3234	Homo sapiens	Residual Activity	%	88.0
	12212165	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	7.0	CHEMBL3234	Homo sapiens	Residual Activity	%	7.0
	12212166	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	2.0	CHEMBL3234	Homo sapiens	Residual Activity	%	2.0
	12212167	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	92.0	CHEMBL3234	Homo sapiens	Residual Activity	%	92.0
	12212168	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	108.0	CHEMBL3234	Homo sapiens	Residual Activity	%	108.0
	12212169	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	94.0	CHEMBL3234	Homo sapiens	Residual Activity	%	94.0
	12212170	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	95.0	CHEMBL3234	Homo sapiens	Residual Activity	%	95.0
	12212171	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	4.0	CHEMBL3234	Homo sapiens	Residual Activity	%	4.0
	12212172	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	102.0	CHEMBL3234	Homo sapiens	Residual Activity	%	102.0
	12212173	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	86.0	CHEMBL3234	Homo sapiens	Residual Activity	%	86.0
	12212174	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	-1.0	CHEMBL3234	Homo sapiens	Residual Activity	%	-1.0
	12212175	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	68.0	CHEMBL3234	Homo sapiens	Residual Activity	%	68.0
	12212176	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	11.0	CHEMBL3234	Homo sapiens	Residual Activity	%	11.0
	12212177	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	104.0	CHEMBL3234	Homo sapiens	Residual Activity	%	104.0
	12212178	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	49.0	CHEMBL3234	Homo sapiens	Residual Activity	%	49.0
	12212179	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	106.0	CHEMBL3234	Homo sapiens	Residual Activity	%	106.0
	12212180	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	94.0	CHEMBL3234	Homo sapiens	Residual Activity	%	94.0
	12212181	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	96.0	CHEMBL3234	Homo sapiens	Residual Activity	%	96.0
	12212182	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	111.0	CHEMBL3234	Homo sapiens	Residual Activity	%	111.0
	12212183	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	89.0	CHEMBL3234	Homo sapiens	Residual Activity	%	89.0
	12212184	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	45.0	CHEMBL3234	Homo sapiens	Residual Activity	%	45.0
	12212185	CHEMBL2219109	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	91.0	CHEMBL3234	Homo sapiens	Residual Activity	%	91.0
	12248364	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	77.0	CHEMBL3234	Homo sapiens	Residual Activity	%	77.0
	12248365	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	92.0	CHEMBL3234	Homo sapiens	Residual Activity	%	92.0
	12248366	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	96.0	CHEMBL3234	Homo sapiens	Residual Activity	%	96.0
	12248367	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	93.0	CHEMBL3234	Homo sapiens	Residual Activity	%	93.0
	12248368	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	68.0	CHEMBL3234	Homo sapiens	Residual Activity	%	68.0
	12248369	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	83.0	CHEMBL3234	Homo sapiens	Residual Activity	%	83.0
	12248370	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	26.0	CHEMBL3234	Homo sapiens	Residual Activity	%	26.0
	12248371	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	48.0	CHEMBL3234	Homo sapiens	Residual Activity	%	48.0
	12248372	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	92.0	CHEMBL3234	Homo sapiens	Residual Activity	%	92.0
	12248373	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	52.0	CHEMBL3234	Homo sapiens	Residual Activity	%	52.0
	12248374	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	85.0	CHEMBL3234	Homo sapiens	Residual Activity	%	85.0
	12248375	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	90.0	CHEMBL3234	Homo sapiens	Residual Activity	%	90.0
	12248376	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	82.0	CHEMBL3234	Homo sapiens	Residual Activity	%	82.0
	12248377	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	32.0	CHEMBL3234	Homo sapiens	Residual Activity	%	32.0
	12248378	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	78.0	CHEMBL3234	Homo sapiens	Residual Activity	%	78.0
	12248379	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	77.0	CHEMBL3234	Homo sapiens	Residual Activity	%	77.0
	12248380	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	97.0	CHEMBL3234	Homo sapiens	Residual Activity	%	97.0
	12248381	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	92.0	CHEMBL3234	Homo sapiens	Residual Activity	%	92.0
	12248382	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	66.0	CHEMBL3234	Homo sapiens	Residual Activity	%	66.0
	12248383	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	49.0	CHEMBL3234	Homo sapiens	Residual Activity	%	49.0
	12248384	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	70.0	CHEMBL3234	Homo sapiens	Residual Activity	%	70.0
	12248385	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	63.0	CHEMBL3234	Homo sapiens	Residual Activity	%	63.0
	12248386	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	85.0	CHEMBL3234	Homo sapiens	Residual Activity	%	85.0
	12248387	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	80.0	CHEMBL3234	Homo sapiens	Residual Activity	%	80.0
	12248388	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	90.0	CHEMBL3234	Homo sapiens	Residual Activity	%	90.0
	12248389	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	34.0	CHEMBL3234	Homo sapiens	Residual Activity	%	34.0
	12248390	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	23.0	CHEMBL3234	Homo sapiens	Residual Activity	%	23.0
	12248391	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	32.0	CHEMBL3234	Homo sapiens	Residual Activity	%	32.0
	12248392	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	79.0	CHEMBL3234	Homo sapiens	Residual Activity	%	79.0
	12248393	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	80.0	CHEMBL3234	Homo sapiens	Residual Activity	%	80.0
	12248394	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	86.0	CHEMBL3234	Homo sapiens	Residual Activity	%	86.0
	12248395	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	7.0	CHEMBL3234	Homo sapiens	Residual Activity	%	7.0
	12248396	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	91.0	CHEMBL3234	Homo sapiens	Residual Activity	%	91.0
	12248397	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	85.0	CHEMBL3234	Homo sapiens	Residual Activity	%	85.0
	12248398	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	88.0	CHEMBL3234	Homo sapiens	Residual Activity	%	88.0
	12248399	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	79.0	CHEMBL3234	Homo sapiens	Residual Activity	%	79.0
	12248400	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	22.0	CHEMBL3234	Homo sapiens	Residual Activity	%	22.0
	12248401	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	73.0	CHEMBL3234	Homo sapiens	Residual Activity	%	73.0
	12248402	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	94.0	CHEMBL3234	Homo sapiens	Residual Activity	%	94.0
	12248403	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	59.0	CHEMBL3234	Homo sapiens	Residual Activity	%	59.0
	12248404	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	101.0	CHEMBL3234	Homo sapiens	Residual Activity	%	101.0
	12248405	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	84.0	CHEMBL3234	Homo sapiens	Residual Activity	%	84.0
	12248406	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	31.0	CHEMBL3234	Homo sapiens	Residual Activity	%	31.0
	12248407	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	40.0	CHEMBL3234	Homo sapiens	Residual Activity	%	40.0
	12248408	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	7.0	CHEMBL3234	Homo sapiens	Residual Activity	%	7.0
	12248409	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	68.0	CHEMBL3234	Homo sapiens	Residual Activity	%	68.0
	12248410	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	79.0	CHEMBL3234	Homo sapiens	Residual Activity	%	79.0
	12248411	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	60.0	CHEMBL3234	Homo sapiens	Residual Activity	%	60.0
	12248412	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	89.0	CHEMBL3234	Homo sapiens	Residual Activity	%	89.0
	12248413	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	83.0	CHEMBL3234	Homo sapiens	Residual Activity	%	83.0
	12248414	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	65.0	CHEMBL3234	Homo sapiens	Residual Activity	%	65.0
	12248415	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	2.0	CHEMBL3234	Homo sapiens	Residual Activity	%	2.0
	12248416	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	58.0	CHEMBL3234	Homo sapiens	Residual Activity	%	58.0
	12248417	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	69.0	CHEMBL3234	Homo sapiens	Residual Activity	%	69.0
	12248418	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	78.0	CHEMBL3234	Homo sapiens	Residual Activity	%	78.0
	12248419	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	59.0	CHEMBL3234	Homo sapiens	Residual Activity	%	59.0
	12248420	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	69.0	CHEMBL3234	Homo sapiens	Residual Activity	%	69.0
	12248421	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	73.0	CHEMBL3234	Homo sapiens	Residual Activity	%	73.0
	12248422	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	71.0	CHEMBL3234	Homo sapiens	Residual Activity	%	71.0
	12248423	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	66.0	CHEMBL3234	Homo sapiens	Residual Activity	%	66.0
	12248424	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	61.0	CHEMBL3234	Homo sapiens	Residual Activity	%	61.0
	12248425	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	7.0	CHEMBL3234	Homo sapiens	Residual Activity	%	7.0
	12248426	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	84.0	CHEMBL3234	Homo sapiens	Residual Activity	%	84.0
	12248427	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	83.0	CHEMBL3234	Homo sapiens	Residual Activity	%	83.0
	12248428	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	98.0	CHEMBL3234	Homo sapiens	Residual Activity	%	98.0
	12248429	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	76.0	CHEMBL3234	Homo sapiens	Residual Activity	%	76.0
	12248430	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	78.0	CHEMBL3234	Homo sapiens	Residual Activity	%	78.0
	12248431	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	79.0	CHEMBL3234	Homo sapiens	Residual Activity	%	79.0
	12248432	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	76.0	CHEMBL3234	Homo sapiens	Residual Activity	%	76.0
	12248433	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	4.0	CHEMBL3234	Homo sapiens	Residual Activity	%	4.0
	12248434	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	68.0	CHEMBL3234	Homo sapiens	Residual Activity	%	68.0
	12248435	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	42.0	CHEMBL3234	Homo sapiens	Residual Activity	%	42.0
	12248436	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	74.0	CHEMBL3234	Homo sapiens	Residual Activity	%	74.0
	12248437	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	35.0	CHEMBL3234	Homo sapiens	Residual Activity	%	35.0
	12248438	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	57.0	CHEMBL3234	Homo sapiens	Residual Activity	%	57.0
	12248439	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	53.0	CHEMBL3234	Homo sapiens	Residual Activity	%	53.0
	12248440	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	60.0	CHEMBL3234	Homo sapiens	Residual Activity	%	60.0
	12248441	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	13.0	CHEMBL3234	Homo sapiens	Residual Activity	%	13.0
	12248442	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	69.0	CHEMBL3234	Homo sapiens	Residual Activity	%	69.0
	12248443	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL3234	Homo sapiens	Residual Activity	%	0.0
	12248444	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	86.0	CHEMBL3234	Homo sapiens	Residual Activity	%	86.0
	12248445	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	71.0	CHEMBL3234	Homo sapiens	Residual Activity	%	71.0
	12248446	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	69.0	CHEMBL3234	Homo sapiens	Residual Activity	%	69.0
	12248447	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	93.0	CHEMBL3234	Homo sapiens	Residual Activity	%	93.0
	12248448	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	10.0	CHEMBL3234	Homo sapiens	Residual Activity	%	10.0
	12248449	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	96.0	CHEMBL3234	Homo sapiens	Residual Activity	%	96.0
	12248450	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	85.0	CHEMBL3234	Homo sapiens	Residual Activity	%	85.0
	12248451	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	105.0	CHEMBL3234	Homo sapiens	Residual Activity	%	105.0
	12248452	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	96.0	CHEMBL3234	Homo sapiens	Residual Activity	%	96.0
	12248453	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	15.0	CHEMBL3234	Homo sapiens	Residual Activity	%	15.0
	12248454	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	85.0	CHEMBL3234	Homo sapiens	Residual Activity	%	85.0
	12248455	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	76.0	CHEMBL3234	Homo sapiens	Residual Activity	%	76.0
	12248456	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	23.0	CHEMBL3234	Homo sapiens	Residual Activity	%	23.0
	12248457	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	78.0	CHEMBL3234	Homo sapiens	Residual Activity	%	78.0
	12248458	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	94.0	CHEMBL3234	Homo sapiens	Residual Activity	%	94.0
	12248459	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	99.0	CHEMBL3234	Homo sapiens	Residual Activity	%	99.0
	12248460	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	80.0	CHEMBL3234	Homo sapiens	Residual Activity	%	80.0
	12248461	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	87.0	CHEMBL3234	Homo sapiens	Residual Activity	%	87.0
	12248462	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	85.0	CHEMBL3234	Homo sapiens	Residual Activity	%	85.0
	12248463	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	75.0	CHEMBL3234	Homo sapiens	Residual Activity	%	75.0
	12248464	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	54.0	CHEMBL3234	Homo sapiens	Residual Activity	%	54.0
	12248465	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	3.0	CHEMBL3234	Homo sapiens	Residual Activity	%	3.0
	12248466	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	88.0	CHEMBL3234	Homo sapiens	Residual Activity	%	88.0
	12248467	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	76.0	CHEMBL3234	Homo sapiens	Residual Activity	%	76.0
	12248468	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	41.0	CHEMBL3234	Homo sapiens	Residual Activity	%	41.0
	12248469	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	81.0	CHEMBL3234	Homo sapiens	Residual Activity	%	81.0
	12248470	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	76.0	CHEMBL3234	Homo sapiens	Residual Activity	%	76.0
	12248471	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	80.0	CHEMBL3234	Homo sapiens	Residual Activity	%	80.0
	12248472	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	89.0	CHEMBL3234	Homo sapiens	Residual Activity	%	89.0
	12248473	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	48.0	CHEMBL3234	Homo sapiens	Residual Activity	%	48.0
	12248474	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	77.0	CHEMBL3234	Homo sapiens	Residual Activity	%	77.0
	12248475	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	24.0	CHEMBL3234	Homo sapiens	Residual Activity	%	24.0
	12248476	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	30.0	CHEMBL3234	Homo sapiens	Residual Activity	%	30.0
	12248477	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	79.0	CHEMBL3234	Homo sapiens	Residual Activity	%	79.0
	12248478	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	72.0	CHEMBL3234	Homo sapiens	Residual Activity	%	72.0
	12248479	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	75.0	CHEMBL3234	Homo sapiens	Residual Activity	%	75.0
	12248480	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	24.0	CHEMBL3234	Homo sapiens	Residual Activity	%	24.0
	12248481	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	87.0	CHEMBL3234	Homo sapiens	Residual Activity	%	87.0
	12248482	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	84.0	CHEMBL3234	Homo sapiens	Residual Activity	%	84.0
	12248483	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	95.0	CHEMBL3234	Homo sapiens	Residual Activity	%	95.0
	12248484	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	64.0	CHEMBL3234	Homo sapiens	Residual Activity	%	64.0
	12248485	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	24.0	CHEMBL3234	Homo sapiens	Residual Activity	%	24.0
	12248486	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	41.0	CHEMBL3234	Homo sapiens	Residual Activity	%	41.0
	12248487	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	74.0	CHEMBL3234	Homo sapiens	Residual Activity	%	74.0
	12248488	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	4.0	CHEMBL3234	Homo sapiens	Residual Activity	%	4.0
	12248489	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	78.0	CHEMBL3234	Homo sapiens	Residual Activity	%	78.0
	12248490	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	20.0	CHEMBL3234	Homo sapiens	Residual Activity	%	20.0
	12248491	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	89.0	CHEMBL3234	Homo sapiens	Residual Activity	%	89.0
	12248492	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	60.0	CHEMBL3234	Homo sapiens	Residual Activity	%	60.0
	12248493	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	10.0	CHEMBL3234	Homo sapiens	Residual Activity	%	10.0
	12248494	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	62.0	CHEMBL3234	Homo sapiens	Residual Activity	%	62.0
	12248495	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	13.0	CHEMBL3234	Homo sapiens	Residual Activity	%	13.0
	12251160	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	57.0	CHEMBL3234	Homo sapiens	Residual Activity	%	57.0
	12251161	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	71.0	CHEMBL3234	Homo sapiens	Residual Activity	%	71.0
	12251162	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	4.0	CHEMBL3234	Homo sapiens	Residual Activity	%	4.0
	12251163	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	27.0	CHEMBL3234	Homo sapiens	Residual Activity	%	27.0
	12251164	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	75.0	CHEMBL3234	Homo sapiens	Residual Activity	%	75.0
	12251165	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	31.0	CHEMBL3234	Homo sapiens	Residual Activity	%	31.0
	12251166	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	6.0	CHEMBL3234	Homo sapiens	Residual Activity	%	6.0
	12251167	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	72.0	CHEMBL3234	Homo sapiens	Residual Activity	%	72.0
	12251168	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	67.0	CHEMBL3234	Homo sapiens	Residual Activity	%	67.0
	12251169	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	88.0	CHEMBL3234	Homo sapiens	Residual Activity	%	88.0
	12251170	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	102.0	CHEMBL3234	Homo sapiens	Residual Activity	%	102.0
	12251171	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	64.0	CHEMBL3234	Homo sapiens	Residual Activity	%	64.0
	12251172	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	68.0	CHEMBL3234	Homo sapiens	Residual Activity	%	68.0
	12251173	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	75.0	CHEMBL3234	Homo sapiens	Residual Activity	%	75.0
	12251174	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	22.0	CHEMBL3234	Homo sapiens	Residual Activity	%	22.0
	12251175	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	60.0	CHEMBL3234	Homo sapiens	Residual Activity	%	60.0
	12251176	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	37.0	CHEMBL3234	Homo sapiens	Residual Activity	%	37.0
	12251177	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	72.0	CHEMBL3234	Homo sapiens	Residual Activity	%	72.0
	12251178	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	71.0	CHEMBL3234	Homo sapiens	Residual Activity	%	71.0
	12251179	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	59.0	CHEMBL3234	Homo sapiens	Residual Activity	%	59.0
	12251180	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	70.0	CHEMBL3234	Homo sapiens	Residual Activity	%	70.0
	12251181	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	66.0	CHEMBL3234	Homo sapiens	Residual Activity	%	66.0
	12251182	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	63.0	CHEMBL3234	Homo sapiens	Residual Activity	%	63.0
	12251183	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	67.0	CHEMBL3234	Homo sapiens	Residual Activity	%	67.0
	12251184	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	59.0	CHEMBL3234	Homo sapiens	Residual Activity	%	59.0
	12251185	CHEMBL2219106	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	17.0	CHEMBL3234	Homo sapiens	Residual Activity	%	17.0
	12251186	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	8.0	CHEMBL3234	Homo sapiens	Residual Activity	%	8.0
	12251187	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	38.0	CHEMBL3234	Homo sapiens	Residual Activity	%	38.0
	12251188	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	52.0	CHEMBL3234	Homo sapiens	Residual Activity	%	52.0
	12251189	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	53.0	CHEMBL3234	Homo sapiens	Residual Activity	%	53.0
	12251190	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	30.0	CHEMBL3234	Homo sapiens	Residual Activity	%	30.0
	12251191	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	68.0	CHEMBL3234	Homo sapiens	Residual Activity	%	68.0
	12251192	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	5.0	CHEMBL3234	Homo sapiens	Residual Activity	%	5.0
	12251193	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	13.0	CHEMBL3234	Homo sapiens	Residual Activity	%	13.0
	12251194	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	67.0	CHEMBL3234	Homo sapiens	Residual Activity	%	67.0
	12251195	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	21.0	CHEMBL3234	Homo sapiens	Residual Activity	%	21.0
	12251196	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	88.0	CHEMBL3234	Homo sapiens	Residual Activity	%	88.0
	12251197	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	77.0	CHEMBL3234	Homo sapiens	Residual Activity	%	77.0
	12251198	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	45.0	CHEMBL3234	Homo sapiens	Residual Activity	%	45.0
	12251199	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	3.0	CHEMBL3234	Homo sapiens	Residual Activity	%	3.0
	12251200	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	22.0	CHEMBL3234	Homo sapiens	Residual Activity	%	22.0
	12251201	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	74.0	CHEMBL3234	Homo sapiens	Residual Activity	%	74.0
	12251202	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	34.0	CHEMBL3234	Homo sapiens	Residual Activity	%	34.0
	12251203	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	60.0	CHEMBL3234	Homo sapiens	Residual Activity	%	60.0
	12251204	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	70.0	CHEMBL3234	Homo sapiens	Residual Activity	%	70.0
	12251205	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	31.0	CHEMBL3234	Homo sapiens	Residual Activity	%	31.0
	12251206	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	36.0	CHEMBL3234	Homo sapiens	Residual Activity	%	36.0
	12251207	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	21.0	CHEMBL3234	Homo sapiens	Residual Activity	%	21.0
	12251208	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	73.0	CHEMBL3234	Homo sapiens	Residual Activity	%	73.0
	12251209	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	38.0	CHEMBL3234	Homo sapiens	Residual Activity	%	38.0
	12251210	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	74.0	CHEMBL3234	Homo sapiens	Residual Activity	%	74.0
	12251211	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	6.0	CHEMBL3234	Homo sapiens	Residual Activity	%	6.0
	12251212	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	5.0	CHEMBL3234	Homo sapiens	Residual Activity	%	5.0
	12251213	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	4.0	CHEMBL3234	Homo sapiens	Residual Activity	%	4.0
	12251214	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	71.0	CHEMBL3234	Homo sapiens	Residual Activity	%	71.0
	12251215	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	65.0	CHEMBL3234	Homo sapiens	Residual Activity	%	65.0
	12251216	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	72.0	CHEMBL3234	Homo sapiens	Residual Activity	%	72.0
	12251217	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	2.0	CHEMBL3234	Homo sapiens	Residual Activity	%	2.0
	12251218	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	42.0	CHEMBL3234	Homo sapiens	Residual Activity	%	42.0
	12251219	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	77.0	CHEMBL3234	Homo sapiens	Residual Activity	%	77.0
	12251220	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	65.0	CHEMBL3234	Homo sapiens	Residual Activity	%	65.0
	12251221	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	64.0	CHEMBL3234	Homo sapiens	Residual Activity	%	64.0
	12251222	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	6.0	CHEMBL3234	Homo sapiens	Residual Activity	%	6.0
	12251223	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	81.0	CHEMBL3234	Homo sapiens	Residual Activity	%	81.0
	12251224	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	79.0	CHEMBL3234	Homo sapiens	Residual Activity	%	79.0
	12251225	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	52.0	CHEMBL3234	Homo sapiens	Residual Activity	%	52.0
	12251226	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	103.0	CHEMBL3234	Homo sapiens	Residual Activity	%	103.0
	12251227	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	74.0	CHEMBL3234	Homo sapiens	Residual Activity	%	74.0
	12251228	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	9.0	CHEMBL3234	Homo sapiens	Residual Activity	%	9.0
	12251229	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	8.0	CHEMBL3234	Homo sapiens	Residual Activity	%	8.0
	12251230	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	1.0	CHEMBL3234	Homo sapiens	Residual Activity	%	1.0
	12251231	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	65.0	CHEMBL3234	Homo sapiens	Residual Activity	%	65.0
	12251232	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	74.0	CHEMBL3234	Homo sapiens	Residual Activity	%	74.0
	12251233	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	25.0	CHEMBL3234	Homo sapiens	Residual Activity	%	25.0
	12251234	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	76.0	CHEMBL3234	Homo sapiens	Residual Activity	%	76.0
	12251235	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	68.0	CHEMBL3234	Homo sapiens	Residual Activity	%	68.0
	12251236	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	53.0	CHEMBL3234	Homo sapiens	Residual Activity	%	53.0
	12251237	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	1.0	CHEMBL3234	Homo sapiens	Residual Activity	%	1.0
	12251238	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	19.0	CHEMBL3234	Homo sapiens	Residual Activity	%	19.0
	12251239	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	60.0	CHEMBL3234	Homo sapiens	Residual Activity	%	60.0
	12251240	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	70.0	CHEMBL3234	Homo sapiens	Residual Activity	%	70.0
	12251241	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	76.0	CHEMBL3234	Homo sapiens	Residual Activity	%	76.0
	12251242	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	20.0	CHEMBL3234	Homo sapiens	Residual Activity	%	20.0
	12251243	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	38.0	CHEMBL3234	Homo sapiens	Residual Activity	%	38.0
	12251244	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	51.0	CHEMBL3234	Homo sapiens	Residual Activity	%	51.0
	12251245	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	58.0	CHEMBL3234	Homo sapiens	Residual Activity	%	58.0
	12251246	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	15.0	CHEMBL3234	Homo sapiens	Residual Activity	%	15.0
	12251247	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	5.0	CHEMBL3234	Homo sapiens	Residual Activity	%	5.0
	12251248	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	64.0	CHEMBL3234	Homo sapiens	Residual Activity	%	64.0
	12251249	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	75.0	CHEMBL3234	Homo sapiens	Residual Activity	%	75.0
	12251250	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	93.0	CHEMBL3234	Homo sapiens	Residual Activity	%	93.0
	12251251	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	32.0	CHEMBL3234	Homo sapiens	Residual Activity	%	32.0
	12251252	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	76.0	CHEMBL3234	Homo sapiens	Residual Activity	%	76.0
	12251253	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	66.0	CHEMBL3234	Homo sapiens	Residual Activity	%	66.0
	12251254	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	57.0	CHEMBL3234	Homo sapiens	Residual Activity	%	57.0
	12251255	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	5.0	CHEMBL3234	Homo sapiens	Residual Activity	%	5.0
	12251256	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	55.0	CHEMBL3234	Homo sapiens	Residual Activity	%	55.0
	12251257	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	7.0	CHEMBL3234	Homo sapiens	Residual Activity	%	7.0
	12251258	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	54.0	CHEMBL3234	Homo sapiens	Residual Activity	%	54.0
	12251259	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	19.0	CHEMBL3234	Homo sapiens	Residual Activity	%	19.0
	12251260	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	24.0	CHEMBL3234	Homo sapiens	Residual Activity	%	24.0
	12251261	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	23.0	CHEMBL3234	Homo sapiens	Residual Activity	%	23.0
	12251262	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	46.0	CHEMBL3234	Homo sapiens	Residual Activity	%	46.0
	12251263	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	3.0	CHEMBL3234	Homo sapiens	Residual Activity	%	3.0
	12251264	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	56.0	CHEMBL3234	Homo sapiens	Residual Activity	%	56.0
	12251265	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	3.0	CHEMBL3234	Homo sapiens	Residual Activity	%	3.0
	12251266	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	61.0	CHEMBL3234	Homo sapiens	Residual Activity	%	61.0
	12251267	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	25.0	CHEMBL3234	Homo sapiens	Residual Activity	%	25.0
	12251268	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	56.0	CHEMBL3234	Homo sapiens	Residual Activity	%	56.0
	12251269	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	94.0	CHEMBL3234	Homo sapiens	Residual Activity	%	94.0
	12251270	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	10.0	CHEMBL3234	Homo sapiens	Residual Activity	%	10.0
	12251271	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	62.0	CHEMBL3234	Homo sapiens	Residual Activity	%	62.0
	12251272	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	51.0	CHEMBL3234	Homo sapiens	Residual Activity	%	51.0
	12251273	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	52.0	CHEMBL3234	Homo sapiens	Residual Activity	%	52.0
	12251274	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	82.0	CHEMBL3234	Homo sapiens	Residual Activity	%	82.0
	12251275	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	5.0	CHEMBL3234	Homo sapiens	Residual Activity	%	5.0
	12251276	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	70.0	CHEMBL3234	Homo sapiens	Residual Activity	%	70.0
	12251277	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	40.0	CHEMBL3234	Homo sapiens	Residual Activity	%	40.0
	12251278	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	4.0	CHEMBL3234	Homo sapiens	Residual Activity	%	4.0
	12251279	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	71.0	CHEMBL3234	Homo sapiens	Residual Activity	%	71.0
	12251280	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	61.0	CHEMBL3234	Homo sapiens	Residual Activity	%	61.0
	12251281	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	98.0	CHEMBL3234	Homo sapiens	Residual Activity	%	98.0
	12251282	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	38.0	CHEMBL3234	Homo sapiens	Residual Activity	%	38.0
	12251283	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	82.0	CHEMBL3234	Homo sapiens	Residual Activity	%	82.0
	12251284	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	74.0	CHEMBL3234	Homo sapiens	Residual Activity	%	74.0
	12251285	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	67.0	CHEMBL3234	Homo sapiens	Residual Activity	%	67.0
	12251286	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	39.0	CHEMBL3234	Homo sapiens	Residual Activity	%	39.0
	12251287	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	1.0	CHEMBL3234	Homo sapiens	Residual Activity	%	1.0
	12251288	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	87.0	CHEMBL3234	Homo sapiens	Residual Activity	%	87.0
	12251289	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	94.0	CHEMBL3234	Homo sapiens	Residual Activity	%	94.0
	12251290	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	28.0	CHEMBL3234	Homo sapiens	Residual Activity	%	28.0
	12251291	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	70.0	CHEMBL3234	Homo sapiens	Residual Activity	%	70.0
	12251292	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	71.0	CHEMBL3234	Homo sapiens	Residual Activity	%	71.0
	12251293	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	57.0	CHEMBL3234	Homo sapiens	Residual Activity	%	57.0
	12251294	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	69.0	CHEMBL3234	Homo sapiens	Residual Activity	%	69.0
	12251295	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	28.0	CHEMBL3234	Homo sapiens	Residual Activity	%	28.0
	12251296	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	29.0	CHEMBL3234	Homo sapiens	Residual Activity	%	29.0
	12251297	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	20.0	CHEMBL3234	Homo sapiens	Residual Activity	%	20.0
	12251298	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	6.0	CHEMBL3234	Homo sapiens	Residual Activity	%	6.0
	12251299	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	27.0	CHEMBL3234	Homo sapiens	Residual Activity	%	27.0
	12251300	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	60.0	CHEMBL3234	Homo sapiens	Residual Activity	%	60.0
	12251301	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	64.0	CHEMBL3234	Homo sapiens	Residual Activity	%	64.0
	12251302	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	6.0	CHEMBL3234	Homo sapiens	Residual Activity	%	6.0
	12251303	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	45.0	CHEMBL3234	Homo sapiens	Residual Activity	%	45.0
	12251304	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	53.0	CHEMBL3234	Homo sapiens	Residual Activity	%	53.0
	12251305	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	94.0	CHEMBL3234	Homo sapiens	Residual Activity	%	94.0
	12251306	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	23.0	CHEMBL3234	Homo sapiens	Residual Activity	%	23.0
	12251307	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	4.0	CHEMBL3234	Homo sapiens	Residual Activity	%	4.0
	12251308	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	13.0	CHEMBL3234	Homo sapiens	Residual Activity	%	13.0
	12251309	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	56.0	CHEMBL3234	Homo sapiens	Residual Activity	%	56.0
	12251310	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	0.0	CHEMBL3234	Homo sapiens	Residual Activity	%	0.0
	12251311	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	60.0	CHEMBL3234	Homo sapiens	Residual Activity	%	60.0
	12251312	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	4.0	CHEMBL3234	Homo sapiens	Residual Activity	%	4.0
	12251313	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	69.0	CHEMBL3234	Homo sapiens	Residual Activity	%	69.0
	12251314	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	24.0	CHEMBL3234	Homo sapiens	Residual Activity	%	24.0
	12251315	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	4.0	CHEMBL3234	Homo sapiens	Residual Activity	%	4.0
	12251316	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	56.0	CHEMBL3234	Homo sapiens	Residual Activity	%	56.0
	12251317	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	12.0	CHEMBL3234	Homo sapiens	Residual Activity	%	12.0
	12251318	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	27.0	CHEMBL3234	Homo sapiens	Residual Activity	%	27.0
	12251319	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	63.0	CHEMBL3234	Homo sapiens	Residual Activity	%	63.0
	12251320	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	1.0	CHEMBL3234	Homo sapiens	Residual Activity	%	1.0
	12251321	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	5.0	CHEMBL3234	Homo sapiens	Residual Activity	%	5.0
	12251322	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	60.0	CHEMBL3234	Homo sapiens	Residual Activity	%	60.0
	12251323	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	5.0	CHEMBL3234	Homo sapiens	Residual Activity	%	5.0
	12251324	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	1.0	CHEMBL3234	Homo sapiens	Residual Activity	%	1.0
	12251325	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	53.0	CHEMBL3234	Homo sapiens	Residual Activity	%	53.0
	12251326	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	41.0	CHEMBL3234	Homo sapiens	Residual Activity	%	41.0
	12251327	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	72.0	CHEMBL3234	Homo sapiens	Residual Activity	%	72.0
	12251328	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	81.0	CHEMBL3234	Homo sapiens	Residual Activity	%	81.0
	12251329	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	18.0	CHEMBL3234	Homo sapiens	Residual Activity	%	18.0
	12251330	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	66.0	CHEMBL3234	Homo sapiens	Residual Activity	%	66.0
	12251331	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	56.0	CHEMBL3234	Homo sapiens	Residual Activity	%	56.0
	12251332	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	9.0	CHEMBL3234	Homo sapiens	Residual Activity	%	9.0
	12251333	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	26.0	CHEMBL3234	Homo sapiens	Residual Activity	%	26.0
	12251334	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	16.0	CHEMBL3234	Homo sapiens	Residual Activity	%	16.0
	12251335	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	64.0	CHEMBL3234	Homo sapiens	Residual Activity	%	64.0
	12251336	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	33.0	CHEMBL3234	Homo sapiens	Residual Activity	%	33.0
	12251337	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	48.0	CHEMBL3234	Homo sapiens	Residual Activity	%	48.0
	12251338	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	49.0	CHEMBL3234	Homo sapiens	Residual Activity	%	49.0
	12251339	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	48.0	CHEMBL3234	Homo sapiens	Residual Activity	%	48.0
	12251340	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	55.0	CHEMBL3234	Homo sapiens	Residual Activity	%	55.0
	12251341	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	32.0	CHEMBL3234	Homo sapiens	Residual Activity	%	32.0
	12251342	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	24.0	CHEMBL3234	Homo sapiens	Residual Activity	%	24.0
	12251343	CHEMBL2219107	Millipore: Percentage of residual kinase activity of HCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	12.0	CHEMBL3234	Homo sapiens	Residual Activity	%	12.0
	12251344	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	102.0	CHEMBL3234	Homo sapiens	Residual Activity	%	102.0
	12251345	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	97.0	CHEMBL3234	Homo sapiens	Residual Activity	%	97.0
	12251346	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	98.0	CHEMBL3234	Homo sapiens	Residual Activity	%	98.0
	12251347	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	100.0	CHEMBL3234	Homo sapiens	Residual Activity	%	100.0
	12251348	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	62.0	CHEMBL3234	Homo sapiens	Residual Activity	%	62.0
	12251349	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	96.0	CHEMBL3234	Homo sapiens	Residual Activity	%	96.0
	12251350	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	56.0	CHEMBL3234	Homo sapiens	Residual Activity	%	56.0
	12251351	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	40.0	CHEMBL3234	Homo sapiens	Residual Activity	%	40.0
	12251352	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	90.0	CHEMBL3234	Homo sapiens	Residual Activity	%	90.0
	12251353	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	51.0	CHEMBL3234	Homo sapiens	Residual Activity	%	51.0
	12251354	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	95.0	CHEMBL3234	Homo sapiens	Residual Activity	%	95.0
	12251355	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	99.0	CHEMBL3234	Homo sapiens	Residual Activity	%	99.0
	12251356	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	86.0	CHEMBL3234	Homo sapiens	Residual Activity	%	86.0
	12251357	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	43.0	CHEMBL3234	Homo sapiens	Residual Activity	%	43.0
	12251358	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	64.0	CHEMBL3234	Homo sapiens	Residual Activity	%	64.0
	12251359	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	93.0	CHEMBL3234	Homo sapiens	Residual Activity	%	93.0
	12251360	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	104.0	CHEMBL3234	Homo sapiens	Residual Activity	%	104.0
	12251361	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	95.0	CHEMBL3234	Homo sapiens	Residual Activity	%	95.0
	12251362	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	95.0	CHEMBL3234	Homo sapiens	Residual Activity	%	95.0
	12251363	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	68.0	CHEMBL3234	Homo sapiens	Residual Activity	%	68.0
	12251364	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	98.0	CHEMBL3234	Homo sapiens	Residual Activity	%	98.0
	12251365	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	87.0	CHEMBL3234	Homo sapiens	Residual Activity	%	87.0
	12251366	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	107.0	CHEMBL3234	Homo sapiens	Residual Activity	%	107.0
	12251367	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	97.0	CHEMBL3234	Homo sapiens	Residual Activity	%	97.0
	12251368	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	114.0	CHEMBL3234	Homo sapiens	Residual Activity	%	114.0
	12251369	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	17.0	CHEMBL3234	Homo sapiens	Residual Activity	%	17.0
	12251370	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	8.0	CHEMBL3234	Homo sapiens	Residual Activity	%	8.0
	12251371	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	29.0	CHEMBL3234	Homo sapiens	Residual Activity	%	29.0
	12251372	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	91.0	CHEMBL3234	Homo sapiens	Residual Activity	%	91.0
	12251373	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	95.0	CHEMBL3234	Homo sapiens	Residual Activity	%	95.0
	12251374	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	100.0	CHEMBL3234	Homo sapiens	Residual Activity	%	100.0
	12251375	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	5.0	CHEMBL3234	Homo sapiens	Residual Activity	%	5.0
	12251376	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	102.0	CHEMBL3234	Homo sapiens	Residual Activity	%	102.0
	12251377	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	101.0	CHEMBL3234	Homo sapiens	Residual Activity	%	101.0
	12251378	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	102.0	CHEMBL3234	Homo sapiens	Residual Activity	%	102.0
	12251379	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	93.0	CHEMBL3234	Homo sapiens	Residual Activity	%	93.0
	12251380	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	19.0	CHEMBL3234	Homo sapiens	Residual Activity	%	19.0
	12251381	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	99.0	CHEMBL3234	Homo sapiens	Residual Activity	%	99.0
	12251382	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	102.0	CHEMBL3234	Homo sapiens	Residual Activity	%	102.0
	12251383	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	86.0	CHEMBL3234	Homo sapiens	Residual Activity	%	86.0
	12251384	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	109.0	CHEMBL3234	Homo sapiens	Residual Activity	%	109.0
	12251385	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	97.0	CHEMBL3234	Homo sapiens	Residual Activity	%	97.0
	12251386	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	69.0	CHEMBL3234	Homo sapiens	Residual Activity	%	69.0
	12251387	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	41.0	CHEMBL3234	Homo sapiens	Residual Activity	%	41.0
	12251388	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	11.0	CHEMBL3234	Homo sapiens	Residual Activity	%	11.0
	12251389	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	104.0	CHEMBL3234	Homo sapiens	Residual Activity	%	104.0
	12251390	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	99.0	CHEMBL3234	Homo sapiens	Residual Activity	%	99.0
	12251391	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	63.0	CHEMBL3234	Homo sapiens	Residual Activity	%	63.0
	12251392	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	111.0	CHEMBL3234	Homo sapiens	Residual Activity	%	111.0
	12251393	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	102.0	CHEMBL3234	Homo sapiens	Residual Activity	%	102.0
	12251394	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	98.0	CHEMBL3234	Homo sapiens	Residual Activity	%	98.0
	12251395	CHEMBL2219108	Millipore: Percentage of residual kinase activity of HCK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	1.0	CHEMBL3234	Homo sapiens	Residual Activity	%	1.0
	12626665	CHEMBL2317115	Inhibition of HCK (unknown origin) at 1 uM	B	COc1cc(Nc2ncc(Cl)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)CC1		CHEMBL2312140	=	Inhibition	%	50.0	CHEMBL3234	Homo sapiens	INH	%	50.0
	12660159	CHEMBL2329211	Inhibition of HCK (unknown origin) at 1 uM	B	COc1cc(Oc2ccccc2)ccc1-c1nc([C@H]2C[C@@](C)(O)C2)n2ccnc(N)c12		CHEMBL2325940	>	Inhibition	%	80.0	CHEMBL3234	Homo sapiens	INH	%	80.0
	12685261	CHEMBL2342050	Inhibition of HCK (unknown origin) assessed as residual activity at 100 nM after 1 hr by competitive binding assay relative to control	B	CCc1ccc(C(=O)Nc2cc(CN3CCN(C)CC3)cc(C(F)(F)F)c2)cc1C#Cc1cnc2ccnn2c1		CHEMBL2336015	=	Activity	%	30.0	CHEMBL3234	Homo sapiens	Activity	%	30.0
	12693230	CHEMBL2343914	Inhibition of HCK (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL3234	Homo sapiens	IC50	nM	10000.0
	12728811	CHEMBL2352884	Inhibition of HCK (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	89.0	CHEMBL3234	Homo sapiens	Activity	%	89.0
	12729056	CHEMBL2351962	Inhibition of HCK (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	105.0	CHEMBL3234	Homo sapiens	Activity	%	105.0
	12729941	CHEMBL2352177	Inhibition of HCK (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	74.0	CHEMBL3234	Homo sapiens	Activity	%	74.0
	12730199	CHEMBL2352884	Inhibition of HCK (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	95.0	CHEMBL3234	Homo sapiens	Activity	%	95.0
	13301292	CHEMBL2384615	Inhibition of Hck (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1ccccc1		CHEMBL2380845	=	IC50	nM	958.0	CHEMBL3234	Homo sapiens	IC50	nM	958.0
Not Active	13335982	CHEMBL2394041	Inhibition of HCK (unknown origin) transfected in mouse Ba/F3 cells at 5 uM after 24 hrs	B	Cc1ccc(-n2cnc3cc(Nc4nnc(C)c5ccccc45)ccc32)cc1		CHEMBL2390986		Inhibition	%		CHEMBL3234	Homo sapiens	INH		
Not Active	13335983	CHEMBL2394041	Inhibition of HCK (unknown origin) transfected in mouse Ba/F3 cells at 5 uM after 24 hrs	B	Fc1ccc(-c2n[nH]cc2-c2ccncc2)cc1Cl		CHEMBL2390985		Inhibition	%		CHEMBL3234	Homo sapiens	INH		
Not Active	13336041	CHEMBL2394065	Inhibition of HCK (unknown origin) transfected in mouse Ba/F3 cells at 1 uM after 24 hrs	B	Cc1cccc(C(=O)Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL2390984		Inhibition	%		CHEMBL3234	Homo sapiens	INH		
Not Active	13336042	CHEMBL2394065	Inhibition of HCK (unknown origin) transfected in mouse Ba/F3 cells at 1 uM after 24 hrs	B	Cc1ccc(-c2cc(NC(=O)c3ccc(F)cc3)[nH]n2)cc1		CHEMBL2390983		Inhibition	%		CHEMBL3234	Homo sapiens	INH		
Not Active	13336043	CHEMBL2394065	Inhibition of HCK (unknown origin) transfected in mouse Ba/F3 cells at 1 uM after 24 hrs	B	COc1ccc(C(=O)Nc2cc(-c3ccccc3)[nH]n2)cc1		CHEMBL167454		Inhibition	%		CHEMBL3234	Homo sapiens	INH		
	13375846	CHEMBL2405108	Inhibition of HCK (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	2.0	CHEMBL3234	Homo sapiens	INH	%	2.0
	13395509	CHEMBL2410630	Inhibition of HCK (unknown origin)	B	Nc1ncnc2c1c(-c1ccc(Cl)cc1)nn2-c1cccc(-c2cnnn2CCCCCC(=O)NO)c1		CHEMBL2408778	=	Ki	nM	504.0	CHEMBL3234	Homo sapiens	Ki	nM	504.0
	13419628	CHEMBL2422082	Inhibition of HCK (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	15.0	CHEMBL3234	Homo sapiens	INH	%	15.0
	13419629	CHEMBL2422082	Inhibition of HCK (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	22.0	CHEMBL3234	Homo sapiens	INH	%	22.0
	13419630	CHEMBL2422082	Inhibition of HCK (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	41.0	CHEMBL3234	Homo sapiens	INH	%	41.0
	13442350	CHEMBL2429674	Competitive binding affinity to HCK (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL3234	Homo sapiens	INH	%	50.0
	13445485	CHEMBL2429674	Competitive binding affinity to HCK (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	66.0	CHEMBL3234	Homo sapiens	INH	%	66.0
	13448540	CHEMBL2429674	Competitive binding affinity to HCK (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL3234	Homo sapiens	INH	%	50.0
	13448676	CHEMBL2429674	Competitive binding affinity to HCK (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL3234	Homo sapiens	INH	%	50.0
	13451471	CHEMBL2429674	Competitive binding affinity to HCK (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	=	Inhibition	%	78.0	CHEMBL3234	Homo sapiens	INH	%	78.0
	13454656	CHEMBL2429674	Competitive binding affinity to HCK (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL3234	Homo sapiens	INH	%	50.0
	13872130	CHEMBL3101755	Inhibition of human Hck assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	100.0	CHEMBL3234	Homo sapiens	Activity	%	100.0
	13965713	CHEMBL3135925	Inhibition of human HCK catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	18.5	CHEMBL3234	Homo sapiens	INH	%	18.5
	13966091	CHEMBL3137079	Inhibition of human HCK catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	30.0	CHEMBL3234	Homo sapiens	INH	%	30.0
	13973993	CHEMBL3135893	Inhibition of human HCK catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	4.0	CHEMBL3234	Homo sapiens	INH	%	4.0
	13974084	CHEMBL3134922	Inhibition of human HCK catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	11.0	CHEMBL3234	Homo sapiens	INH	%	11.0
	13974175	CHEMBL3137115	Inhibition of human HCK catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	29.0	CHEMBL3234	Homo sapiens	INH	%	29.0
	13974266	CHEMBL3136244	Inhibition of human HCK catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	22.5	CHEMBL3234	Homo sapiens	INH	%	22.5
	13975004	CHEMBL3135300	Inhibition of human HCK catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	69.5	CHEMBL3234	Homo sapiens	INH	%	69.5
	13975095	CHEMBL3136867	Inhibition of human HCK catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	0.0	CHEMBL3234	Homo sapiens	INH	%	0.0
	13975186	CHEMBL3135640	Inhibition of human HCK catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	7.0	CHEMBL3234	Homo sapiens	INH	%	7.0
	13975277	CHEMBL3137160	Inhibition of human HCK catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	3.0	CHEMBL3234	Homo sapiens	INH	%	3.0
	13975920	CHEMBL3136394	Inhibition of human HCK catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	19.5	CHEMBL3234	Homo sapiens	INH	%	19.5
	13976013	CHEMBL3135213	Inhibition of human HCK catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	35.0	CHEMBL3234	Homo sapiens	INH	%	35.0
	13976104	CHEMBL3136775	Inhibition of human HCK catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	48.5	CHEMBL3234	Homo sapiens	INH	%	48.5
	14553173	CHEMBL3223620	Inhibition of HCK (unknown origin)	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	IC50	nM	8.0	CHEMBL3234	Homo sapiens	IC50	uM	0.008
	14553185	CHEMBL3223620	Inhibition of HCK (unknown origin)	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	IC50	nM	23.0	CHEMBL3234	Homo sapiens	IC50	uM	0.023
	14553198	CHEMBL3223620	Inhibition of HCK (unknown origin)	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	IC50	nM	88.0	CHEMBL3234	Homo sapiens	IC50	uM	0.088
	14553206	CHEMBL3223620	Inhibition of HCK (unknown origin)	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	IC50	nM	130.0	CHEMBL3234	Homo sapiens	IC50	uM	0.13
	14553218	CHEMBL3223620	Inhibition of HCK (unknown origin)	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	IC50	nM	260.0	CHEMBL3234	Homo sapiens	IC50	uM	0.26
	14582518	CHEMBL3242519	Inhibition of human Hck assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	94.5	CHEMBL3234	Homo sapiens	Activity	%	94.5
	15002497	CHEMBL3366573	Inhibition of HCK (unknown origin) assessed as residual activity at 10 uM relative to control	B	Cc1cc(O)cc(-c2nn(C)cc2-c2cc(N3CCOCC3)nc(-c3cccnc3)n2)c1		CHEMBL3310332	=	Activity	%	28.0	CHEMBL3234	Homo sapiens	Activity	%	28.0
	15018609	CHEMBL3366833	Inhibition of HCK (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	13.9	CHEMBL3234	Homo sapiens	INH	%	13.9
	15600497	CHEMBL3580035	Inhibition of human activated Hck assessed as residual activity at 10 uM relative to control	B	Nc1ncnc2c1c(-c1ccc(Cl)cc1)nn2CC(Cl)c1ccccc1		CHEMBL3578214	=	Activity	%	2.0	CHEMBL3234	Homo sapiens	Activity	%	2.0
	15600498	CHEMBL3580034	Inhibition of human Hck assessed as residual activity at 10 uM relative to control	B	Nc1ncnc2c1c(-c1ccc(Cl)cc1)nn2CC(Cl)c1ccccc1		CHEMBL3578214	=	Activity	%	7.0	CHEMBL3234	Homo sapiens	Activity	%	7.0
	15622559	CHEMBL3588270	Inhibition of human recombinant Hck at 1 uM	B	Cc1cc2cn[nH]c2cc1-c1cccc2c(N)c(C(N)=O)nnc12		CHEMBL3586447	=	Inhibition	%	82.0	CHEMBL3234	Homo sapiens	INH	%	82.0
	15622567	CHEMBL3588283	Inhibition of human recombinant Hck	B	Cc1cc2cn[nH]c2cc1-c1cccc2c(N)c(C(N)=O)nnc12		CHEMBL3586447	=	IC50	nM	99.0	CHEMBL3234	Homo sapiens	IC50	nM	99.0
	15650145	CHEMBL3595411	Inhibition of human HCK at 0.1 uM relative to control	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593290	=	Inhibition	%	45.0	CHEMBL3234	Homo sapiens	INH	%	45.0
	15715096	CHEMBL3619919	Inhibition of Hck (unknown origin)	B	C[C@@H](NC(=O)CCCCCC(=O)Nc1cccc(Nc2nccc(Nc3cc(C4CC4)[nH]n3)n2)c1)c1ccco1		CHEMBL3617740	=	Ki	nM	1200.0	CHEMBL3234	Homo sapiens	Ki	uM	1.2
	15715097	CHEMBL3619919	Inhibition of Hck (unknown origin)	B	O=C(CCCCCC(=O)N1CCC[C@@H]1c1ccco1)Nc1cccc(Nc2nccc(Nc3cc(C4CC4)[nH]n3)n2)c1		CHEMBL3617738	=	Ki	nM	730.0	CHEMBL3234	Homo sapiens	Ki	uM	0.73
	15715098	CHEMBL3619919	Inhibition of Hck (unknown origin)	B	CCCC(=O)Nc1cccc(Nc2nccc(Nc3cc(C4CC4)[nH]n3)n2)c1		CHEMBL3617732	=	Ki	nM	980.0	CHEMBL3234	Homo sapiens	Ki	uM	0.98
	15715127	CHEMBL3619919	Inhibition of Hck (unknown origin)	B	C=CC(=O)N1CCCC1c1ccco1		CHEMBL3617729	>	Ki	nM	1250000.0	CHEMBL3234	Homo sapiens	Ki	uM	1250.0
Not Active	15723456	CHEMBL3620309	Inhibition of HCK (unknown origin) at 10 uM after 40 mins by scintillation counting analysis	B	Cc1ccccc1C(=O)Nc1cnoc1C		CHEMBL3616990		Inhibition	%		CHEMBL3234	Homo sapiens	INH		
	15736140	CHEMBL3627537	Inhibition of human Hck at 0.1 uM	B	Cc1nn(-c2ccnc(Nc3ccc4c(c3)c(Cl)c(C)n4C)n2)cc1CN1CC(O)C1		CHEMBL3622956	<	Inhibition	%	25.0	CHEMBL3234	Homo sapiens	INH	%	25.0
	15756964	CHEMBL3630519	Inhibition of HCK (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	91.06	CHEMBL3234	Homo sapiens	INH	%	91.06
	15757759	CHEMBL3630519	Inhibition of HCK (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	99.15	CHEMBL3234	Homo sapiens	INH	%	99.15
	15758738	CHEMBL3630519	Inhibition of HCK (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	69.98	CHEMBL3234	Homo sapiens	INH	%	69.98
278530	16258393	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	1894.0	CHEMBL3234	Homo sapiens	IC50	nM	1894.0
306887	16261011	CHEMBL3707629	Inhibition Assay: The inhibitory activity measurement against the kinases mentioned above was measured in the kinase inhibition reaction mixture containing 2 ul purified kinase protein (10-50 ng), 20 mM Tris-HCl, pH 8.0, 5 mM MgCl2, 0.5 mM dithiothreitol, 0.01 mM ATP, 4 ug of poly(D4Y)n peptide substrate (Promega), 0.2 uCi of 32P-ATP and the each compound shown in tablel. The mixture was incubated for 15 min at 30° C. and the reaction was then ended by adding a half volume of 30% phosphoric acid solution. Subsequently, the reaction mixture solution was spotted in avidin coated membrane (Promega). This membrane was washed using 50 mM phosphate, 0.1N NaCl buffer (pH 6.0) solution for 10 min 5 times and then the radioactivity of each spot was quantified by using a BAS image analyzer (Fuji).	B	Oc1cccc(Nc2ccnc3cc(-c4cccc(CN5CCOCC5)c4)sc23)c1		CHEMBL2336005	=	IC50	nM	4.4	CHEMBL3234	Homo sapiens	IC50	nM	4.4
278535	16261848	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)n(C)c34)c3ccccc23)cc1		CHEMBL1090979	=	IC50	nM	2.0	CHEMBL3234	Homo sapiens	IC50	nM	2.0
278555	16267862	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCc3ccnc4[nH]c(=O)cnc34)c3ccccc23)cc1		CHEMBL3695594	=	IC50	nM	22.0	CHEMBL3234	Homo sapiens	IC50	nM	22.0
278562	16270010	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1ccc(-n2nc(C(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)cc1		CHEMBL3695578	=	IC50	nM	4.0	CHEMBL3234	Homo sapiens	IC50	nM	4.0
278551	16273101	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c(Cl)c2Cl)n(-c2ccc(CO)cc2)n1		CHEMBL3695591	=	IC50	nM	4.0	CHEMBL3234	Homo sapiens	IC50	nM	4.0
278540	16274374	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)c(C)nc34)c3ccccc23)cc1		CHEMBL1214135	=	IC50	nM	5.0	CHEMBL3234	Homo sapiens	IC50	nM	5.0
278547	16275827	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ncnc4[nH]c(=O)[nH]c34)c3ccccc23)cc1		CHEMBL3695587	=	IC50	nM	36.0	CHEMBL3234	Homo sapiens	IC50	nM	36.0
278558	16279777	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CNS(=O)(=O)Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)cc1		CHEMBL3695574	=	IC50	nM	3.0	CHEMBL3234	Homo sapiens	IC50	nM	3.0
278548	16280086	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)n(-c2ccc(O)cc2)n1		CHEMBL3695588	=	IC50	nM	18.0	CHEMBL3234	Homo sapiens	IC50	nM	18.0
278550	16282813	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1cc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)ccc1CO		CHEMBL3695590	=	IC50	nM	5.0	CHEMBL3234	Homo sapiens	IC50	nM	5.0
278553	16292804	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)s1		CHEMBL3695593	=	IC50	nM	3.0	CHEMBL3234	Homo sapiens	IC50	nM	3.0
278549	16293143	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)n(-c2ccc(CO)cc2)n1		CHEMBL3695589	=	IC50	nM	24.0	CHEMBL3234	Homo sapiens	IC50	nM	24.0
278537	16294287	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)n(-c2ccccc2)n1		CHEMBL1214131	=	IC50	nM	3.0	CHEMBL3234	Homo sapiens	IC50	nM	3.0
278544	16294855	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)n(C(C)C)c34)c3ccccc23)cc1		CHEMBL3695585	=	IC50	nM	8.0	CHEMBL3234	Homo sapiens	IC50	nM	8.0
278545	16294897	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)n(C)c34)c(Cl)c2Cl)cc1		CHEMBL3695586	=	IC50	nM	4.0	CHEMBL3234	Homo sapiens	IC50	nM	4.0
278532	16295601	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COCC(=O)Nc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3695569	=	IC50	nM	3.0	CHEMBL3234	Homo sapiens	IC50	nM	3.0
278563	16296481	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)n(-c2ccc(S(C)(=O)=O)cc2)n1		CHEMBL3695579	=	IC50	nM	3.0	CHEMBL3234	Homo sapiens	IC50	nM	3.0
278564	16300338	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)n(-c2ccc(Cl)c(Cl)c2)n1		CHEMBL3695580	=	IC50	nM	4.0	CHEMBL3234	Homo sapiens	IC50	nM	4.0
278565	16305744	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CSc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)cc1		CHEMBL3695581	=	IC50	nM	4.0	CHEMBL3234	Homo sapiens	IC50	nM	4.0
278541	16313671	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)cc1		CHEMBL3695582	<	IC50	nM	2.0	CHEMBL3234	Homo sapiens	IC50	nM	2.0
278542	16314555	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)n(C)c34)c3ccccc23)cc1		CHEMBL3695583	=	IC50	nM	3.0	CHEMBL3234	Homo sapiens	IC50	nM	3.0
278559	16315339	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)n(-c2ccc(Cl)cc2)n1		CHEMBL3695575	=	IC50	nM	918.0	CHEMBL3234	Homo sapiens	IC50	nM	918.0
278561	16320393	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1ccc(-n2nc(C3(C)CC3)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)cc1		CHEMBL3695577	=	IC50	nM	4.0	CHEMBL3234	Homo sapiens	IC50	nM	4.0
304677	16321423	CHEMBL3705504	Enzyme Inhibition Assay: The kinase enzyme binding activities of compounds disclosed herein were determined using a proprietary assay which measures active site-directed competition binding to an immobilized ligand (Fabian, M. A. et al., Nature Biotechnol., 2005, 23:329-336). These assays were conducted by DiscoverX (formerly Ambit; San Diego, Calif.). The Kd value (Dissociation constant value) was calculated as the index of affinity of the compounds to each kinase. The enzyme inhibitory activities of compounds disclosed herein were determined by FRET using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen Ltd., Paisley, UK). In all cases, the site-specific protease cleaves non-phosphorylated peptide only and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor), for which low ratios indicate high phosphorylation and high ratios indicate low phosphorylation levels.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)cc1		CHEMBL3701217	=	Kd	nM	8.0	CHEMBL3234	Homo sapiens	Kd	nM	8.0
278554	16326796	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)cc1		CHEMBL3695573	=	IC50	nM	458.0	CHEMBL3234	Homo sapiens	IC50	nM	458.0
278543	16329628	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CCn1c(=O)[nH]c2nccc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(OC)cc4)c4ccccc34)c21		CHEMBL3695584	=	IC50	nM	5.0	CHEMBL3234	Homo sapiens	IC50	nM	5.0
278556	16330179	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)n(C)c34)c3ccccc23)cn1		CHEMBL3695572	=	IC50	nM	5.0	CHEMBL3234	Homo sapiens	IC50	nM	5.0
278536	16331545	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ncccc23)n(-c2ccccc2)n1		CHEMBL3695570	=	IC50	nM	7.0	CHEMBL3234	Homo sapiens	IC50	nM	7.0
278557	16332195	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)cc1		CHEMBL3695573	=	IC50	nM	5.0	CHEMBL3234	Homo sapiens	IC50	nM	5.0
278531	16334008	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COCC(=O)Nc1cc(COc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3695568	=	IC50	nM	47.0	CHEMBL3234	Homo sapiens	IC50	nM	47.0
278539	16334483	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1nc2c(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccccc4)c4ccccc34)ccnc2[nH]c1=O		CHEMBL1214132	=	IC50	nM	3.0	CHEMBL3234	Homo sapiens	IC50	nM	3.0
278552	16336123	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)n(-c2ccc(CO)nc2)n1		CHEMBL3695592	=	IC50	nM	3.0	CHEMBL3234	Homo sapiens	IC50	nM	3.0
278560	16336294	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1ccc(-n2nc(C3CC3)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)cc1		CHEMBL3695576	=	IC50	nM	9.0	CHEMBL3234	Homo sapiens	IC50	nM	9.0
278538	16336800	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)cnc34)c3ccccc23)cc1		CHEMBL1214134	=	IC50	nM	3.0	CHEMBL3234	Homo sapiens	IC50	nM	3.0
278546	16341466	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ncccc23)cc1		CHEMBL3695571	<	IC50	nM	2.0	CHEMBL3234	Homo sapiens	IC50	nM	2.0
278533	16343161	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)cc1		CHEMBL1090975	<	IC50	nM	2.0	CHEMBL3234	Homo sapiens	IC50	nM	2.0
191807	16343621	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ncnc4[nH]c(=O)cnc34)c3ccccc23)cc1		CHEMBL3695595	=	IC50	nM	458.0	CHEMBL3234	Homo sapiens	IC50	nM	458.0
278534	16347987	CHEMBL3707675	Fluorescence Resonance Energy Transfer (FRET) Assay: The enzyme inhibitory activity of test compounds was determined by fluorescence resonance energy transfer (FRET) using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen). Recombinant, phosphorylated p38 MAPK (MAPK12:Millipore) was diluted in HEPES buffer, mixed with compound at the desired final concentrations and incubated for 2 hr at RT. The FRET peptide (2 uM) and ATP (100 uM) were next added to the enzyme/compound mixture and incubated for 1 hr. Development reagent (protease) was added for 1 hr prior to detection in a fluorescence microplate reader. The site-specific protease only cleaves non-phosphorylated peptide and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor) with high ratios indicating high phosphorylation levels and low ratios indicating low phosphorylation levels.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)n(-c2ccccc2)n1		CHEMBL1093756	<	IC50	nM	2.0	CHEMBL3234	Homo sapiens	IC50	nM	2.0
306888	16348864	CHEMBL3707629	Inhibition Assay: The inhibitory activity measurement against the kinases mentioned above was measured in the kinase inhibition reaction mixture containing 2 ul purified kinase protein (10-50 ng), 20 mM Tris-HCl, pH 8.0, 5 mM MgCl2, 0.5 mM dithiothreitol, 0.01 mM ATP, 4 ug of poly(D4Y)n peptide substrate (Promega), 0.2 uCi of 32P-ATP and the each compound shown in tablel. The mixture was incubated for 15 min at 30° C. and the reaction was then ended by adding a half volume of 30% phosphoric acid solution. Subsequently, the reaction mixture solution was spotted in avidin coated membrane (Promega). This membrane was washed using 50 mM phosphate, 0.1N NaCl buffer (pH 6.0) solution for 10 min 5 times and then the radioactivity of each spot was quantified by using a BAS image analyzer (Fuji).	B	Oc1cccc(Nc2ccnc3cc(-c4cccc(CN5CCOCC5)c4)sc23)c1		CHEMBL2336005	=	IC50	nM	50.7	CHEMBL3234	Homo sapiens	IC50	nM	50.7
	16421915	CHEMBL3750397	Inhibition of HCK (unknown origin)	B	C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1		CHEMBL3651966	>	IC50	nM	10000.0	CHEMBL3234	Homo sapiens	IC50	uM	10.0
	16425313	CHEMBL3751071	Inhibition of Hck (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	3.0	CHEMBL3234	Homo sapiens	INH	%	3.0
	16425945	CHEMBL3748759	Inhibition of HCK (unknown origin) expressed in BaF3 cells assessed as inhibition of cell proliferation after 72 hrs by CelltiterGlo assay	B	CN(C)CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3745919	=	GI50	nM	880.0	CHEMBL3234	Homo sapiens	GI50	uM	0.88
	16425970	CHEMBL3749072	Inhibition of HCK (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CN(C)CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3745919	=	Activity	%	0.5	CHEMBL3234	Homo sapiens	Activity	%	0.5
	16431854	CHEMBL3748208	Inhibition of human HCK using [KVEKIGEGTYGVVYK] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL3234	Homo sapiens	IC50	uM	10.0
	16446726	CHEMBL3757131	Inhibition of recombinant human HCK assessed as residual activity at 1 uM by radiometric assay in presence of [gamma-33P]-ATP relative to control	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341	=	Activity	%	14.1	CHEMBL3234	Homo sapiens	Activity	%	14.1
	16446735	CHEMBL3757138	Inhibition of recombinant human HCK by radiometric assay in presence of [gamma-33P]-ATP	B	CC(C)n1nc(-c2cc(C3CC3)on2)c2c(N)ncnc21		CHEMBL3753341	=	IC50	nM	137.0	CHEMBL3234	Homo sapiens	IC50	nM	137.0
	16450869	CHEMBL3762885	Inhibition of HCK (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	65.6	CHEMBL3234	Homo sapiens	INH	%	65.6
	16457777	CHEMBL3761577	Inhibition of HCK (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccccc3C(N)=O)cc12)c1ccccc1		CHEMBL3759085	=	Inhibition	%	2.0	CHEMBL3234	Homo sapiens	INH	%	2.0
	16457778	CHEMBL3761577	Inhibition of HCK (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccc(C(=O)NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3758800	=	Inhibition	%	3.0	CHEMBL3234	Homo sapiens	INH	%	3.0
	16457779	CHEMBL3761577	Inhibition of HCK (unknown origin) at 500 nM	B	CN(C)CCNC(=O)c1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3s2)cc1		CHEMBL3758376	=	Inhibition	%	15.0	CHEMBL3234	Homo sapiens	INH	%	15.0
	16457780	CHEMBL3761577	Inhibition of HCK (unknown origin) at 500 nM	B	COc1cc(C(N)=O)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3759480	=	Inhibition	%	13.0	CHEMBL3234	Homo sapiens	INH	%	13.0
	16457781	CHEMBL3761577	Inhibition of HCK (unknown origin) at 500 nM	B	COc1ccc(C(=O)NCCN(C)C)cc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3758582	=	Inhibition	%	15.0	CHEMBL3234	Homo sapiens	INH	%	15.0
	16457782	CHEMBL3761577	Inhibition of HCK (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3759559	=	Inhibition	%	7.0	CHEMBL3234	Homo sapiens	INH	%	7.0
	16457783	CHEMBL3761577	Inhibition of HCK (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3758682	=	Inhibition	%	20.0	CHEMBL3234	Homo sapiens	INH	%	20.0
	16457784	CHEMBL3761577	Inhibition of HCK (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccccc3)ncnc2s1		CHEMBL3758768	=	Inhibition	%	28.0	CHEMBL3234	Homo sapiens	INH	%	28.0
	16457785	CHEMBL3761577	Inhibition of HCK (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3sc(-c4ccc(CO)cc4OC)cc23)c1		CHEMBL3758802	=	Inhibition	%	-4.0	CHEMBL3234	Homo sapiens	INH	%	-4.0
	16457786	CHEMBL3761577	Inhibition of HCK (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3758351	=	Inhibition	%	15.0	CHEMBL3234	Homo sapiens	INH	%	15.0
	16457787	CHEMBL3761577	Inhibition of HCK (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	18.0	CHEMBL3234	Homo sapiens	INH	%	18.0
	16496012	CHEMBL3779707	Inhibition of N-terminal His6-tagged recombinant human HCK expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	6.0	CHEMBL3234	Homo sapiens	Activity	%	6.0
	16508199	CHEMBL3779707	Inhibition of N-terminal His6-tagged recombinant human HCK expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	4.0	CHEMBL3234	Homo sapiens	Activity	%	4.0
	16509176	CHEMBL3779707	Inhibition of N-terminal His6-tagged recombinant human HCK expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	1.0	CHEMBL3234	Homo sapiens	Activity	%	1.0
	16510506	CHEMBL3784007	Inhibition of TEL-HCK (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	CNc1nc(Nc2ccc(C)c(N)c2)ncc1C(=O)Nc1cc(NC(=O)c2cccc(C(F)(F)F)c2)ccc1C		CHEMBL3780219	=	GI50	nM	980.0	CHEMBL3234	Homo sapiens	GI50	uM	0.98
	16510507	CHEMBL3784007	Inhibition of TEL-HCK (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	GI50	nM	9700.0	CHEMBL3234	Homo sapiens	GI50	uM	9.7
	16510508	CHEMBL3784007	Inhibition of TEL-HCK (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	GI50	nM	4100.0	CHEMBL3234	Homo sapiens	GI50	uM	4.1
	16510509	CHEMBL3784007	Inhibition of TEL-HCK (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	GI50	nM	39.0	CHEMBL3234	Homo sapiens	GI50	uM	0.039
	16510631	CHEMBL3784723	Inhibition of full length human wild type HCK expressed in bacterial expression system assessed as residual activity at 1 uM relative to control	B	CNc1nc(Nc2ccc(C)c(N)c2)ncc1C(=O)Nc1cc(NC(=O)c2cccc(C(F)(F)F)c2)ccc1C		CHEMBL3780219	=	Activity	%	0.7	CHEMBL3234	Homo sapiens	Activity	%	0.7
	16512909	CHEMBL3783186	Inhibition of HCK (unknown origin) preincubated for 2 hrs followed by FRET peptide addition measured after 1 hr by Z-LYTE assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	19000.0	CHEMBL3234	Homo sapiens	IC50	nM	19000.0
	16512910	CHEMBL3783186	Inhibition of HCK (unknown origin) preincubated for 2 hrs followed by FRET peptide addition measured after 1 hr by Z-LYTE assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCn3ccnc3)c3ccccc23)cc1		CHEMBL336001	=	IC50	nM	4937.0	CHEMBL3234	Homo sapiens	IC50	nM	4937.0
	16512911	CHEMBL3783186	Inhibition of HCK (unknown origin) preincubated for 2 hrs followed by FRET peptide addition measured after 1 hr by Z-LYTE assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCc3ccccn3)c3ccccc23)cc1		CHEMBL3781528	>	IC50	nM	19000.0	CHEMBL3234	Homo sapiens	IC50	nM	19000.0
	16512912	CHEMBL3783186	Inhibition of HCK (unknown origin) preincubated for 2 hrs followed by FRET peptide addition measured after 1 hr by Z-LYTE assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCc3cccnc3)c3ccccc23)cc1		CHEMBL343227	>	IC50	nM	19000.0	CHEMBL3234	Homo sapiens	IC50	nM	19000.0
	16512913	CHEMBL3783186	Inhibition of HCK (unknown origin) preincubated for 2 hrs followed by FRET peptide addition measured after 1 hr by Z-LYTE assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCc3ccncc3)c3ccccc23)cc1		CHEMBL143134	=	IC50	nM	901.0	CHEMBL3234	Homo sapiens	IC50	nM	901.0
	16512914	CHEMBL3783186	Inhibition of HCK (unknown origin) preincubated for 2 hrs followed by FRET peptide addition measured after 1 hr by Z-LYTE assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCc3ccnc(N)c3)c3ccccc23)cc1		CHEMBL3781587	=	IC50	nM	829.0	CHEMBL3234	Homo sapiens	IC50	nM	829.0
	16512915	CHEMBL3783186	Inhibition of HCK (unknown origin) preincubated for 2 hrs followed by FRET peptide addition measured after 1 hr by Z-LYTE assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCc3ccncc3N)c3ccccc23)cc1		CHEMBL3780111	=	IC50	nM	625.0	CHEMBL3234	Homo sapiens	IC50	nM	625.0
	16512916	CHEMBL3783186	Inhibition of HCK (unknown origin) preincubated for 2 hrs followed by FRET peptide addition measured after 1 hr by Z-LYTE assay	B	CC(=O)Nc1cc(CCOc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3781430	=	IC50	nM	82.0	CHEMBL3234	Homo sapiens	IC50	nM	82.0
	16512917	CHEMBL3783186	Inhibition of HCK (unknown origin) preincubated for 2 hrs followed by FRET peptide addition measured after 1 hr by Z-LYTE assay	B	CC(=O)Nc1cnccc1CCOc1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccc(C)cc2)c2ccccc12		CHEMBL3780488	=	IC50	nM	482.0	CHEMBL3234	Homo sapiens	IC50	nM	482.0
	16512918	CHEMBL3783186	Inhibition of HCK (unknown origin) preincubated for 2 hrs followed by FRET peptide addition measured after 1 hr by Z-LYTE assay	B	COCC(=O)Nc1cnccc1CCOc1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccc(C)cc2)c2ccccc12		CHEMBL3782036	=	IC50	nM	1117.0	CHEMBL3234	Homo sapiens	IC50	nM	1117.0
	16512919	CHEMBL3783186	Inhibition of HCK (unknown origin) preincubated for 2 hrs followed by FRET peptide addition measured after 1 hr by Z-LYTE assay	B	COCC(=O)Nc1cc(CCOc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3780154	=	IC50	nM	164.0	CHEMBL3234	Homo sapiens	IC50	nM	164.0
	16512920	CHEMBL3783186	Inhibition of HCK (unknown origin) preincubated for 2 hrs followed by FRET peptide addition measured after 1 hr by Z-LYTE assay	B	CNC(=O)c1cc(CCOc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3780089	>	IC50	nM	17000.0	CHEMBL3234	Homo sapiens	IC50	nM	17000.0
	16512921	CHEMBL3783186	Inhibition of HCK (unknown origin) preincubated for 2 hrs followed by FRET peptide addition measured after 1 hr by Z-LYTE assay	B	COCCNC(=O)c1cc(CCOc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3780629	>	IC50	nM	16000.0	CHEMBL3234	Homo sapiens	IC50	nM	16000.0
	16512922	CHEMBL3783186	Inhibition of HCK (unknown origin) preincubated for 2 hrs followed by FRET peptide addition measured after 1 hr by Z-LYTE assay	B	CC(=O)Nc1nccn1CCOc1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccc(C)cc2)c2ccccc12		CHEMBL3782009	=	IC50	nM	3221.0	CHEMBL3234	Homo sapiens	IC50	nM	3221.0
	16512923	CHEMBL3783186	Inhibition of HCK (unknown origin) preincubated for 2 hrs followed by FRET peptide addition measured after 1 hr by Z-LYTE assay	B	COCCNC(=O)c1cc(COc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3780410	>	IC50	nM	16000.0	CHEMBL3234	Homo sapiens	IC50	nM	16000.0
	16512924	CHEMBL3783186	Inhibition of HCK (unknown origin) preincubated for 2 hrs followed by FRET peptide addition measured after 1 hr by Z-LYTE assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCc3ccnc(C(=O)NCCN4CCOCC4)c3)c3ccccc23)cc1		CHEMBL3781413	>	IC50	nM	15000.0	CHEMBL3234	Homo sapiens	IC50	nM	15000.0
	16512925	CHEMBL3783186	Inhibition of HCK (unknown origin) preincubated for 2 hrs followed by FRET peptide addition measured after 1 hr by Z-LYTE assay	B	COC(=O)Nc1cc(CCOc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3781532	=	IC50	nM	26.0	CHEMBL3234	Homo sapiens	IC50	nM	26.0
	16512926	CHEMBL3783186	Inhibition of HCK (unknown origin) preincubated for 2 hrs followed by FRET peptide addition measured after 1 hr by Z-LYTE assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCc3ccnc(NS(C)(=O)=O)c3)c3ccccc23)cc1		CHEMBL3780714	=	IC50	nM	2141.0	CHEMBL3234	Homo sapiens	IC50	nM	2141.0
	16512927	CHEMBL3783186	Inhibition of HCK (unknown origin) preincubated for 2 hrs followed by FRET peptide addition measured after 1 hr by Z-LYTE assay	B	CC(=O)Nc1cc(COc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3781102	=	IC50	nM	51.0	CHEMBL3234	Homo sapiens	IC50	nM	51.0
	16512928	CHEMBL3783186	Inhibition of HCK (unknown origin) preincubated for 2 hrs followed by FRET peptide addition measured after 1 hr by Z-LYTE assay	B	CNC(=O)Nc1cc(CCOc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3781687	=	IC50	nM	26.0	CHEMBL3234	Homo sapiens	IC50	nM	26.0
	16512929	CHEMBL3783186	Inhibition of HCK (unknown origin) preincubated for 2 hrs followed by FRET peptide addition measured after 1 hr by Z-LYTE assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCc3ccnc(NC(=O)c4ccccc4)c3)c3ccccc23)cc1		CHEMBL3780519	=	IC50	nM	13291.0	CHEMBL3234	Homo sapiens	IC50	nM	13291.0
	16512930	CHEMBL3783186	Inhibition of HCK (unknown origin) preincubated for 2 hrs followed by FRET peptide addition measured after 1 hr by Z-LYTE assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCc3ccnc(NC(=O)Cc4ccccc4)c3)c3ccccc23)cc1		CHEMBL3781473	=	IC50	nM	692.0	CHEMBL3234	Homo sapiens	IC50	nM	692.0
	16512931	CHEMBL3783186	Inhibition of HCK (unknown origin) preincubated for 2 hrs followed by FRET peptide addition measured after 1 hr by Z-LYTE assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCc3ccnc(NC(=O)CN(C)C)c3)c3ccccc23)cc1		CHEMBL3781244	=	IC50	nM	197.0	CHEMBL3234	Homo sapiens	IC50	nM	197.0
	16512932	CHEMBL3783186	Inhibition of HCK (unknown origin) preincubated for 2 hrs followed by FRET peptide addition measured after 1 hr by Z-LYTE assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCc3ccnc(NC(=O)CN4CCOCC4)c3)c3ccccc23)cc1		CHEMBL3780667	=	IC50	nM	187.0	CHEMBL3234	Homo sapiens	IC50	nM	187.0
	16512933	CHEMBL3783186	Inhibition of HCK (unknown origin) preincubated for 2 hrs followed by FRET peptide addition measured after 1 hr by Z-LYTE assay	B	CSCC(=O)Nc1cc(COc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3781245	=	IC50	nM	208.0	CHEMBL3234	Homo sapiens	IC50	nM	208.0
	16512934	CHEMBL3783186	Inhibition of HCK (unknown origin) preincubated for 2 hrs followed by FRET peptide addition measured after 1 hr by Z-LYTE assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCc3ccnc(NC(=O)CS(C)(=O)=O)c3)c3ccccc23)cc1		CHEMBL3780832	=	IC50	nM	110.0	CHEMBL3234	Homo sapiens	IC50	nM	110.0
	16512935	CHEMBL3783186	Inhibition of HCK (unknown origin) preincubated for 2 hrs followed by FRET peptide addition measured after 1 hr by Z-LYTE assay	B	COCC(=O)Nc1cc(COc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3695568	=	IC50	nM	52.0	CHEMBL3234	Homo sapiens	IC50	nM	52.0
	16512936	CHEMBL3783186	Inhibition of HCK (unknown origin) preincubated for 2 hrs followed by FRET peptide addition measured after 1 hr by Z-LYTE assay	B	COCC(=O)N(C)c1cc(COc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3780386	=	IC50	nM	8673.0	CHEMBL3234	Homo sapiens	IC50	nM	8673.0
	16512937	CHEMBL3783186	Inhibition of HCK (unknown origin) preincubated for 2 hrs followed by FRET peptide addition measured after 1 hr by Z-LYTE assay	B	COCC(=O)Nc1cc(C(C)Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3781982	=	IC50	nM	807.0	CHEMBL3234	Homo sapiens	IC50	nM	807.0
	16512938	CHEMBL3783186	Inhibition of HCK (unknown origin) preincubated for 2 hrs followed by FRET peptide addition measured after 1 hr by Z-LYTE assay	B	COCC(=O)Nc1cc(C(C)(C)Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3781999	=	IC50	nM	8552.0	CHEMBL3234	Homo sapiens	IC50	nM	8552.0
	16565628	CHEMBL3803245	Inhibition of full length human recombinant N-terminal GST-His6-tagged HCK (M1 to P505 residues) expressed in baculovirus infected sf9 cells using KVEKIGEGTYGVVYK as substrate at 100 uM incubated for 10 mins by scintillation counting method relative to control	B	COc1ccc(/C=N/Nc2cc(C)c3ccccc3n2)cc1		CHEMBL3798597	=	Inhibition	%	0.0	CHEMBL3234	Homo sapiens	INH	%	0.0
	16565629	CHEMBL3803245	Inhibition of full length human recombinant N-terminal GST-His6-tagged HCK (M1 to P505 residues) expressed in baculovirus infected sf9 cells using KVEKIGEGTYGVVYK as substrate at 100 uM incubated for 10 mins by scintillation counting method relative to control	B	C/C(=N\Nc1ccc2ccccc2n1)c1ccccc1O		CHEMBL1892026	=	Inhibition	%	0.0	CHEMBL3234	Homo sapiens	INH	%	0.0
	16565630	CHEMBL3803245	Inhibition of full length human recombinant N-terminal GST-His6-tagged HCK (M1 to P505 residues) expressed in baculovirus infected sf9 cells using KVEKIGEGTYGVVYK as substrate at 100 uM incubated for 10 mins by scintillation counting method relative to control	B	Cc1cc(N/N=C/c2ccc(O)cc2)nc2ccccc12		CHEMBL3799359	=	Inhibition	%	0.0	CHEMBL3234	Homo sapiens	INH	%	0.0
	16565631	CHEMBL3803245	Inhibition of full length human recombinant N-terminal GST-His6-tagged HCK (M1 to P505 residues) expressed in baculovirus infected sf9 cells using KVEKIGEGTYGVVYK as substrate at 100 uM incubated for 10 mins by scintillation counting method relative to control	B	COc1ccc(-c2nnc3c(NCCN4CCOCC4)cccn23)cc1OC		CHEMBL3798991	=	Inhibition	%	0.0	CHEMBL3234	Homo sapiens	INH	%	0.0
	16565689	CHEMBL3801097	Inhibition of HCK (unknown origin)	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	3.4	CHEMBL3234	Homo sapiens	Kd	nM	3.4
	16565690	CHEMBL3801097	Inhibition of HCK (unknown origin)	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	8500.0	CHEMBL3234	Homo sapiens	Kd	nM	8500.0
	16593607	CHEMBL3811747	Inhibition of GST-tagged full length human recombinant HCK expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	>=	Inhibition	%	80.0	CHEMBL3234	Homo sapiens	INH	%	80.0
	16593615	CHEMBL3811754	Inhibition of GST-tagged full length human recombinant HCK expressed in baculovirus using Fluorescein-Poly GT as substrate	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	=	IC50	nM	22.0	CHEMBL3234	Homo sapiens	IC50	nM	22.0
	16614496	CHEMBL3816694	Inhibition of human HCK at 1 uM using [KVEKIGEGTYGVVYK] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	-4.0	CHEMBL3234	Homo sapiens	INH	%	-4.0
	16618195	CHEMBL3816360	Inhibition of full length recombinant human N-terminal GST-tagged HCK expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL3234	Homo sapiens	INH	%	50.0
	16739385	CHEMBL3857054	Inhibition of recombinant full length human N-terminal GST-tagged HCK expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3901622	=	Inhibition	%	21.0	CHEMBL3234	Homo sapiens	INH	%	21.0
	16739386	CHEMBL3857054	Inhibition of recombinant full length human N-terminal GST-tagged HCK expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN4CCCCC4)cc3)cc12)c1ccccc1		CHEMBL3891846	=	Inhibition	%	20.0	CHEMBL3234	Homo sapiens	INH	%	20.0
	16739387	CHEMBL3857054	Inhibition of recombinant full length human N-terminal GST-tagged HCK expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	18.0	CHEMBL3234	Homo sapiens	INH	%	18.0
	16837408	CHEMBL3876080	Inhibition of human full length N-terminal GST-tagged HCK cytoplasmic domain expressed in baculovirus expression system	B	CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884319	=	IC50	nM	1855.0	CHEMBL3234	Homo sapiens	IC50	nM	1855.0
342613	17720004	CHEMBL3887541	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	3.7	CHEMBL3234	Homo sapiens	IC50	nM	3.7
342634	17720025	CHEMBL3887541	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 μM ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL3647967	=	IC50	nM	1.0	CHEMBL3234	Homo sapiens	IC50	nM	1.0
385005	17758427	CHEMBL3888247	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	3.7	CHEMBL3234	Homo sapiens	IC50	nM	3.7
385026	17758448	CHEMBL3888247	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL3647967	=	IC50	nM	1.0	CHEMBL3234	Homo sapiens	IC50	nM	1.0
Inactive	17905784	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905785	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905786	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905787	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905788	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905789	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905790	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905791	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905792	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905793	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905794	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905795	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905796	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905797	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Active	17905798	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	=	Kd	nM	1070.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	1070.0
Inactive	17905799	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905800	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905801	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905802	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905803	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905804	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Active	17905805	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	143.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	143.0
Inactive	17905806	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905807	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905808	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905809	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Active	17905810	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	=	Kd	nM	1247.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	1247.0
Active	17905811	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	=	Kd	nM	900.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	900.0
Inactive	17905812	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905813	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905814	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905815	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905816	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905817	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905818	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905819	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905820	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905821	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905822	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905823	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905824	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Active	17905825	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	=	Kd	nM	1594.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	1594.0
Inactive	17905826	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Active	17905827	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	136.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	136.0
Active	17905828	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	=	Kd	nM	1161.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	1161.0
Active	17905829	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	=	Kd	nM	623.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	623.0
Active	17905830	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	10043.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	10043.0
Inactive	17905831	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905832	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905833	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905834	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905835	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905836	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905837	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905838	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905839	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905840	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905841	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905842	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905843	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905844	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905845	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905846	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905847	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905848	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905849	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905850	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905851	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Active	17905852	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	1081.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	1081.0
Inactive	17905853	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905854	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905855	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905856	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905857	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905858	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905859	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905860	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Active	17905861	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	=	Kd	nM	2886.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	2886.0
Inactive	17905862	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905863	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905864	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905865	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905866	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905867	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905868	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905869	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905870	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905871	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905872	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905873	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905874	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Active	17905875	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	=	Kd	nM	176.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	176.0
Inactive	17905876	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905877	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905878	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Active	17905879	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	6394.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	6394.0
Inactive	17905880	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905881	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905882	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905883	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905884	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905885	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905886	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Active	17905887	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	1316.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	1316.0
Inactive	17905888	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905889	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905890	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905891	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905892	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905893	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905894	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905895	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905896	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905897	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Active	17905898	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	Kd	nM	42.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	42.0
Inactive	17905899	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905900	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905901	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905902	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Active	17905903	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	=	Kd	nM	712.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	712.0
Inactive	17905904	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905905	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905906	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905907	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905908	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905909	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905910	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905911	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905912	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905913	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905914	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905915	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905916	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905917	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905918	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905919	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905920	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905921	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905922	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Active	17905923	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	=	Kd	nM	103.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	103.0
Inactive	17905924	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905925	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905926	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905927	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905928	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905929	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905930	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905931	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905932	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905933	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Active	17905934	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	=	Kd	nM	283.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	283.0
Inactive	17905935	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905936	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905937	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17905938	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	1503.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	1503.0
Inactive	17905939	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905940	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905941	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905942	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Active	17905943	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	137.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	137.0
Inactive	17905944	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905945	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905946	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905947	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Active	17905948	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	29.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	29.0
Inactive	17905949	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905950	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905951	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905952	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905953	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905954	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905955	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Active	17905956	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	1056.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	1056.0
Inactive	17905957	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Active	17905958	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	Kd	nM	1098.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	1098.0
Inactive	17905959	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905960	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905961	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905962	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17905963	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	=	Kd	nM	6.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	6.0
Active	17905964	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	Kd	nM	100.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	100.0
Active	17905965	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Kd	nM	82.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	82.0
Inactive	17905966	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905967	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905968	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Active	17905969	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	66.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	66.0
Inactive	17905970	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905971	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905972	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905973	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905974	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905975	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905976	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905977	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905978	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905979	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905980	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905981	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905982	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905983	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905984	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905985	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Active	17905986	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	664.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	664.0
Inactive	17905987	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905988	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Active	17905989	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1943.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	1943.0
Uncertain	17905990	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	=	Kd	nM	1646.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	1646.0
Inactive	17905991	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905992	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905993	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905994	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905995	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905996	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905997	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905998	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Active	17905999	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	1180.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	1180.0
Inactive	17906000	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17906001	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Active	17906002	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	116.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	116.0
Inactive	17906003	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17906004	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Kd	nM	621.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	621.0
Inactive	17906005	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Active	17906006	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	=	Kd	nM	436.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	436.0
Inactive	17906007	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17906008	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17906009	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Active	17906010	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	Kd	nM	15993.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	15993.0
Inactive	17906011	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17906012	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17906013	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17906014	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17906015	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17906016	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17906017	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17906018	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17906019	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17906020	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17906021	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17906022	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17906023	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17906024	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17906025	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17906026	CHEMBL3991730	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL3234	Homo sapiens	Kd apparent	nM	30000.0
	17985360	CHEMBL3999014	Inhibition of full-length recombinant human HCK assessed as residual activity at 100 uM using poly(Glu,Tyr)4:1 as substrate by ADP-Glo bioluminescence assay relative to control relative to control	B	CC(=O)c1cccc(Nc2nc(-c3sc(NC(=O)OC(C)(C)C)nc3C)cs2)c1		CHEMBL4085374	=	Activity	%	100.0	CHEMBL3234	Homo sapiens	Activity	%	100.0
	17996258	CHEMBL4001407	Inhibition of human wild type full length HCK (M22 to P526 residues) expressed in bacterial expression system at 10 uM by KinomeScan method relative to control	B	Cc1nc2nc(Sc3ccccc3)cnc2cc1NC(=O)Nc1ccccc1		CHEMBL4083528	=	Inhibition	%	13.0	CHEMBL3234	Homo sapiens	INH	%	13.0
	18114324	CHEMBL4025170	Inhibition of wild-type human full length HCK (M22 to P526 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL3234	Homo sapiens	Activity	%	100.0
Active	18149684	CHEMBL4033359	Inhibition of human HCK at 0.5 uM relative to control	B	COc1cc2ncnc(Oc3ccc(NC(=O)Nc4ccc(CN5CCOCC5)c(C(F)(F)F)c4)c4ccccc34)c2cc1OC		CHEMBL4075561		Inhibition	%		CHEMBL3234	Homo sapiens	INH		
Active	18149685	CHEMBL4033359	Inhibition of human HCK at 0.5 uM relative to control	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Inhibition	%		CHEMBL3234	Homo sapiens	INH		
	18203694	CHEMBL4043981	Inhibition of wild-type human full length HCK (M22 to P526 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	10.0	CHEMBL3234	Homo sapiens	Activity	%	10.0
	18211588	CHEMBL4045690	Inhibition of HCK activation Loop (EGAKFPIKWTAPEAINFGSFTIK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-2.2	CHEMBL3234	Homo sapiens	INH	%	-2.2
	18211835	CHEMBL4045931	Inhibition of HCK activation Loop (EGAKFPIKWTAPEAINFGSFTIK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-7.4	CHEMBL3234	Homo sapiens	INH	%	-7.4
	18253825	CHEMBL4055197	Inhibition of wild-type human full length HCK (M22 to P526 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL3234	Homo sapiens	Activity	%	100.0
	18253826	CHEMBL4055197	Inhibition of wild-type human full length HCK (M22 to P526 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL3234	Homo sapiens	Activity	%	100.0
	18262079	CHEMBL4056676	Inhibition of HCK (75 to 526 residues) (unknown origin) expressed in Sf9 insect cells after 120 mins	B	CN1CCN([C@H]2CC[C@H](n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL45177	=	IC50	nM	0.4266	CHEMBL3234	Homo sapiens	pIC50		9.37
	18262080	CHEMBL4056676	Inhibition of HCK (75 to 526 residues) (unknown origin) expressed in Sf9 insect cells after 120 mins	B	CC(C)C[C@H](N[C@H]1CC[C@H](n2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1)C(=O)N(C)C		CHEMBL4103186	=	IC50	nM	691.83	CHEMBL3234	Homo sapiens	pIC50		6.16
	18262081	CHEMBL4056676	Inhibition of HCK (75 to 526 residues) (unknown origin) expressed in Sf9 insect cells after 120 mins	B	CNC(=O)[C@H](CC(C)C)N[C@H]1CC[C@H](n2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL4085262	=	IC50	nM	112.2	CHEMBL3234	Homo sapiens	pIC50		6.95
	18262082	CHEMBL4056676	Inhibition of HCK (75 to 526 residues) (unknown origin) expressed in Sf9 insect cells after 120 mins	B	CC(C)C[C@H](N[C@H]1CC[C@H](n2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1)C(N)=O		CHEMBL4065334	=	IC50	nM	208.93	CHEMBL3234	Homo sapiens	pIC50		6.68
	18262083	CHEMBL4056676	Inhibition of HCK (75 to 526 residues) (unknown origin) expressed in Sf9 insect cells after 120 mins	B	CC(C)C[C@H](N[C@H]1CC[C@H](n2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1)C(=O)O		CHEMBL4093003	=	IC50	nM	10.96	CHEMBL3234	Homo sapiens	pIC50		7.96
	18262084	CHEMBL4056676	Inhibition of HCK (75 to 526 residues) (unknown origin) expressed in Sf9 insect cells after 120 mins	B	CCOC(=O)[C@H](CC(C)C)N[C@H]1CC[C@H](n2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL4073943	=	IC50	nM	1318.26	CHEMBL3234	Homo sapiens	pIC50		5.88
	18262085	CHEMBL4056678	Inhibition of HCK (unknown origin)	B	Cc1nnc2n1CCN([C@H]1CC[C@H](n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC1)C2		CHEMBL4063307	=	IC50	nM	89.13	CHEMBL3234	Homo sapiens	pIC50		7.05
	18262086	CHEMBL4056678	Inhibition of HCK (unknown origin)	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@H](N[C@H]2CCNC2=O)CC1		CHEMBL4061078	=	IC50	nM	13.49	CHEMBL3234	Homo sapiens	pIC50		7.87
	18262087	CHEMBL4056678	Inhibition of HCK (unknown origin)	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@H](NCc2ccncc2)CC1		CHEMBL4071932	=	IC50	nM	8.913	CHEMBL3234	Homo sapiens	pIC50		8.05
	18262088	CHEMBL4056678	Inhibition of HCK (unknown origin)	B	NC(=O)CN[C@H]1CC[C@H](n2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL4087733	=	IC50	nM	7.586	CHEMBL3234	Homo sapiens	pIC50		8.12
	18262089	CHEMBL4056678	Inhibition of HCK (unknown origin)	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@H](NCC(=O)O)CC1		CHEMBL4066401	=	IC50	nM	4.169	CHEMBL3234	Homo sapiens	pIC50		8.38
	18262090	CHEMBL4056678	Inhibition of HCK (unknown origin)	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@H](N2CCN(CCO)CC2)CC1		CHEMBL4095434	=	IC50	nM	3.467	CHEMBL3234	Homo sapiens	pIC50		8.46
	18262091	CHEMBL4056678	Inhibition of HCK (unknown origin)	B	CC(C)N1CCN([C@H]2CC[C@H](n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL4075002	=	IC50	nM	0.257	CHEMBL3234	Homo sapiens	pIC50		9.59
	18262092	CHEMBL4056678	Inhibition of HCK (unknown origin)	B	Cc1nnc2n1CCN([C@H]1CC[C@H](n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC1)C2		CHEMBL4063307	=	IC50	nM	90.0	CHEMBL3234	Homo sapiens	IC50	nM	90.0
	18262093	CHEMBL4056678	Inhibition of HCK (unknown origin)	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@H](N[C@H]2CCNC2=O)CC1		CHEMBL4061078	=	IC50	nM	13.5	CHEMBL3234	Homo sapiens	IC50	nM	13.5
	18262094	CHEMBL4056678	Inhibition of HCK (unknown origin)	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@H](NCc2ccncc2)CC1		CHEMBL4071932	=	IC50	nM	9.0	CHEMBL3234	Homo sapiens	IC50	nM	9.0
	18262095	CHEMBL4056678	Inhibition of HCK (unknown origin)	B	NC(=O)CN[C@H]1CC[C@H](n2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL4087733	=	IC50	nM	7.6	CHEMBL3234	Homo sapiens	IC50	nM	7.6
	18262096	CHEMBL4056678	Inhibition of HCK (unknown origin)	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@H](NCC(=O)O)CC1		CHEMBL4066401	=	IC50	nM	4.2	CHEMBL3234	Homo sapiens	IC50	nM	4.2
	18262097	CHEMBL4056678	Inhibition of HCK (unknown origin)	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@H](N2CCN(CCO)CC2)CC1		CHEMBL4095434	=	IC50	nM	3.5	CHEMBL3234	Homo sapiens	IC50	nM	3.5
	18262098	CHEMBL4056678	Inhibition of HCK (unknown origin)	B	CC(C)N1CCN([C@H]2CC[C@H](n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL4075002	=	IC50	nM	0.26	CHEMBL3234	Homo sapiens	IC50	nM	0.26
	18262099	CHEMBL4056677	Inhibition of human HCK (81 to 526 residues) expressed in Sf9 insect cells after 120 mins	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCOCC1		CHEMBL296103	=	IC50	nM	31.0	CHEMBL3234	Homo sapiens	IC50	nM	31.0
	18262100	CHEMBL4056677	Inhibition of human HCK (81 to 526 residues) expressed in Sf9 insect cells after 120 mins	B	CN1CCN([C@H]2CC[C@H](n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL45177	=	IC50	nM	0.43	CHEMBL3234	Homo sapiens	IC50	nM	0.43
	18262101	CHEMBL4056676	Inhibition of HCK (75 to 526 residues) (unknown origin) expressed in Sf9 insect cells after 120 mins	B	CC(C)C[C@H](N[C@H]1CC[C@H](n2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1)C(=O)N(C)C		CHEMBL4103186	=	IC50	nM	686.0	CHEMBL3234	Homo sapiens	IC50	nM	686.0
	18262102	CHEMBL4056676	Inhibition of HCK (75 to 526 residues) (unknown origin) expressed in Sf9 insect cells after 120 mins	B	CNC(=O)[C@H](CC(C)C)N[C@H]1CC[C@H](n2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL4085262	=	IC50	nM	111.0	CHEMBL3234	Homo sapiens	IC50	nM	111.0
	18262103	CHEMBL4056676	Inhibition of HCK (75 to 526 residues) (unknown origin) expressed in Sf9 insect cells after 120 mins	B	CC(C)C[C@H](N[C@H]1CC[C@H](n2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1)C(N)=O		CHEMBL4065334	=	IC50	nM	210.0	CHEMBL3234	Homo sapiens	IC50	nM	210.0
	18262104	CHEMBL4056676	Inhibition of HCK (75 to 526 residues) (unknown origin) expressed in Sf9 insect cells after 120 mins	B	CC(C)C[C@H](N[C@H]1CC[C@H](n2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1)C(=O)O		CHEMBL4093003	=	IC50	nM	11.0	CHEMBL3234	Homo sapiens	IC50	nM	11.0
	18262105	CHEMBL4056676	Inhibition of HCK (75 to 526 residues) (unknown origin) expressed in Sf9 insect cells after 120 mins	B	CCOC(=O)[C@H](CC(C)C)N[C@H]1CC[C@H](n2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL4073943	=	IC50	nM	1323.0	CHEMBL3234	Homo sapiens	IC50	nM	1323.0
	18265870	CHEMBL4057320	Inhibition of Hck (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	30.3	CHEMBL3234	Homo sapiens	INH	%	30.3
	18266064	CHEMBL4057514	Inhibition of Hck (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	3.3	CHEMBL3234	Homo sapiens	INH	%	3.3
	18269003	CHEMBL4058134	Inhibition of recombinant human N-terminal His6-tagged HCK (230 to 497 residues) expressed in baculovirus Sf21 insect cells preincubated for 5 mins followed by substrate addition after 30 to 60 mins in presence of ATP by fluorescence assay	B	C=CS(=O)(=O)N1CCC[C@@H]1Cn1cc(-c2ccc3c(c2)OCO3)c2c(N)ncnc21		CHEMBL4095253	=	IC50	nM	199.4	CHEMBL3234	Homo sapiens	IC50	nM	199.4
	18282818	CHEMBL4120403	Inhibition of Hck (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	30.3	CHEMBL3234	Homo sapiens	INH	%	30.3
	18283044	CHEMBL4120629	Inhibition of Hck (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	6.7	CHEMBL3234	Homo sapiens	INH	%	6.7
	18283269	CHEMBL4120854	Inhibition of Hck (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	0.0	CHEMBL3234	Homo sapiens	INH	%	0.0
	18330820	CHEMBL4136279	Inhibition of recombinant HCK (unknown origin) at 1 uM by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Inhibition	%	84.0	CHEMBL3234	Homo sapiens	INH	%	84.0
	18440236	CHEMBL4157060	Binding affinity to wild-type human full length HCK (M22 to P526 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL3234	Homo sapiens	Activity	%	100.0
	18458826	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	CN1CCN([C@H]2CC[C@H](n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL45177	=	IC50	nM	0.4	CHEMBL3234	Homo sapiens	IC50	nM	0.4
	18458827	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	CC(C)CCN[C@H]1CC[C@H](n2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL4207785	=	IC50	nM	226.0	CHEMBL3234	Homo sapiens	IC50	nM	226.0
	18458828	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	CC(C)CCN[C@H]1CC[C@@H](n2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL4213372	=	IC50	nM	119.0	CHEMBL3234	Homo sapiens	IC50	nM	119.0
	18458829	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	CC(C)C[C@H](N[C@H]1CC[C@H](n2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1)C(=O)O		CHEMBL4093003	=	IC50	nM	4.4	CHEMBL3234	Homo sapiens	IC50	nM	4.4
	18458830	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	CC(C)C[C@H](N[C@H]1CC[C@@H](n2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1)C(=O)O		CHEMBL4208669	=	IC50	nM	105.0	CHEMBL3234	Homo sapiens	IC50	nM	105.0
	18458831	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	CC(C)C[C@@H](N[C@H]1CC[C@H](n2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1)C(=O)O		CHEMBL4209498	=	IC50	nM	27.0	CHEMBL3234	Homo sapiens	IC50	nM	27.0
	18458832	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	CC(C)C[C@@H](N[C@H]1CC[C@@H](n2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1)C(=O)O		CHEMBL4212432	=	IC50	nM	137.0	CHEMBL3234	Homo sapiens	IC50	nM	137.0
	18458833	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@H](NCC(=O)O)CC1		CHEMBL4066401	=	IC50	nM	3.7	CHEMBL3234	Homo sapiens	IC50	nM	3.7
	18458834	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@@H](NCC(=O)O)CC1		CHEMBL4202763	=	IC50	nM	12.0	CHEMBL3234	Homo sapiens	IC50	nM	12.0
	18458835	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	C[C@H](N[C@H]1CC[C@H](n2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1)C(=O)O		CHEMBL4206460	=	IC50	nM	6.9	CHEMBL3234	Homo sapiens	IC50	nM	6.9
	18458836	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	C[C@H](N[C@H]1CC[C@@H](n2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1)C(=O)O		CHEMBL4209614	=	IC50	nM	73.0	CHEMBL3234	Homo sapiens	IC50	nM	73.0
	18458837	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	C[C@@H](N[C@H]1CC[C@H](n2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1)C(=O)O		CHEMBL4212500	=	IC50	nM	36.0	CHEMBL3234	Homo sapiens	IC50	nM	36.0
	18458838	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	C[C@@H](N[C@H]1CC[C@@H](n2cc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1)C(=O)O		CHEMBL4205815	=	IC50	nM	36.0	CHEMBL3234	Homo sapiens	IC50	nM	36.0
	18458839	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@H](NCCC(=O)O)CC1		CHEMBL4203665	=	IC50	nM	15.0	CHEMBL3234	Homo sapiens	IC50	nM	15.0
	18458840	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@H](N[C@@H](CO)C(=O)O)CC1		CHEMBL4208645	=	IC50	nM	1.8	CHEMBL3234	Homo sapiens	IC50	nM	1.8
	18458841	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@@H](N[C@@H](CO)C(=O)O)CC1		CHEMBL4203767	=	IC50	nM	40.0	CHEMBL3234	Homo sapiens	IC50	nM	40.0
	18458842	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@H](N[C@H](CO)C(=O)O)CC1		CHEMBL4215201	=	IC50	nM	6.3	CHEMBL3234	Homo sapiens	IC50	nM	6.3
	18458843	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@@H](N[C@H](CO)C(=O)O)CC1		CHEMBL4203527	=	IC50	nM	23.0	CHEMBL3234	Homo sapiens	IC50	nM	23.0
	18458844	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@H](N[C@H]2CCOC2=O)CC1		CHEMBL4202997	=	IC50	nM	28.0	CHEMBL3234	Homo sapiens	IC50	nM	28.0
	18458845	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@@H](N[C@H]2CCOC2=O)CC1		CHEMBL4207885	=	IC50	nM	5.4	CHEMBL3234	Homo sapiens	IC50	nM	5.4
	18458846	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@H](N2CCC[C@H]2C(=O)O)CC1		CHEMBL4207351	=	IC50	nM	52.0	CHEMBL3234	Homo sapiens	IC50	nM	52.0
	18458847	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@@H](N2CCC[C@H]2C(=O)O)CC1		CHEMBL4212241	=	IC50	nM	79.0	CHEMBL3234	Homo sapiens	IC50	nM	79.0
	18458848	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@H](N2CCC[C@@H]2C(=O)O)CC1		CHEMBL4211710	=	IC50	nM	200.0	CHEMBL3234	Homo sapiens	IC50	nM	200.0
	18458849	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@@H](N2CCC[C@@H]2C(=O)O)CC1		CHEMBL4216680	=	IC50	nM	65.0	CHEMBL3234	Homo sapiens	IC50	nM	65.0
	18458850	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@H](N[C@@H](Cc2ccccc2)C(=O)O)CC1		CHEMBL4216163	=	IC50	nM	7.5	CHEMBL3234	Homo sapiens	IC50	nM	7.5
	18458851	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@@H](N[C@@H](Cc2ccccc2)C(=O)O)CC1		CHEMBL4204499	=	IC50	nM	74.0	CHEMBL3234	Homo sapiens	IC50	nM	74.0
	18458852	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@H](N[C@H](Cc2ccccc2)C(=O)O)CC1		CHEMBL4205400	=	IC50	nM	24.0	CHEMBL3234	Homo sapiens	IC50	nM	24.0
	18458853	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@@H](N[C@H](Cc2ccccc2)C(=O)O)CC1		CHEMBL4210294	=	IC50	nM	18.0	CHEMBL3234	Homo sapiens	IC50	nM	18.0
	18458854	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@H](N[C@@H](Cc2ccc(O)cc2)C(=O)O)CC1		CHEMBL4209781	=	IC50	nM	7.4	CHEMBL3234	Homo sapiens	IC50	nM	7.4
	18458855	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@@H](N[C@@H](Cc2ccc(O)cc2)C(=O)O)CC1		CHEMBL4214689	=	IC50	nM	39.0	CHEMBL3234	Homo sapiens	IC50	nM	39.0
	18458856	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@H](N[C@H](Cc2ccc(O)cc2)C(=O)O)CC1		CHEMBL4213227	=	IC50	nM	15.0	CHEMBL3234	Homo sapiens	IC50	nM	15.0
	18458857	CHEMBL4180100	Inhibition of recombinant human HCK SH3-SH2-KD (75 to 526 residues) after 20 mins by mobility shift assay	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2[C@H]1CC[C@@H](N[C@H](Cc2ccc(O)cc2)C(=O)O)CC1		CHEMBL4218162	=	IC50	nM	13.0	CHEMBL3234	Homo sapiens	IC50	nM	13.0
	18484192	CHEMBL4185839	Binding affinity to wild-type human full length HCK (M22 to P526 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL3234	Homo sapiens	Activity	%	100.0
	18484676	CHEMBL4185839	Binding affinity to wild-type human full length HCK (M22 to P526 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	74.0	CHEMBL3234	Homo sapiens	Activity	%	74.0
	18507766	CHEMBL4190996	Inhibition of recombinant human activated Hck (230 to 497 residues) at 1 uM using GGMEDIYFEFMGGKKK as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	93.0	CHEMBL3234	Homo sapiens	INH	%	93.0
	18507767	CHEMBL4190995	Inhibition of recombinant human Hck (230 to 497 residues) at 1 uM using KVEKIGEGTYGVVYK (Cdc2 peptide) as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	50.0	CHEMBL3234	Homo sapiens	INH	%	50.0
	18558659	CHEMBL4201059	Inhibition of human HCK at 1 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850	=	Inhibition	%	98.9	CHEMBL3234	Homo sapiens	INH	%	98.9
	18653607	CHEMBL4230100	Inhibition of HCK (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	107.0	CHEMBL3234	Homo sapiens	INH	%	107.0
	18653608	CHEMBL4230100	Inhibition of HCK (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	81.0	CHEMBL3234	Homo sapiens	INH	%	81.0
	18655496	CHEMBL4230739	Binding affinity to wild-type human full length HCK (M22 to P526 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	83.0	CHEMBL3234	Homo sapiens	Activity	%	83.0
	18665414	CHEMBL4233333	Inhibition of HCK (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	1000.0	CHEMBL3234	Homo sapiens	IC50	nM	1000.0
	18674693	CHEMBL4235365	Inhibition of HCK (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	2000.0	CHEMBL3234	Homo sapiens	Ki	nM	2000.0
	18674694	CHEMBL4235365	Inhibition of HCK (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	2000.0	CHEMBL3234	Homo sapiens	Ki	nM	2000.0
Not Determined	18674695	CHEMBL4235365	Inhibition of HCK (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525		Ki			CHEMBL3234	Homo sapiens	Ki		
	18737821	CHEMBL4261418	Inhibition of recombinant human Hck (230 to 497 residues) using KVEKIGEGTYGVV as substrate after 40 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	CCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4281823	=	IC50	nM	142.0	CHEMBL3234	Homo sapiens	IC50	nM	142.0
	18751096	CHEMBL4263818	Inhibition of HCK (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	-2.0	CHEMBL3234	Homo sapiens	INH	%	-2.0
	18751575	CHEMBL4264328	Binding affinity to wild-type human full length HCK (M22 to P526 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	100.0	CHEMBL3234	Homo sapiens	Activity	%	100.0
	18857992	CHEMBL4307838	Binding affinity to wild-type human full length HCK (M22 to P526 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	100.0	CHEMBL3234	Homo sapiens	Activity	%	100.0
	18892885	CHEMBL4314851	Inhibition of recombinant human HCK (230 to 497 residues) assessed as residual activity at 10 uM using Cdc2 peptide as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	106.0	CHEMBL3234	Homo sapiens	Activity	%	106.0
	18892886	CHEMBL4314852	Inhibition of recombinant human activated HCK (230 to 497 residues) assessed as residual activity at 10 uM using GGMEDIYFEFMGGKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	115.0	CHEMBL3234	Homo sapiens	Activity	%	115.0
	18919478	CHEMBL4322834	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged HCK (unknown origin) (25 to 526 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	263.0	CHEMBL3234	Homo sapiens	Kd	nM	263.0
	18919666	CHEMBL4322834	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged HCK (unknown origin) (25 to 526 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	280.0	CHEMBL3234	Homo sapiens	Kd	nM	280.0
	18937975	CHEMBL4327714	Inhibition of human HCK assessed as residual activity at 1 uM using KVEKIGEGTYGVVYK as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	93.09	CHEMBL3234	Homo sapiens	Activity	%	93.09
	18937976	CHEMBL4327714	Inhibition of human HCK assessed as residual activity at 1 uM using KVEKIGEGTYGVVYK as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	99.5	CHEMBL3234	Homo sapiens	Activity	%	99.5
	18938558	CHEMBL4328078	Inhibition of human HCK assessed as residual activity at 100 uM using KVEKIGEGTYGVVYK as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL3234	Homo sapiens	Activity	%	65.0
	18938936	CHEMBL4328442	Inhibition of human HCK using KVEKIGEGTYGVVYK as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.9	CHEMBL3234	Homo sapiens	IC50	10'-9M	1.9
	18958904	CHEMBL4333426	Binding affinity to wild-type human full length HCK (M22 to P526 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	90.0	CHEMBL3234	Homo sapiens	Activity	%	90.0
	18964339	CHEMBL4335107	Inhibition of human HCK (230 to 497 residues) assessed as residual activity at 1 uM using KVEKIGEGTYGVVYK as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	72.0	CHEMBL3234	Homo sapiens	Activity	%	72.0
	18964340	CHEMBL4335107	Inhibition of human HCK (230 to 497 residues) assessed as residual activity at 1 uM using KVEKIGEGTYGVVYK as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	73.0	CHEMBL3234	Homo sapiens	Activity	%	73.0
	18964341	CHEMBL4335108	Inhibition of human HCK activated (230 to 497 residues) assessed as residual activity at 1 uM using GGMEDIYFEFMGGKKK as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	80.0	CHEMBL3234	Homo sapiens	Activity	%	80.0
	18964342	CHEMBL4335108	Inhibition of human HCK activated (230 to 497 residues) assessed as residual activity at 1 uM using GGMEDIYFEFMGGKKK as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	103.0	CHEMBL3234	Homo sapiens	Activity	%	103.0
	18971924	CHEMBL4336934	Inhibition of human HCK (230 to 497 residues) assessed as residual activity at 10 uM using Cdc2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	9.0	CHEMBL3234	Homo sapiens	Activity	%	9.0
	18971925	CHEMBL4336935	Inhibition of human HCK activated (230 to 497 residues) assessed as residual activity at 10 uM using GGMEDIYFEFMGGKKK as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	21.0	CHEMBL3234	Homo sapiens	Activity	%	21.0
	19018951	CHEMBL4347064	Inhibition of HCK (unknown origin)	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C[C@H]1CCCN1C[C@@H]1CO1		CHEMBL4525187	=	IC50	nM	33.0	CHEMBL3234	Homo sapiens	IC50	nM	33.0
Not Active	19039756	CHEMBL4351886	Inhibition of recombinant human activated HCK (230 to 497 residues) at 10 uM using GGMEDIYFEFMGGKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL3234	Homo sapiens	INH		
Not Active	19039757	CHEMBL4351885	Inhibition of recombinant human HCK (230 to 497 residues) at 10 uM using Cdc2 peptide as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL3234	Homo sapiens	INH		
Active	19041133	CHEMBL4352394	Inhibition of human HCK at 10 uM using KVEKIGEGTYGVVYK as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL3234	Homo sapiens	INH		
	19059616	CHEMBL4357917	Binding affinity to wild-type human full length HCK (M22 to P526 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	0.8	CHEMBL3234	Homo sapiens	Activity	%	0.8
	19059897	CHEMBL4358198	Inhibition of HCK (unknown origin)	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	IC50	nM	3.0	CHEMBL3234	Homo sapiens	IC50	nM	3.0
	19063671	CHEMBL4359458	Binding affinity to wild-type human full length HCK (M22 to P526 residues) expressed in bacterial expression system at 100 nM by Kinomescan method relative to control	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213	>	Activity	%	90.0	CHEMBL3234	Homo sapiens	Activity	%	90.0
	19072918	CHEMBL4362093	Effect on Hck at Y411 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to control	B	CCOc1ccc(-c2nc(C(=O)NO)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4443725	=	FC		0.75	CHEMBL3234	Homo sapiens	FC		0.75
	19072957	CHEMBL4362132	Effect on Hck at Y411 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin	B	CCOc1ccc(-c2nc(C(=O)NO)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4443725	=	FC		0.84	CHEMBL3234	Homo sapiens	FC		0.84
	19072996	CHEMBL4362093	Effect on Hck at Y411 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to control	B	CCOc1ccc(-c2nc(C(=O)NO)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4443725	=	log2FC		-0.42	CHEMBL3234	Homo sapiens	log2FC		-0.42
	19073035	CHEMBL4362132	Effect on Hck at Y411 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin	B	CCOc1ccc(-c2nc(C(=O)NO)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4443725	=	log2FC		-0.26	CHEMBL3234	Homo sapiens	log2FC		-0.26
	19073097	CHEMBL4362093	Effect on Hck at Y411 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to control	B	CCOc1ccc(-c2nc(/C(N)=N/O)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4515196	=	FC		0.66	CHEMBL3234	Homo sapiens	FC		0.66
	19073136	CHEMBL4362132	Effect on Hck at Y411 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin	B	CCOc1ccc(-c2nc(/C(N)=N/O)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4515196	=	FC		0.78	CHEMBL3234	Homo sapiens	FC		0.78
	19073175	CHEMBL4362093	Effect on Hck at Y411 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to control	B	CCOc1ccc(-c2nc(/C(N)=N/O)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4515196	=	log2FC		-0.59	CHEMBL3234	Homo sapiens	log2FC		-0.59
	19073214	CHEMBL4362132	Effect on Hck at Y411 phosphorylation level in human NCI-H1975 incubated for 12 hrs by human phosphokinase proteome profiler array relative to beta-catenin	B	CCOc1ccc(-c2nc(/C(N)=N/O)c3[nH]c(=O)n(-c4ccccc4OC)c3n2)cc1		CHEMBL4515196	=	log2FC		-0.36	CHEMBL3234	Homo sapiens	log2FC		-0.36
Active	19085619	CHEMBL4364836	Inhibition of HCK phosphorylation in human KARPAS299 cells at 10 uM incubated for 3 hrs by mass spectrometry-based global phospho-proteomic analysis	B	COc1cc(NC(=O)NCc2cccnc2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCOCC3)c(OC)c2)n1		CHEMBL4514156		Inhibition	%		CHEMBL3234	Homo sapiens	INH		
	19087837	CHEMBL4365092	Inhibition of human recombinant N-terminal GST tagged HCK (230 to 497 residues) expressed in baculovirus infected Sf9 cells using poly (Glu,Tyr) 4:1 as substrate measured after 60 mins in presence of ATP by ADP-Glo kinase assay	B	Nc1n[nH]c2cc(-c3ccc(C(=O)NCCNC(=O)c4ccc(Cl)c(C(F)(F)F)c4)cc3)ccc12		CHEMBL4467809	>	IC50	nM	100000.0	CHEMBL3234	Homo sapiens	IC50	uM	100.0
	19090182	CHEMBL4365756	Inhibition of wild-type human full length HCK (M22 to P526 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	75.0	CHEMBL3234	Homo sapiens	Activity	%	75.0
	19091951	CHEMBL4366425	Inhibition of human HCK at 100 nM using KVEKIGEGTYGVVYK as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	7.23	CHEMBL3234	Homo sapiens	INH	%	7.23
	19144865	CHEMBL4377881	Inhibition of recombinant human HCK (230 to 497 residues) at 1 uM using Cdc2 peptide as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	9.0	CHEMBL3234	Homo sapiens	INH	%	9.0
	19144866	CHEMBL4377882	Inhibition of recombinant human activated HCK (230 to 497 residues) at 1 uM using GGMEDIYFEFMGGKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	5.0	CHEMBL3234	Homo sapiens	INH	%	5.0
	19146949	CHEMBL4378843	Inhibition of recombinant human Hck (230 to 497 residues) at 10 uM using KVEKIGEGTYGVVYK as substrate after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1	Outside typical range	CHEMBL4459587	=	Inhibition	%	-12.0	CHEMBL3234	Homo sapiens	INH	%	-12.0
	19146950	CHEMBL4378842	Inhibition of recombinant human Hck activated (230 to 497 residues) at 10 uM using GGMEDIYFEFMGGKKK as substrate after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	3.0	CHEMBL3234	Homo sapiens	INH	%	3.0
	19147875	CHEMBL4379349	Inhibition of human HCK recombinant (230 to 497 residues) using KVEKIGEGTYGVV as substrate after 40 mins by [gamma-33ATP] radiometric assay	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL3234	Homo sapiens	IC50	uM	10.0
	19147876	CHEMBL4379350	Inhibition of human recombinant activated HCK (230 to 497 residues) using GGMEDIYFEFMGG as substrate after 40 mins by [gamma-33ATP] radiometric assay	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL3234	Homo sapiens	IC50	uM	10.0
	19159444	CHEMBL4382548	Binding affinity to wild-type human full length HCK (M22 to P526 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	49.0	CHEMBL3234	Homo sapiens	Activity	%	49.0
	19191563	CHEMBL4389267	Inhibition of wild-type human full length HCK (M22 to P526 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	98.0	CHEMBL3234	Homo sapiens	INH	%	98.0
	19191930	CHEMBL4389744	Inhibition of wild-type human full length HCK (M22 to P526 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	76.0	CHEMBL3234	Homo sapiens	INH	%	76.0
	19200186	CHEMBL4391370	Binding affinity to wild-type human full length HCK (M22 to P526 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	100.0	CHEMBL3234	Homo sapiens	Activity	%	100.0
	19266447	CHEMBL4405397	Inhibition of wild-type human full length HCK (M22 to P526 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL3234	Homo sapiens	INH	%	50.0
	19276010	CHEMBL4408013	Inhibition of recombinant human HCK (230 to 497 residues) at 1 uM using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	66.0	CHEMBL3234	Homo sapiens	INH	%	66.0
	19276011	CHEMBL4408014	Inhibition of recombinant activated human HCK (230 to 497 residues) at 1 uM using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	33.0	CHEMBL3234	Homo sapiens	INH	%	33.0
Not Active	19306169	CHEMBL4414993	Inhibition of human HCK at 1 uM using poly[Glu:Tyr] (4:1) as substrate preincubated for 15 to 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by filter binding method	A	C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1		CHEMBL3936761		Inhibition	%		CHEMBL3234	Homo sapiens	INH		
	19312954	CHEMBL4416509	Inhibition of recombinant human N-terminal His6-tagged HCK (230 to 497 residues) expressed in baculovirus infected Sf21 insect cells at 10 uM using Src peptide as substrate relative to control	B	N#CC[C@H]1CC[C@H](n2c(=O)[nH]c3cnc(Nc4ccc[nH]c4=O)nc32)CC1		CHEMBL4463007	<	Inhibition	%	50.0	CHEMBL3234	Homo sapiens	INH	%	50.0
	19476578	CHEMBL4479726	Inhibition of full-length human N-terminal GST-tagged HCK expressed in baculovirus expression system by Z'-LYTE assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	=	IC50	nM	30.0	CHEMBL3234	Homo sapiens	IC50	nM	30.0
	19476678	CHEMBL4479726	Inhibition of full-length human N-terminal GST-tagged HCK expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	=	IC50	nM	33.0	CHEMBL3234	Homo sapiens	IC50	nM	33.0
	19476778	CHEMBL4479726	Inhibition of full-length human N-terminal GST-tagged HCK expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	=	IC50	nM	2.8	CHEMBL3234	Homo sapiens	IC50	nM	2.8
	19476878	CHEMBL4479726	Inhibition of full-length human N-terminal GST-tagged HCK expressed in baculovirus expression system by Z'-LYTE assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	=	IC50	nM	6400.0	CHEMBL3234	Homo sapiens	IC50	nM	6400.0
	20600447	CHEMBL4603302	Inhibition of recombinant full length N-terminal GST-tagged human HCK expressed in baculovirus expression system using Tyr 02 as substrate after 1 hr in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	=	IC50	nM	37630.0	CHEMBL3234	Homo sapiens	IC50	uM	37.63
	22392072	CHEMBL4667167	Inhibition of recombinant human N-terminal GST-tagged full length HCK expressed in baculovirus expression system using Tyr 02 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	4.5	CHEMBL3234	Homo sapiens	INH	%	4.5
	22423567	CHEMBL4674359	Inhibition of human HCK using KVEKIGEGTYGVVYK as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	75.62	CHEMBL3234	Homo sapiens	Activity	%	75.62
	22423568	CHEMBL4674359	Inhibition of human HCK using KVEKIGEGTYGVVYK as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	79.49	CHEMBL3234	Homo sapiens	Activity	%	79.49
	22820486	CHEMBL4716245	Inhibition of N-terminal His6-tagged recombinant human HCK (230 to 497 residues) expressed in baculovirus infected Sf21 cells assessed as residual activity at 1 uM relative to control	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Activity	%	84.0	CHEMBL3234	Homo sapiens	Activity	%	84.0
	22820487	CHEMBL4716245	Inhibition of N-terminal His6-tagged recombinant human HCK (230 to 497 residues) expressed in baculovirus infected Sf21 cells assessed as residual activity at 1 uM relative to control	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Activity	%	4.0	CHEMBL3234	Homo sapiens	Activity	%	4.0
	22836252	CHEMBL4718864	Inhibition of recombinant full length N-terminal GST-tagged human HCK expressed in baculovirus expression system at 500 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	18.0	CHEMBL3234	Homo sapiens	INH	%	18.0
	22836253	CHEMBL4718864	Inhibition of recombinant full length N-terminal GST-tagged human HCK expressed in baculovirus expression system at 500 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OCC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4786776	=	Inhibition	%	31.0	CHEMBL3234	Homo sapiens	INH	%	31.0
	22836254	CHEMBL4718864	Inhibition of recombinant full length N-terminal GST-tagged human HCK expressed in baculovirus expression system at 500 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CN(C)CCNCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1F		CHEMBL4748367	=	Inhibition	%	36.0	CHEMBL3234	Homo sapiens	INH	%	36.0
	22836255	CHEMBL4718864	Inhibition of recombinant full length N-terminal GST-tagged human HCK expressed in baculovirus expression system at 500 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CCOc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4776396	=	Inhibition	%	27.0	CHEMBL3234	Homo sapiens	INH	%	27.0
	22836256	CHEMBL4718864	Inhibition of recombinant full length N-terminal GST-tagged human HCK expressed in baculovirus expression system at 500 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	COc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4783569	=	Inhibition	%	30.0	CHEMBL3234	Homo sapiens	INH	%	30.0
	22836257	CHEMBL4718864	Inhibition of recombinant full length N-terminal GST-tagged human HCK expressed in baculovirus expression system at 500 nM using Tyr 02 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4780286	=	Inhibition	%	29.0	CHEMBL3234	Homo sapiens	INH	%	29.0
	22843232	CHEMBL4720252	Inhibition of HCK (unknown origin)	B	C=CC(=O)N1CCC(Cn2cc(-c3ccc4c(c3)OCO4)c3c(N)ncnc32)CC1		CHEMBL4755698	=	IC50	nM	1111.6	CHEMBL3234	Homo sapiens	IC50	nM	1111.6
	22843233	CHEMBL4720252	Inhibition of HCK (unknown origin)	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	3.7	CHEMBL3234	Homo sapiens	IC50	nM	3.7
	22843722	CHEMBL4720708	Inhibition of human HCK using KVEKIGEGTYGVVYK as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	3.03	CHEMBL3234	Homo sapiens	IC50	10^-9M	3.03
	22844074	CHEMBL4721060	Inhibition of human HCK assessed as residual activity using KVEKIGEGTYGVVYK as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	84.81	CHEMBL3234	Homo sapiens	Activity	%	84.81
	22844730	CHEMBL4721405	Inhibition of wild-type human full length HCK (M22 to P526 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	87.23	CHEMBL3234	Homo sapiens	Activity	%	87.23
	22845477	CHEMBL4721758	Binding affinity to Nluc-tagged HCK (unknown origin) expressed in HeLa cells assessed as change in melting temperature incubated for 30 to 60 mins by NaLTSA assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Delta Tm	degrees C	7.43	CHEMBL3234	Homo sapiens	deltaTm	degrees C	7.43
	22845497	CHEMBL4721778	Binding affinity to human HCK using KVEKIGEGTYGVVYK as substrate by radiometric hotspot kinase assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	0.11	CHEMBL3234	Homo sapiens	IC50	nM	0.11
	22853926	CHEMBL4724369	Inhibition of HCK (unknown origin)	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	15.3	CHEMBL3234	Homo sapiens	IC50	nM	15.3
	22950577	CHEMBL4766144	Inhibition of human HCK (230 to 497 residues) using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis	B	Cc1ccc(NC(=O)c2ccc(C)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CC[C@H](O)CC2)c2ncnc(N)c12		CHEMBL4798527	=	IC50	nM	3.0	CHEMBL3234	Homo sapiens	IC50	uM	0.003
	22952859	CHEMBL4766796	Inhibition of human HCK (230 to 497 residues) assessed as residual activity at 10 uM using KVEKIGEGTYGVVYK as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	-1.0	CHEMBL3234	Homo sapiens	Activity	%	-1.0
	22953070	CHEMBL4767007	Inhibition of human HCK (230 to 497 residues) using KVEKIGEGTYGVVYK as substrate after 40 mins by [gamma-33ATP] radiometric assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	IC50	nM	87.0	CHEMBL3234	Homo sapiens	IC50	uM	0.087
	23122602	CHEMBL4804953	Inhibition of human HCK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	96.0	CHEMBL3234	Homo sapiens	Activity	%	96.0
	23123297	CHEMBL4805541	Inhibition of human HCK assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	95.0	CHEMBL3234	Homo sapiens	Activity	%	95.0
	23123601	CHEMBL4805845	Inhibition of DNA-tagged human HCK assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL3234	Homo sapiens	Activity	%	100.0
	23124684	CHEMBL4806558	Inhibition of human HCK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	96.0	CHEMBL3234	Homo sapiens	Activity	%	96.0
	23124685	CHEMBL4806558	Inhibition of human HCK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	96.0	CHEMBL3234	Homo sapiens	Activity	%	96.0
	23128155	CHEMBL4807860	Inhibition of HCK (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	<	Activity	%	25.0	CHEMBL3234	Homo sapiens	Activity	%	25.0
	23128156	CHEMBL4807860	Inhibition of HCK (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	<	Activity	%	25.0	CHEMBL3234	Homo sapiens	Activity	%	25.0
	23128157	CHEMBL4807860	Inhibition of HCK (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Activity	%	25.0	CHEMBL3234	Homo sapiens	Activity	%	25.0
	23192959	CHEMBL4818920	Inhibition of recombinant human HCK (230 to 497 residues) using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	C=CC(=O)N1CC[C@@H](NC(=O)c2sc3nccc4c3c2NC(=O)N4c2ccc(Oc3ccccc3)cc2C)C1		CHEMBL4851021	>	IC50	nM	30000.0	CHEMBL3234	Homo sapiens	IC50	uM	30.0
	23205680	CHEMBL4821567	Inhibition of HCK (unknown origin)	B	COc1cc(Nc2nc(NCc3cccc(NC(=O)CCl)c3)n3ccnc3c2C(N)=O)cc(OC)c1		CHEMBL4870513	>	IC50	nM	1000.0	CHEMBL3234	Homo sapiens	IC50	uM	1.0
	23291032	CHEMBL4839490	Inhibition of human recombinant HCK (230 to 497) by radiometric scintillation counting analysis	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	=	IC50	nM	57.0	CHEMBL3234	Homo sapiens	IC50	nM	57.0
	23291033	CHEMBL4839490	Inhibition of human recombinant HCK (230 to 497) by radiometric scintillation counting analysis	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	IC50	nM	9.0	CHEMBL3234	Homo sapiens	IC50	nM	9.0
	23291258	CHEMBL4839535	Inhibition of human recombinant HCK (230 to 497) at 5 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	=	Inhibition	%	1.0	CHEMBL3234	Homo sapiens	INH	%	1.0
	23291259	CHEMBL4839535	Inhibition of human recombinant HCK (230 to 497) at 5 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4850154	=	Inhibition	%	68.0	CHEMBL3234	Homo sapiens	INH	%	68.0
	23291260	CHEMBL4839535	Inhibition of human recombinant HCK (230 to 497) at 5 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	Inhibition	%	11.0	CHEMBL3234	Homo sapiens	INH	%	11.0
	23291330	CHEMBL4839559	Inhibition of human recombinant HCK (230 to 497) at 50 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	=	Inhibition	%	64.0	CHEMBL3234	Homo sapiens	INH	%	64.0
	23291331	CHEMBL4839559	Inhibition of human recombinant HCK (230 to 497) at 50 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4850154	=	Inhibition	%	92.0	CHEMBL3234	Homo sapiens	INH	%	92.0
	23291332	CHEMBL4839559	Inhibition of human recombinant HCK (230 to 497) at 50 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	Inhibition	%	92.0	CHEMBL3234	Homo sapiens	INH	%	92.0
	23291402	CHEMBL4839583	Inhibition of human recombinant HCK (230 to 497) at 500 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	=	Inhibition	%	89.0	CHEMBL3234	Homo sapiens	INH	%	89.0
	23291403	CHEMBL4839583	Inhibition of human recombinant HCK (230 to 497) at 500 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4850154	=	Inhibition	%	93.0	CHEMBL3234	Homo sapiens	INH	%	93.0
	23291404	CHEMBL4839583	Inhibition of human recombinant HCK (230 to 497) at 500 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	Inhibition	%	97.0	CHEMBL3234	Homo sapiens	INH	%	97.0
Not Active	23317437	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23317905	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	80.0	CHEMBL3234	Homo sapiens	% Control	%	80.0
Not Active	23318573	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23319055	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23319692	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23320167	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	82.8	CHEMBL3234	Homo sapiens	% Control	%	82.8
Not Active	23320845	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23321313	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	82.0	CHEMBL3234	Homo sapiens	% Control	%	82.0
Not Active	23321943	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	92.0	CHEMBL3234	Homo sapiens	% Control	%	92.0
Not Active	23322411	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	92.0	CHEMBL3234	Homo sapiens	% Control	%	92.0
Not Active	23323100	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	88.0	CHEMBL3234	Homo sapiens	% Control	%	88.0
Not Active	23323568	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23324026	CHEMBL4880645	Hck (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	16.0	CHEMBL3234	Homo sapiens	% inhibition	%	16.0
Not Active	23324422	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23325057	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	70.0	CHEMBL3234	Homo sapiens	% Control	%	70.0
Not Active	23325525	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23326172	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	54.0	CHEMBL3234	Homo sapiens	% Control	%	54.0
Not Active	23326640	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	89.0	CHEMBL3234	Homo sapiens	% Control	%	89.0
Not Active	23327340	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	69.0	CHEMBL3234	Homo sapiens	% Control	%	69.0
Not Active	23327808	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	86.0	CHEMBL3234	Homo sapiens	% Control	%	86.0
Not Active	23328395	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	69.0	CHEMBL3234	Homo sapiens	% Control	%	69.0
Not Active	23328863	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	92.0	CHEMBL3234	Homo sapiens	% Control	%	92.0
Not Active	23329364	CHEMBL4881071	Hck(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	95.0	CHEMBL3234	Homo sapiens	% residual kinase activity	%	95.0
Not Active	23329365	CHEMBL4881072	Hck(h) activated Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	107.0	CHEMBL3234	Homo sapiens	% residual kinase activity	%	107.0
Not Active	23329809	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	95.0	CHEMBL3234	Homo sapiens	% Control	%	95.0
Not Active	23330277	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	95.0	CHEMBL3234	Homo sapiens	% Control	%	95.0
Not Active	23331033	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23331501	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23332088	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	72.1	CHEMBL3234	Homo sapiens	% Control	%	72.1
Not Active	23332554	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	98.7	CHEMBL3234	Homo sapiens	% Control	%	98.7
Not Active	23333272	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	87.7	CHEMBL3234	Homo sapiens	% Control	%	87.7
Not Active	23333911	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	97.0	CHEMBL3234	Homo sapiens	% Control	%	97.0
Not Active	23334379	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	98.0	CHEMBL3234	Homo sapiens	% Control	%	98.0
Not Active	23335358	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23335826	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23336453	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23336921	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	99.0	CHEMBL3234	Homo sapiens	% Control	%	99.0
Not Active	23337614	CHEMBL4881985	HCK Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	85.0	CHEMBL3234	Homo sapiens	% Ctrl	%	85.0
Not Active	23338002	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	79.0	CHEMBL3234	Homo sapiens	% Control	%	79.0
Not Active	23338470	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23339082	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23339550	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23340187	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23340655	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23341312	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23341780	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23342396	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23342864	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23343494	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23343962	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	81.0	CHEMBL3234	Homo sapiens	% Control	%	81.0
Not Active	23344600	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	93.0	CHEMBL3234	Homo sapiens	% Control	%	93.0
Not Active	23345173	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23345641	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23346218	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	83.3	CHEMBL3234	Homo sapiens	% Control	%	83.3
Not Active	23346687	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	71.9	CHEMBL3234	Homo sapiens	% Control	%	71.9
Not Active	23347289	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	94.6	CHEMBL3234	Homo sapiens	% Control	%	94.6
Not Active	23347778	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23348357	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23348825	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23349412	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	85.0	CHEMBL3234	Homo sapiens	% Control	%	85.0
Not Active	23350030	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23350498	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23351103	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	95.0	CHEMBL3234	Homo sapiens	% Control	%	95.0
Not Active	23351571	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	87.0	CHEMBL3234	Homo sapiens	% Control	%	87.0
Not Active	23352065	CHEMBL4882756	HCK Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	7.675	CHEMBL3234	Homo sapiens	% Inhibition	%	7.6749
Not Active	23352595	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	84.0	CHEMBL3234	Homo sapiens	% Control	%	84.0
Not Active	23353063	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	96.0	CHEMBL3234	Homo sapiens	% Control	%	96.0
Not Active	23353945	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23354413	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23355145	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23355613	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	94.0	CHEMBL3234	Homo sapiens	% Control	%	94.0
Not Active	23356249	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23356717	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23357326	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	88.0	CHEMBL3234	Homo sapiens	% Control	%	88.0
Not Active	23357973	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	98.0	CHEMBL3234	Homo sapiens	% Control	%	98.0
Not Active	23358441	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23359027	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	79.7	CHEMBL3234	Homo sapiens	% Control	%	79.7
Not Active	23359625	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	98.0	CHEMBL3234	Homo sapiens	% Control	%	98.0
Not Active	23360093	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	91.0	CHEMBL3234	Homo sapiens	% Control	%	91.0
Not Active	23360678	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	95.0	CHEMBL3234	Homo sapiens	% Control	%	95.0
Not Active	23361146	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23361719	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23362255	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23362723	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23364365	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	71.0	CHEMBL3234	Homo sapiens	% Control	%	71.0
Not Active	23364833	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	99.0	CHEMBL3234	Homo sapiens	% Control	%	99.0
Not Active	23365572	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23366115	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	87.0	CHEMBL3234	Homo sapiens	% Control	%	87.0
Not Active	23366705	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23367173	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23367591	CHEMBL4883944	HCK ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	98.0	CHEMBL3234	Homo sapiens	% Residual activity with Skepinone-L	%	98.0
Not Active	23368051	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	96.0	CHEMBL3234	Homo sapiens	% Control	%	96.0
Not Active	23368519	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23369118	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	91.0	CHEMBL3234	Homo sapiens	% Control	%	91.0
Not Active	23369586	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	80.0	CHEMBL3234	Homo sapiens	% Control	%	80.0
Not Active	23370086	CHEMBL4884330	Hck(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	88.0	CHEMBL3234	Homo sapiens	% residual kinase activity	%	88.0
Not Active	23370087	CHEMBL4884331	Hck(h) activated Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	109.0	CHEMBL3234	Homo sapiens	% residual kinase activity	%	109.0
Not Active	23370554	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23371022	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	66.0	CHEMBL3234	Homo sapiens	% Control	%	66.0
Not Active	23371831	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23372299	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
	23372758	CHEMBL4884723	HCK(HCK1LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL3234	Homo sapiens	pIC50		6.0
	23373167	CHEMBL4885014	HCK(HCK1LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL3234	Homo sapiens	pIC50		6.0
	23373528	CHEMBL4885305	HCK(HCK1LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL3234	Homo sapiens	pIC50		6.0
Not Active	23375265	CHEMBL4886247	hemopoietic cell kinase (activated) Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	-3.0	CHEMBL3234	Homo sapiens	% inhibition	%	-3.0
Not Active	23375266	CHEMBL4886248	hemopoietic cell kinase  Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	-2.0	CHEMBL3234	Homo sapiens	% inhibition	%	-2.0
Not Active	23375726	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23376194	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23376771	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	94.0	CHEMBL3234	Homo sapiens	% Control	%	94.0
Not Active	23377239	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	90.0	CHEMBL3234	Homo sapiens	% Control	%	90.0
Not Active	23378099	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	99.0	CHEMBL3234	Homo sapiens	% Control	%	99.0
Not Active	23378567	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23379734	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23380202	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23380896	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23381544	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23382012	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23382636	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23383104	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23383811	CHEMBL4887445	HCK Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	90.0	CHEMBL3234	Homo sapiens	% Ctrl	%	90.0
Not Active	23384294	CHEMBL4887889	Hck(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	0.45	CHEMBL3234	Homo sapiens	% inhibition	%	0.45
Not Active	23384295	CHEMBL4887890	Hck(h) activated Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	-6.21	CHEMBL3234	Homo sapiens	% inhibition	%	-6.21
Not Active	23385019	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
Not Active	23385486	CHEMBL4879743	KinomeScan assay: inhibition of HCK	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL3234	Homo sapiens	% Control	%	100.0
